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CHAPTER ONE 
GENERAL INTRODUCTION 
 
 
 
 
Justyna Sikorska  
   2 
 
 
The rich diversity of natural product chemical skeletons isolated from marine 
organisms, in parallel with their pronounced biological activity, clearly highlights the 
importance of natural products drug discovery. Marine organisms such as tunicates, 
sponges and mollusks have been a focus of work in many laboratories and have led to 
the discovery of compounds already approved as anticancer drugs or in clinical trials, 
e.g.  ecteinascidin  743  (Yondelis
®)  (Fayette  et  al.,  2006),  dehydrodidemnin  B 
(Aplidin
®) (Le Tourneau et al., 2007), KRN7000 (Alpha-GalCer
®) (Schneiders et al., 
2011). Therefore, extracts of a 2004 collection of sixty tunicates from Algoa Bay, 
South Africa were subjected to biological and chemical screening to identify potential 
new drug leads. To facilitate the process of isolation and identification of new and 
biologically active pure compounds, the prioritized extracts were further subjected to 
activity-guided fractionation supported by a dereplication approach. Dereplication of 
known and/or “nuisance” compounds was based on comparison of taxonomic, MS and 
NMR data for each active fraction or pure compound with information gathered in 
MarinLit, a database of the marine natural products literature. This screening process 
led to identification of three groups of biologically active natural products that are 
presented in chapters 2 – 4.  Due to the limited amounts of tunicate extracts in hand, 
most of the pure compounds were isolated in sub-milligram quantities. Therefore, the 
application  of  some  less  routine  and  more  recent  NMR  techniques  in  structure 
assignment was necessary, and demonstrates the extended scope of natural products 
isolation and elucidation to very limited quantities of pure metabolites.  
The following  chapters  present  details  of the  approach undertaken to  identify 
bioactive  natural  products  from  tunicates  through  application  of  activity-guided 
fractionation and modern NMR techniques, which are reviewed in the remainder of 
this  chapter  (Chapter  One).  Chapter  Two  describes  screening  of  the  sixty  South 
African  tunicate  extracts  for  cytotoxicity  to  brine  shrimp  and  Neuro-2A  mouse 
neuroblastoma  cells  and  antibacterial  activity  against  Staphylococcus  aureus  and 
Vibro cholerae. Also described in this chapter is the applicability of 
1H NMR and 
diffusion-ordered  spectroscopy  (DOSY)  to  chemical  screening,  as  well  as  the 3 
 
 
compounds  identified  in  this  process  (homarine,  rubrolides  and  previously  miss-
assigned nucleosides). 
Chapter  Three  lays  out  the  structural  assignment  and  preliminary  biological 
evaluation of mandelalides A-D, isolated from a new Lissoclinum species. The relative 
configuration  was  established  after  interpretation  of  homo-  and  hetero-nuclear 
coupling constants in parallel with ROESY analysis. The applicability of qROESY 
was  explored  to  assign  mandelalide  B  conformation.  Assignment  of  absolute 
configuration  was  accomplished  after  hydrolysis  of  the  monosaccharide  unit  of 
mandelalide A, its chiral GC-MS analysis and consideration of ROESY correlations 
between  monosaccharide  and  aglycone.  Evaluation  of  the  cytotoxic  properties  of 
mandelalides A and B revealed nanomolar activity against NCI-H460 human lung and 
Neuro-2A mouse neuroblastoma cell lines. 
Chapter  Four  presents  the  isolation  and  structure  elucidation  of  three  new 
pseudodistaminols A-C and three known amino alcohols isolated from Pseudodistoma 
sp. and Pseudodistoma digitum, respectively. The assignment of planar structure was 
accomplished after analysis of 1D and 2D NMR experiments, while determination of 
absolute configuration resulted from 
1H NMR chemical shift comparisons of S- and R-
Boc-phenylglycine (BPG) derivatives of the amino alcohols. Testing of S- and R-BPG 
amino alcohol derivatives against NCI-H460 and Neuro-2A cell lines indicated only 
mild  cytotoxic  properties,  in  contrast  to  the  potent  cytotoxicity  observed  for  the 
underivatized parent extract. 
The  final  conclusion  chapter  (Chapter  Five)  summarizes  the  outcomes  of  the 
projects described in chapters 2 - 4 and briefly discusses future work that could be 
based on these results. 
 4 
 
 
Progress and new approaches in NMR techniques applicable to natural products  
 
Since the time when the first nuclear magnetic resonance (NMR) spectra were 
acquired,  nuclear  magnetic  resonance  (NMR)  spectroscopy  has  become  a  central 
technique  for  molecular  structure  determination.  This  method  not  only  allows 
establishing number and type of nuclei in an organic molecule, but also characterizes 
their proximal environment and connectivity. Nowadays acquisition of a “standard” 
set of 1D and 2D NMR experiments: 
1H, 
13C, COSY, HSQC, HMBC, NOESY, on 
400-500 MHz spectrometers, in conjugation with high resolution mass spectrometric 
(HR-MS) data, is  a routine approach to  “small molecule” structure assignment on 
milligram and even microgram sample quantities.  
 Advances  in  NMR  techniques  have  enabled  structure  assignment  on  sub-
milligram  quantities  of  natural  products,  and  also  dereplication  and  isolation  of 
unstable  compounds.  In  the  early  days  of  natural  products  isolation  and  structure 
elucidation,  gram  quantities  of  compounds  were  necessary  to  assign  chemical 
structures  by  chemical  degradation  and/or  derivatization  (Murata  et  al.,  2006). 
However, since the 1970’s and 1980’s when 1D and 2D NMR techniques became 
more accessible and allowed for assignment of homo- and hetero-nuclear correlation, 
molecular structure assignment has become strongly rooted in NMR techniques (Bax 
& Summers, 1986; Murata, et al., 2006). Biologically active compounds are often 
minor constituents of organisms, and limited sample availability from many terrestrial 
and  marine  sources  puts  an  even  greater  demand  on  methodologies  that  facilitate 
structure determination. Even though the application of NMR enabled the assignment 
of very close to the correct structure for glycinoeclepin A at 2.2 μM in 1987, and 
ciguatoxin at 0.3 μM in 1990 (Figure 1.1), the unambiguous structure assignment of 
samples  at  low  nanomolar  concentrations  became  feasible  only  more  recently 
(Masamune  et  al.,  1987;  Molinski,  2010).  The  requisite  improvement  in  NMR 
sensitivity  has  been  achieved  by  the  use  of  smaller  probe  volumes  (microprobe 
diameters ranging from 1.0 to 1.7 mm), as well as the development of cryoprobes 5 
 
 
(probes with a built in signal preamplifier cooled to 20 K to decrease the level of 
thermal noise), increasing the signal to noise ratio even 10- to 20-fold and overall 
facilitating structure elucidation of samples in extremely limited quantities.  
 
One of the first nanomole-scale structure assignments was described for sperm-
activating and attracting factor (4 μg, 6 nmol) isolated from eggs of the ascidian Ciona 
intestinalis (Figure 1.2), (Oishi et al., 2004). The 
1H NMR and TOCSY data acquired 
at 500 MHz using a 1.7 mm probe, in tandem with MS-MS data, revealed a sulfated 
sterol  structure,  which  was  subsequently  confirmed  by  total  synthesis  of  the 
compound. 
 
Figure 1.2 Structure of sperm activating and attracting factor. 
Figure 1.1 Structures of ciguatoxin (top) and glycinoeclepin A (bottom). 6 
 
 
Several  cases  of  nanomolar  structure  elucidation  have  been  accomplished  in 
Molinski’s laboratory, where major and minor components of the extract from the 
sponge Phorbas sp. were identified (Dalisay & Molinski, 2009; Dalisay et al., 2009). 
While in 1995 phorboxazoles A and B were isolated in hundreds of milligrams, in 
2003 phorbazides A-E were identified from the same extract and their structures were 
assigned on 0.1-2.7 mg quantities using a 600 MHz spectrometer equipped with an 
inverse 5 mm cryoprobe (Figure 1.3), (Molinski, 2010). Subsequently, state-of-the-art 
structure elucidation was performed on a 600 MHz spectrometer equipped with a 1.7 
mm micro-cryoprobe for muironolide A (90 μg, 152 nmol) and hemi-phorboxazole A 
(16.5 μg, 28 nmol) (Figure 1.3), (Dalisay & Molinski, 2009; Dalisay, et al., 2009). In 
the case of hemi-phorboxazole A, a combination of nano-LC HR-MS data with the 
standard suite of 1D and 2D NMR experiments, measurement of  J couplings, and 
circular dichroism (CD) measurements permitted the final structure assignment. For 
muironolide  A  additional  microscale  degradation  was  necessary  to  determine  the 
stereochemistry of the trans-2-chlorocyclopropylketide element. Overall the examples 
of hemi-phorboxazole A and muironolide A illustrate the extended limits of structure 
assignment possible in natural products research.  
 
 
 
 
 
 
 
 
  Figure 1.3 Structures of phorbazide A, muironolide A and hemi-phorboxazole A 
(from left to right, respectively). 7 
 
 
Another challenge in natural products identification is the isolation and structure 
assignment  of  compounds  prone  to  degradation.  The  application  of  2D  NMR 
experiments to complex mixtures has been shown to be a way to directly determine 
structures  in  complex  organic  extracts.  The  very  interesting  case  of  unstable 
myrmicarin 430A was described by Schroeder et al, who assigned the structure of the 
active component in a mixture collected from the poison glands of African ants based 
on DQFCOSY data (Figure 1.4), (Schroeder et al., 1996).  
 
The DQFCOSY delineated three spin systems for myrmicarin 430A that were in 
turn connected based on HSQC and HMBC correlations, giving enough resolution to 
distinguish it from myrmicarins 215A, 215B and 217, also present in mixture.  
Structure elucidation of the active components (neurotoxic sulfated nucleosides) 
of spider venom directly from the complex mixture has also been described (Taggi et 
al., 2004). The unmodified venom sample was analyzed by DQFCOSY due to the 
much greater resolution of this experiment than for magnitude mode COSY, and the 
resultant  ease  of  measuring  coupling  constants  values. 
1H  NMR  confirmed  the 
presence of ribose anomeric protons, while DQFCOSY led to identification of bis-
sulfated  sugar  fragments  (Figure  1.5).  Due  to  significant  overlap  of  resonances, 
separation of the mixture was needed, however only mono-sulfated compounds were 
isolated  in  pure  form.  Knowing  that  the  bis-sulfated  form  degrades  under 
Figure 1.4 Chemical structures of myrmicarin 430A and sulfated guanosine 
derivatives respectively. 8 
 
 
chromatographic  separation  conditions,  the  authors  increased  the  pH  of  collected 
fractions and isolated the toxins as pyr-d5 salts. The example of sulfated guanosine 
derivatives illustrates the need for screening of natural product extracts not only for 
biological  properties  but  also  by  NMR,  to  help  with  identification  of  labile 
components.  Moreover,  this  methodology  can  facilitate  rapid  identification  or 
dereplication of secondary metabolites (Schroeder et al., 2008). 
 
The continual development of new NMR pulse programs and processing methods 
has  broadened  NMR  applications  to  the  identification  of  single  or  multiple 
Figure 1.5 a) 
1H NMR spectrum of unmodified  T. agrestis venom in D2O at 500 
MHz.  Arrows  indicate:  nucleoside  derivatives   in  red,  proteins   in  green,  and 
polyamines in blue; b) Partial DQFCOSY spectrum: dashed line black boxes 
indicate   cross-peaks of three sulfated ribonucleosides (SR1−SR3); green boxes 
are cross-peaks for polyamines and peptides. Reproduced with permission from 
Andrew E. Taggi et al., JACS, 2004, 126, 10364-10369. Copyright 2012 American 
Chemical Society. 
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components in complex mixtures. The simplest approach involves acquisition of 
1H 
NMR  spectra  for  many  crude  extracts  and  comparison  of  data  through  principle 
component  analysis  (PCA),  for  example,  to  identify  similarities  and  differences 
between analyzed samples, without the need for individual assignment of peaks (Ward 
et al., 2007). Food chemistry, drug authenticity and quality control are the main areas 
of utilization of this technique. However it can be also employed to monitor changes 
in secondary metabolite production of living organisms, or as a solution to the main 
problem of natural product chemists: dereplication of known metabolites. Despite the 
fact that 
1H NMR provides a very useful tool to screen for the presence or absence of 
desired  secondary  metabolites  in  extracts,  its  main  disadvantage  is  overlap  of 
component signals in mixtures. The answer to this problem is the application of 2D 
experiments in which the presence of a second dimension increases the resolution in 
acquired spectra, such as J-resolved, COSY, HSQC or DOSY experiments. Recently 
the application of diffusion ordered spectroscopy (DOSY), “in tube chromatography”, 
has  become  an  important  tool,  especially  for  metabolomic  fingerprinting  and 
unraveling  complex  mixtures  (Cassani  et  al.,  2012;  Politi  et  al.,  2009).  DOSY 
potentially allows extraction of important information directly from mixtures, without 
prior  time  consuming  separations,  and  can  facilitate  the  dereplication  of  known 
compounds.  This  method  enables  separation  of  components  based  on  molecular 
weight/shape, similar to size exclusion chromatography, and results in 2D spectra with 
chemical shift in the F1 and diffusion coefficient in the F2 dimension (Figure 1.6), 
(Huo et al., 2003). Compounds with higher molecular weights diffuse slower than low 
molecular  weight  molecules,  therefore  one  can  differentiate  between  mixture 
components which have sufficiently different molecular weights (Novoa-Carballal et 
al., 2011). The resulting spectrum is very useful because it “correlates” all protons 
within  one  molecule,  without  being  dependent  on  spin  system  correlations  (e.g. 
TOCSY),  so  allowing  one  to  identify  all  protons  for  the  compound  of  interest. 
However, despite its applicability DOSY is greatly under-appreciated in the natural 
products field, with only a few examples in the literature: monitoring of lovastatin 10 
 
 
production by Aspergillus terreus (Macías et al., 2010), identification of agesamides A 
and B (Rodrigues et al., 2009), and ﬂavonoid glycosides derived from quercetin in 
Bidens  sulfurea  and  saponins  in  Agave  brittoniana  leaves  (Macías  et  al.,  2010; 
Rodrigues et al., 2009; Tsuda et al., 2006).  
Recently the application of matrix-assisted DOSY was described, where sample 
was dissolved in a mixture of solvent and deuterated sodium dodecyl sulfate (matrix). 
This  modification  of  DOSY  technique  permits  even  more  effective  differentiation 
between compounds as closely related as flavone, fistein and (+)-catechin (Figure 1.7), 
(Cassani, et al., 2012). 
Figure 1.6 Partial DOSY spectrum for an extract fraction from the sponge Agelas 
sp. containing agesamides A and B. Reproduced with permission from Masashi 
Tsuda et al, Org. Lett., 2006, 8, 4235-4238. Copyright 2012 American Chemical 
Society. 
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1  2  3 
Figure 1.7 Chemical structures of flavone (1), fisetin (2) and (+)-catechin (3), 
upper  line.  DOSY  spectrum  before  and  after  addition  of  SDS  to  mixture  of 
flavone, fisetin and (+)-catechin. Modified with permission from Julia Cassani et 
al., JNP, 2012, 75, 131-134. Copyright 2012 American Chemical Society. 
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Application of NMR techniques to the assignment of relative configuration  
 
The spatial arrangement of functional groups in small molecules is very often 
correlated  with  the  presence  or  absence  of  biological  activity  and  toxicity, 
emphasizing  the  importance  of  the  correct  assignment  of  relative  and  absolute 
configuration to unambiguously determine mechanism of action of biologically active 
new compounds. NMR-based experiments are the most informative when it comes to 
the assignment of relative configuration of organic molecules, with Murata’s J-based 
method,  NOEs,  Kishi’s  chemical  shift  database,  acetonides  and  residual  dipolar 
couplings (RDS) being the complementary methods most commonly used.   
The  nuclear  Overhauser  effect  (NOE)  based  methods,  in  combination  with 
computational  molecular  modeling,  are  common  tools  for  relative  configuration 
assignment of macrocyclic compounds because the presence of NOE correlations is 
indicative  of  close  proximity  (up  to  5-6  Å)  of  two  nuclei  in  space  (Neuhaus  & 
Williamson,  2000).  The  most  recent  applications  of  NOE  for  rigid  molecules 
demonstrated that, in combination with molecular modeling, this technique is capable 
of  very  accurate  conformational  assignment  and  differentiation  between  otherwise 
indistinguishable structural candidates (Butts, Jones, Towers, et al., 2011; Chini et al., 
2011). In particular, when quantitative measurement of NOE distances is performed 
one can distinguish between as challenging stereochemical problems as identification 
of  the  correct  diastereoisomer  of  conicaterol  F  (Figure  1.8),  (Chini,  et  al.,  2011).  
Nevertheless, when interpretation of NOEs for a flexible molecule is attempted, very 
often the assignment of relative configuration is much more challenging due to the fact 
that the resulting NOEs are usually the average of the signals from several lowest 
energy conformers present in solution (Butts, Jones, & Harvey, 2011).  
Murata’s method (J-based configuration analysis, JBCA) can be used to confirm 
stereochemistry  assigned  based  on  NOE  correlations.  The  analysis  of  homo-  and 
hetero-nuclear coupling constants can provide information about relative orientation of 13 
 
 
two nuclei separated by 1, 2 or 3 bonds, due to coupling constant dependence on 
dihedral angle values (Figure 1.9), (Matsumori et al., 1999). The most frequently used 
coupling constants are 
3JHH, easily measured from 
1H NMR, or DQFCOSY if close 
overlap is  observed  in  the 
1H spectrum  (Hoye  et  al.,  1994; Hoye &  Zhao, 2002). 
However, if the information obtained from 
3JHH, is insufficient, the heteronuclear 
2JCH 
and 
3JCH coupling constants are analyzed to obtain supporting information about the 
spatial arrangement of substituents around the analyzed bond (Figure 1.9), (Bifulco, et 
al., 2007; Riccio et al., 2003). 
 
Figure 1.8 Fit of DFT-calculated interproton distances to experimental values from 
1D-ROESY experiments for both diastereoisomers of conicaterol F. The fit for the 
lower  graph  is  clearly  better,  indicating  that  the  second  diastereoisomer  is  the 
correct one. 
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The different experiments have been designed to allow measurement of 
2JCH and 
3JCH  values,  with  the  main  difference  between  them  being  the  ability  to  acquire 
coupling  constants  around  quaternary  centers.    Among  these  experiments  are  the 
phase-sensitive  HMBC,  hetero  half-filtered  TOCSY  (HETLOC),  HSQMBC  or 
selHSQMBC-TOCSY (Kurz et al., 1991; Marquez et al., 2001; Saurí, et al., 2012).  
The HETLOC is the most commonly used technique for natural products due to 
its simplicity in data interpretation and ability to identify not only the size but also the 
magnitude  of  coupling  constants  (Fukushi,  2006).  The  main  drawback  of  this 
experiment  is  that  each  carbon  must  have  at  least  one  proton  attached,  i.e. 
heteronuclear coupling constants can only be obtained for atoms within a spin system 
(comprising  TOCSY-correlated  protons).  The  2D  spectrum  resulting  from  the 
HETLOC  experiment  has 
1H  chemical  shift  information  in  both  F1  and  F2 
dimensions, where for each signal a 
1H chemical shift in F1 represents the carbon 
correlated to the proton indicated in the F2 dimension. All of the resulting correlations 
are split in the F1 dimension by the 
1JCH value, while the displacement of cross peaks 
3JHH large (9 to 12 Hz) 
 
2JCH large (-4 to -7 Hz) 
 
3JCH large (5 to 8 Hz) 
 
3JHH small (0 to 4 Hz) 
 
2JCH small (2 to -2 Hz) 
 
3JCH small (1 to 3 Hz) 
 
Figure 1.9 Relationships between dihedral angles and coupling constant values for 
3JHH, 
2JCH and 
3JCH. 15 
 
 
within  a  correlation  in  the  F2  dimension  is  equal  to  the 
nJCH  value  between  the 
analyzed nuclei (Figure 1.10a).  
The selHSQMBC-TOCSY is the most recent method created for the analysis of 
long range couplings in systems containing quaternary chiral centers  (Saurí, et al., 
Figure 1.10 a) Partial HETLOC spectrum with correlations responsible for peak 
splitting in the F1 and F2 dimensions indicated on the spectrum together with partial 
structure.  b)  The  partial  ʱ/β-selHSQMBC-TOCSY  spectrum  for  progesterone 
showing correlations (indicated on the partial structure) that are responsible for peak 
splitting in the F2 dimension. Figures modified with permission from John Wiley 
and Sons and ACS (Bifulco et al., 2007; Saurí et al., 2012). 
 
responsible for 
splitting in F1  
responsible for 
splitting in F2 
responsible for 
splitting in F2  
a) 
b) 16 
 
 
2012). This experiment enables measurement of the magnitude and sign of coupling 
constants  by  analysis  of  peak  displacement  in  the  F2  dimension  (analogous  to 
HETLOC).  However,  in  contrast  to  HETLOC, 
13C  values  are  observed  in  the  F1 
dimension. Determination of the sign for 
nJCH values requires prior knowledge of any 
peak in the analyzed row that resulted from a three bond coupling constant (always 
positive) and assignment of positive 
nJCH to peaks with the same displacement pattern, 
while  negative 
nJCH  are  assigned  to  peaks  with  the  opposite  displacement  pattern 
(Figure 1.10b).  
As described previously the determination of relative stereochemistry by NMR 
spectroscopy is usually accomplished using a combination of scalar J couplings and 
NOE  measurements  (Tringali,  2001).  However,  when  methods  using  isotropic 
solvents  are  insufficient  to  solve  ambiguities  in  relative  configuration  of  natural 
products,  measurement  of  residual  dipolar  couplings  (RDCs)  is  another  source  of 
structural information (Thiele, 2008). RDCs are through space interactions between 
two nuclei, the size  of  which  depends on the  distance as  well as  direction of  the 
internuclear vector with respect to an external point of reference (Gschwind, 2005). 
Measurement of RDC values in anisotropic solution is used to determine how these 
vectors are aligned relative to a magnetic field, and therefore how they are aligned 
relative to each other. In isotropic solution the values of RDCs average to zero due to 
isotropic tumbling, therefore it is necessary to orient the compound with respect to the 
external  magnetic  field  (B0)  by  use  of  alignment  media  (Marx  et  al.,  2010). 
Measurement  of  RDCs  is  performed  by  acquisition  and  comparison  of  data  in 
isotropic and anisotropic solution, and  is  based on the fact  that  the total  coupling 
constant (T) is the sum of dipolar (D) and scalar (J) coupling constants (Luy et al., 
2004; Thiele & Berger, 2003). In isotropic solution D is averaged to zero and T = J. In 
anisotropic solution, D has positive or negative values different from zero. This allows 
for simple measurement of a D value from two data sets by subtraction (Figure 1.11). 
The experiments commonly used for determination of 
1DCH are: gated decoupled 
13C, 
F1-coupled HSQC and F2-coupled HSQC (Thiele, 2004; Thiele & Berger, 2003). To 17 
 
 
assign 
nDCH and 
nDHH one can use HETLOC and E.COSY pulse sequences (Marquez, 
et al., 2001; Thiele, 2008; Uhrín et al., 1998). 
 
 
 
The applicability of this method for the assignment of diastereotopic groups as 
well as relative configuration has been proven for rigid [e.g. menthol (Verdier et al., 
2003), ludartin (Gil  et  al.,  2008)] and  flexible [e.g. sagittamide A (Schuetz et  al., 
2007),  and  archazolide  A  (Farès  et  al.,  2008)]  compounds.  Sagittamide  A  is  an 
example of a natural product for which two different relative configurations have been 
proposed. The first was based on a combination of J-couplings, NOEs and Kishi’s 
database  of 
13C  chemical  shifts  (Figure  1.12a),  (Lievens  &  Molinski,  2006).  The 
second was based on J-couplings, synthesis of two stereoisomers and comparison of 
1H chemical shifts in the acetate region (Figure 1.12b), (Seike et al., 2006b). Final 
confirmation  of  relative  configuration  came  from  a  separate  study  based  on  J 
couplings and RDC analysis (Schuetz, et al., 2007). The interpretation of 
3JHH, 
2JCH, 
J 
T = 2D + J 
Figure 1.11 Partial (0 to 60 ppm) 
13C NMR gated decoupled spectra (175 MHz) 
for  strychnine:  isotropic  solution  of  strychnine  in  CDCl 3  (top);  anisotropic 
solution of strychnine in poly benzyl-L-glutamate (PBLG) /CDCl3 (bottom).  18 
 
 
and 
3JCH coupling constants for the bonds C-4 to C-10 led to identification of four 
potential configurations (Figure 1.12a, c-e). Knowing that RDCs can yield information 
complementary to that obtained from J-couplings and NOEs, the values of 
1DCH for 
sagittamide A were measured in two different alignment media.  Experimental values 
were used to predict the alignment tensor and to back-calculate RDCs. Comparison of 
RDCs calculated for all structural models and experimental values of RDCs indicated 
that the configuration  previously  proposed by  Lievens  and  shown in  Figure  1.12a 
gives the best fit and the remaining configurations were rejected. 
 
For polyols, the application of coupling constant values, NOEs and RDCs may 
not be conclusive. If the analyzed parameters for the polyol of interest are independent 
of  the  rest  of  the  molecule,  and  the  nearest  steric  interactions  are  at  least  two 
methylene bridges away, one can also use differences in chemical shift values for the 
assignment of relative configuration (Higashibayashi et al., 2003). The first approach 
to utilize 
13C NMR shift variations and create a common 
13C NMR shift database has 
been described by Kishi and used to assign configuration of the C-5/C-10 fragment of 
oasomycin (Kobayashi et al., 1999). Further research indicated the applicability of 
1H 
NMR, 
1H  (OH)  NMR  and  especially 
3JHH  coupling  constant  values  as  relative 
configuration  profile  descriptors  (Higashibayashi,  et  al.,  2003).  The  standard 
Figure 1.12 a) Chemical structure of sagittamide A as proposed by Lievens and 
confirmed by analysis of RDCs, b) Configuration of C4/C10 fragment proposed by 
Seike, c –e) Configurations proposed for sagittamide A by Schuetz. 
a)  b) 
c)  d)  e) 19 
 
 
procedure  for 
13C  NMR  shift  database  utilization  involves:  a)  identification  of  a 
representative fragment, b) synthesis of all possible diastereoisomers, c) measurement 
of 
13C NMR shift values for each synthesized fragment, d) assembly of 
13C NMR shift 
profiles by calculating the deviation (Δδ) from the average chemical shift for each 
nucleus in a natural product fragment and all standards to establish the best fit for the 
natural product. In the case of 1,2,3-triols, 1,3,5-triols, 1,2,3,4-tetraols and 1,2,3,4,5-
pentaols one can avoid synthesis of standards by using previously published 
13C NMR 
shift  values  (Higashibayashi,  et  al.,  2003;  Kobayashi  et  al.,  2000).  A  similar 
methodology should be applied if one wants to analyze 
3JHH coupling constants values. 
However, here the direct comparison of 
3JHH values (no calculation of Δδ values) is 
used and, if all of the parameters were previously published, the synthesis step can be 
excluded (Seike et al., 2006a). 
One of the most recent examples of Kishi’s chemical shift database application 
was assignment of the relative configuration of the polyoxy compound prorocentrol 
(Figure 1.13), (Sugahara et al., 2011). An extensive analysis of J-couplings in parallel 
with NOE correlations was performed for the whole compound. However, assignment 
of 
2,3JCH values for the C-52/C-54 and C-18/C-21 fragments proved impossible and 
prevented assignment of the relative configuration of prorocentrol. Comparisons of 
3JHH values for prorocentrol with those for 1,2,3-triol and 1,2,3,4-tetraol diastereomers 
in the database allowed assignment of the relative configuration of challenging motifs 
as indicated in Figure 1.13. 20 
 
 
 
Assignment of the relative configuration of 1,3-diols can be accomplished after 
their conversion to syn- and anti-1,3-diol acetonides (Rychnovsky et al., 1998). This 
method is based on a comparison of 
13C chemical shifts for acetal methyl groups in 
syn-  and  anti-  acetonides,  which  adopt  chair  and  twist-boat  conformations 
respectively. In the case of the syn acetonide, one of the methyl groups is oriented 
axial and the other is equatorial, resulting in chemical shifts values of ~20 ppm and 
~30 ppm, respectively. However, in the anti acetonide both methyl groups are in very 
similar environments and have chemical shifts ~25 ppm (Figure 1.14), (Rychnovsky, 
et al., 1998). Additionally, comparison of hemiketal C-2 chemical shifts can be used as 
additional  confirmation  of  relative  configuration  because 
13C  chemical  shifts  are 
localized more upfield for syn acetonides than for anti acetonides (Evans et al., 1990).  
One  of  the  more  challenging  structural  assignments  using  the 
13C  acetonide 
method was described for marinisporolide A (Figure 1.15), (Kwon et al., 2008). The 
planar  structure  was  determined  by  use  of  a  full  complement  of  1D  and  2D 
experiments, while to assign the relative configuration of the C-25/C-33 fragment, a 
Figure 1.13 Chemical structure of prorocentrol with measured and standard 
3J HH 
values indicated.  21 
 
 
comparison of chemical shifts to the Kishi Universal NMR database was utilized in 
parallel with conversion to the corresponding acetonides.  
 
   
Figure 1.14 Schematic representation of changes in chemical shift values for 
syn- and anti- acetonides (top and bottom respectively). 
Figure 1.15 Chemical structure of the acetonide derivative of marinisporolide A.  22 
 
 
Application of NMR techniques to the assignment of absolute configuration  
 
A majority of natural products are isolated as enantiomerically pure compounds, 
with at least one chiral center present in the molecule (Kusumi & Ohtani, 1999). Very 
often only the identified enantiomer is responsible for biological activity. In order to 
provide  larger  quantities  of  compounds  by  synthetic  or  semisynthetic  means,  the 
correct absolute configuration of the isolated compound has to be established. The 
main  methods  applicable  to  the  assignment  of  absolute  configuration  are  X-ray 
crystallography, chiral analytical methods, circular dichroism (CD), optical rotation 
and  NMR.  Since  the  nature  of  natural  products  very  often  prevents  good  quality 
crystals from being obtained, and CD, optical rotation and chiral separation all require 
standards for analysis, NMR-based methods are commonly used as an alternative. 
The assignment of absolute configuration by NMR can be accomplished with the 
use of chiral solvating agents (CSA) and chiral derivatizing agents (CDA) (Wenzel, 
2007). While CSA are used for enantiomeric discrimination, CDA  are utilized for 
determination of absolute configuration. The Mosher method (or modified Mosher 
method) is based on derivatization of a compound containing an alcohol, amine, or 
carboxylic group with each enantiomer of the Mosher reagent (a CDA) separately, and 
comparison  of  the  NMR  data  for  the  resulting  diastereomeric  natural  product 
derivatives  (Kusumi  &  Ohtani,  1999).  The  derivatization  reagents  comprise  a 
functional  group  to  couple  to  the  analyzed  molecule,  a  bulky  group  to  prevent 
conformational freedom after binding to the analyzed compound, and a substituent 
(often aromatic) that is able to induce a strong anisotropic effect (Seco et al., 2004). 
After derivatization, the diastereomer in which specific substituents are shielded by 
the  aromatic  group  of  the  CDA  will  exhibit  upfield  chemical  shifts  for  those 
substituents relative to the same substituents in the second diastereoisomer (Figure 
1.16a), (Seco, et al., 2004). This change in chemical shift values, due to the shielding 
effect of the aromatic group, is commonly represented as a Δδ value, calculated for 
MTPA (methoxytrifluoromethylphenylacetic acid) esters as Δδ = δS – δR or Δδ = δR – 23 
 
 
δS, while for MPA and other esters as Δδ = δR – δS, unless stated otherwise (Latypov et 
al., 1996; Ohtani et al., 1991). To establish the absolute configuration, values of Δδ 
should be localized on the structure, and based on their arrangement the configuration 
can be concluded (Figure 1.16b).  
 
 The  first  application  of  the  Mosher  method  was  described  in  1973  when 
Mosher’s group observed that the changes in 
19F and 
1H NMR chemical shifts for 
alcohols  and  amines  derivatized  with  MTPA  can  be  correlated  to  their  absolute 
configuration (Dale & Mosher, 1973; Sullivan et al., 1973). Since then many new 
derivatizing  reagents  for  natural  product  and  synthetic  compounds  have  been 
developed, with the most commonly used being: 
Figure 1.16 a) A schematic representation of the application of the Mosher method 
for  (R)-2-pentanol;  b)  Structure  of  (R)-2-pentanol  with  ΔδRS  values indicated. 
Modified with permission from Jose M. Seco et al., Chem. Rev., 2004, 104, 17-117. 
Copyright 2012 American Chemical Society. 
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a)  For  secondary  alcohols:  MTPA,  MPA,  AMAs  (arylmethoxyacetic  acids), 
glycosides and chiral silylating reagents (ʱ-[trifluoromethyl]-phenol), see Figure 
1.17a (Dale & Mosher, 1973; J. M Seco et al., 1997; Seo et al., 1978; Weibel et 
al., 2000; Williamson et al., 2003). 
b)  For primary alcohols: MTPA, 9-AMA (Latypov, Ferreiro, et al., 1998; Tsuda et 
al., 2003). 
c)  For polyalcohols: MTPA, MPA, AMMAs (Freire et al., 2005; Freire et al., 2010; 
Seco et al., 2000). 
d)  For  primary  amines:  MTPA,  MPA,  BPG  (Boc-phenylglycine),  2-NPP  (N-[2-
nitrophenyl]proline),  CFTA  (ʱ-cyano-ʱ-fluoro-phenylacetic  acid),  chiral 
carbonate reagent-5, see Figure 1.17b (Ahn & Choi, 2007; Latypov et al., 1995; J. 
M. Seco et al., 1997; Seco et al., 1999; Takeuchi et al., 2006). 
e)  For secondary amines: MTPA, MPA  (Gao et al., 2008; Hoye & Renner, 1996a, 
1996b). 
f)  For amino alcohols: MPA (Leiro et al., 2005). 
g)  For  carboxylic  acids:  PGME,  arylethylamines  (e.g.  1-phenylethylenamine), 
BINOL-borates, see Figure 1.17c (Freire et al., 2008; Hoye et al., 2000; Hoye & 
Koltun, 1998; Yabuuchi & Kusumi, 2000).  
The  most  recent  applications  of  the  Mosher  method  involve  a  significant 
improvement in efficiency of the methodology. Instead of the previously described 
double derivatization method with each enantiomer, one can perform derivatization 
with  only  one  enantiomer  of  the  CDA  and  compare  spectra  acquired  at  different 
temperatures (MPA esters), or before and after addition of a chelating reagent (MPA 
esters and amides). The latter approach can conserve limited natural product sample 
quantities while still enabling an assignment of absolute configuration provided that 
the changes in chemical shifts are large enough (García et al., 2002; Latypov, Seco, et 
al., 1998; López et al., 1999). 
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Figure  1.17  The  derivatizing  reagents  used  for  assignment  of  absolute 
configuration of a) alcohols, b) amines, c) acids. 
a) 
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Abstract 
 
The diversity and structural complexity of natural products has been central to the 
development  of  new  pharmaceutical  drug  leads  due  to  a  concomitantly  broader 
spectrum of biological activities than is found for traditional combinatorial libraries. 
Therefore, the secondary metabolites of a collection of sixty tunicate extracts were 
explored through in vitro biological screening against cancer cell lines  and Gram-
positive and -negative bacteria, as well as chemical screening using 
1H and diffusion 
ordered  NMR  spectroscopy  together  with  mass  spectrometry.  Chemical  profiling 
identified the known homarine (1) in several extracts, the moderately antibacterial new 
rubrolide analogues 2-5 and known rubrolides E and F (6 and 7) from a Synoicum 
tunicate species, and previously mis-assigned nucleosides (8-11) from an Antarctic 
tunicate, which are discussed in this chapter. Biological profiling led to the discovery 
of the potent cytotoxins mandelalides A-D (Chapter 3) and pseudodistaminols A-C, 
(2S)-amino-  (3S)-hydroxy-(5E)-tetradecene,  (2S)-amino-(3S)-hydroxy-(5E),13-
tetradecadiene and (1R)-aminotridec-(4E)-en-2-ol (amino alcohols, Chapter 4). 
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Introduction 
 
The identification of new pharmaceutical drug leads is a challenging task, often 
requiring  elaborate  testing  of  libraries  comprising  hundreds  of  thousands  of  pure 
compounds and/or extracts.  Although pharmaceutical companies shifted their focus in 
the  1990’s  to  creation  of  combinatorial  libraries  of  synthetic  compounds,  natural 
product  and  natural  product-derived  drugs  still  constitute  approximately  40%  of 
commercially available drugs (Newman & Cragg, 2012). This may be due to the fact 
that pharmaceutical companies “End up making things they can make, rather than 
what they should make.” C. Decicco (Landers, 2004). Biologically relevant chemical 
space is much smaller than the total chemical space, and the large synthetic chemical 
libraries often do not represent the broad diversity of much smaller libraries of natural 
products, which are complementary with biological structure space (Dobson, 2004). 
The importance of further exploring the diverse chemical space occupied by marine 
and terrestrial natural products is suggested by the parallel in reduced focus on natural 
products discovery and decrease in the number of new molecular entities approved by 
the FDA over the last 20 years (Johnson et al., 2011). This trend again suggests that 
the  discovery  of  new  drugs  should  not  rely  strictly  on  large  synthetic  libraries  of 
compounds that generally have less oxygen and more nitrogen atoms, fewer chiral 
centers and fused rings, and more aromatic rings and rotatable bonds than the more 
rigid and non-planar natural products (Lachance et al., 2012). 
The search for new biologically-relevant chemical entities can be based on two 
complementary  approaches:  biological  and  chemical  screening.    The  advantage  of 
biological evaluation of organic extracts is that it allows for targeted identification of 
active components by activity-guided fractionation. However, to obtain promising hits 
one has to subject crude extracts to a broad spectrum of biological assays. A major 
pitfall of this method is that the active components of extracts are often very minor 
constituents and assays may not be sensitive enough to detect them at low titers in 
these complex mixtures. Also, assay detection systems can be impeded by the UV 36 
 
 
absorbance of a colorful extract, for example, or otherwise “nuisance compounds”. 
Finally, in the case of compounds that should be orally bioavailable (e.g. antibiotics), 
Lipinski’s rule of five parameters is often not taken into account. Chemical screening 
approaches require the use of LC-MS, LC-UV or NMR methodologies to identify 
compounds that are in the “druggable” mass range (< 500 for oral bioavailability), 
have  log  P  <  5  (  P  =  partition  coefficient,  a  measure  of  solubility),  and  possess 
interesting  structural  features.  This  methodology  often  requires  prior  steps  of 
purification  (LC-based  techniques)  or  a  substantial  amount  of  the  compound  of 
interest present in the mixture (NMR techniques). In addition, one does not directly 
account for the presence or absence of activity in the fractions or extracts obtained, but 
instead one uses this method to produce a library of sub-fractions for further testing.   
The combination of both approaches (biological and chemical screening) can lead 
to the identification of compounds that are not only very potent in currently available 
assays, but are also new chemical skeletons that may finally have unique activities 
against new drug targets. Therefore, all 60 tunicate extracts obtained from the South 
African 2004 collection (Algoa Bay, Eastern Cape) were subjected to biological and 
chemical screening. Chemical screening identified known cytotoxin homarine (1), the 
moderately antibacterial new rubrolide analogues 2-5 and known rubrolides E and F (6 
and 7) from a Synoicum species. In addition nucleosides (8-11), of which 8 had been 
previously mis-assigned twice as different new natural products, were identified from 
an Antarctic tunicate. 
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Results and Discussion 
 
A library of sixty organic extracts from tunicates collected in Algoa Bay, South 
Africa (2004) was subjected to biological screening in a brine shrimp cytotoxicity 
assay at a concentration of 100 μg/mL, against the mouse Neuro-2A neuroblastoma 
cell  line  at  30  μg/mL  and  against  Vibrio  cholerae  (N16961,  N0395)  and 
Staphylococcus aureus at 120 μg/mL (Table 2.1).  
The brine shrimp assay identified twelve extracts (Table 2.1) as containing potent 
cytotoxins,  with  extract  SAF04-29  additionally  active  against  Neuro-2A  cells,  and 
extracts  SAF04-40  and  -48  also  active  in  antibacterial  assays.  Bioassay-guided 
fractionation of extract SAF04-53 from a Pseudodistoma species led to isolation of 
linear and cyclized amino alcohols, the identification of which is described in detail in 
chapter 4.  Taxonomy data indicated that extracts SAF-20, -21, -25, -27, -40, -46, -47, 
-48 and -53 are from different species of the genus Pseudodistoma, suggesting the 
presence of amino alcohols in these extracts as well.  
Extract SAF04-29 from a Clavelina species was the only extract that showed 
potent cytotoxicity to brine shrimp and Neuro-2A cells. However, further fractionation 
and  extensive  HPLC  separation  based  on  UV  absorption  resulted  in  cytotoxicity 
distributed  through  all  fractions  and  hindered  identification  of  any  single  active 
component. In another case, extract SAF04-45 showed good cytotoxicity to Neuro-2A 
cells, but a limited amount of extract in parallel with challenging chromatography 
prevented  the  isolation  of  any  active  compounds.  The  application  of  biological 
activity-guided fractionation to extract SAF04-55 from Lissoclinum sp., also active 
against Neuro-2A cells, led to identification of the potent cytotoxins mandelalides A-
D, which are presented in chapter 3. 
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Table 2.1 Biological activity of organic extracts from South African tunicates. 
Extract # 
% cell viability 
Brine shrimp 
assay 
Neuro-2A cell 
line 
Vibrio 
cholerae 
(N16961) 
Vibrio 
cholerae 
(N0395) 
Staphylococcus 
aureus 
SAF04-10  -  97.2  124.7  106.7  118.4 
SAF04-11  -  84.1  129.3  117.4  118.4 
SAF04-12  -  91.9  114.7  90.8  98.2 
SAF04-13  -  92.5  105.7  130.1  116.5 
SAF04-14  -  85.6  119.1  129.4  114.3 
SAF04-15  -  90.3  125.4  156.5  116.0 
SAF04-16  -  99.6  119.2  123.9  99.4 
SAF04-17  -  91.6  125.9  154.3  128.1 
SAF04-18  -  82.5  115.9  125.8  116.1 
SAF04-19  -  80.9  125.3  121.6  112.8 
SAF04-20  0  84.9  120.0  111.2  118.2 
SAF04-21  5  80.0  103.1  132.2  127.9 
SAF04-22  100  85.7  141.9  132.0  115.5 
SAF04-24  100  79.2  99.5  131.5  113.3 
SAF04-25  0  81.1  117.7  132.9  108.1 
SAF04-26  100  80.3  125.8  105.7  105.0 
SAF04-27  0  82.9  126.3  118.7  125.0 
SAF04-28  100  90.6  107.8  116.7  121.0 
SAF04-29  0  40.6  105.3  119.1  130.5 
SAF04-30  100  90.4  128.5  105.1  108.2 
SAF04-31  100  94.1  140.0  121.5  109.6 
SAF04-32  100  92.4  136.0  131.6  117.7 
SAF04-33  100  93.5  117.9  124.6  116.5 
SAF04-34  100  91.6  122.6  100.7  110.2 
SAF04-35  100  90.3  118.4  117.9  114.2 
SAF04-36  100  80.3  123.9  124.7  120.9 
SAF04-37  100  94.7  118.9  97.0  110.2 
SAF04-38  100  80.9  96.2  93.9  84.7 
SAF04-39  100  87.0  133.8  108.3  118.6 
SAF04-40  0  80.9  49.2  51.9  110.4 
SAF04-41  100  95.1  127.3  127.1  118.2 
SAF04-42  100  98.1  126.3  151.1  132.8 
SAF04-44  100  97.7  126.3  112.6  114.4 
SAF04-45  100  62.3  108.1  139.4  97.4 
SAF04-46  0  81.7  134.9  135.4  98.2 
SAF04-47  0  79.5  125.9  134.9  104.6 
SAF04-48  0  74.2  49.8  26.3  101.5 
SAF04-49  100  98.2  114.6  125.5  116.8 
SAF04-50  100  85.9  126.3  96.9  112.6 
SAF04-51  100  100.9  133.4  96.1  108.0 
SAF04-52  100  81.6  113.1  100.5  114.1 
SAF04-53  0  75.9  91.6  96.6  105.6 
SAF04-54  100  98.2  61.8  95.9  65.8 
SAF04-55  100  30.9  133.8  107.9  108.6 
SAF04-56  100  81.6  119.8  145.7  111.2 
SAF04-57  100  98.1  125.9  101.7  116.8 39 
 
 
Table 2.1 (continued) Biological activity of organic extracts from South African 
tunicates. 
Extract # 
% cell viability 
Brine shrimp 
assay 
Neuro-2A cell 
line 
Vibrio 
cholerae 
(N16961) 
Vibrio 
cholerae 
(N0395) 
Staphylococcus 
aureus 
SAF04-58  100  76.9  99.5  93.7  125.6 
SAF04-59  100  87.5  115.2  131.3  144.4 
SAF04-60  25  72.6  117.4  128.6  132.0 
SAF04-61  100  74.6  121.2  111.7  111.9 
SAF04-62  0  75.0  118.0  92.6  116.7 
SAF04-63  100  75.7  123.9  94.1  116.7 
SAF04-64  100  79.0  102.7  121.7  120.2 
SAF04-65  100  84.8  107.1  126.6  123.3 
SAF04-66  100  77.7  120.2  98.8  111.9 
SAF04-67  100  79.9  121.4  102.3  120.3 
SAF04-68  100  95.1  117.3  108.9  125.3 
SAF04-69  100  78.8  107.4  109.3  99.1 
SAF04-70  100  81.5  119.1  117.1  114.3 
SAF04-71  100  96.7  128.3  102.6  110.9 
SAF04-72  100  79.4  103.2  102.2  109.2 
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Analysis of the antibacterial properties of the tunicate extract library identified 
SAF04-40  and  SAF04-48  as  antibacterial  against  both  strains  of  Vibrio  cholerae, 
while SAF04-54 was active against V. cholerae (N16961) and S. aureus. Additionally, 
extract SAF04-54 was also prioritized during chemical screening, as described below. 
From the remaining pool of South African tunicate extracts not active against 
Neuro-2A cells, 17 were randomly selected for chemical screening, together with two 
Antarctic tunicate extracts: SAF04-16, SAF04-19, SAF04-31, SAF04-38, SAF04-44, 
SAF04-51,  SAF04-54,  SAF04-56,  SAF04-57,  SAF04-59,  SAF04-60,  SAF04-61, 
SAF04-62, SAF04-65, SAF04-67, SAF04-68,  SAF04-71 and ARC-11-01, ARC-11-
02. 
1H NMR was used to prioritize fractionation and subsequent biological testing of 
the  first-tier  fractions  (Figure  2.1).  Among  these  selected  extracts,  SAF04-59  was 
fractionated using Sephadex LH-20,followed by C18 reversed phase (RP18) solid phase 
extraction  (SPE). 
1H NMR of the extract and SPE fractions revealed chemical shifts 
localized  at  7.5  –  9.2  ppm  in  the  50%  MeOH–H2O  SPE  fraction  (SAF04-59D1). 
Further  separation  by  RP18  HPLC  yielded  homarine  (1,  Figure  2.2).  Interestingly, 
fractionation  of  extract  SAF04-56  also  resulted  in  the  isolation  of  1,  and  its 
characteristic d-t-d-t 
1H chemical shift pattern was also visible in SAF04-68 (Figure 
2.3). 
To  avoid  further  isolation  of  homarine  2D  DOSY  NMR  analysis  of  extracts 
SAF04-16, -19, -44, -54, -57, -61 and -65 was performed prior to fractionation (Figure 
2.4). Extract SAF04-54 was prioritized for further screening due to the presence of 
components with downfield chemical shifts correlated to midfield chemical shifts. The 
fractionation  by  RP18-SPE  followed  by  LC-MS  analysis  of  the  75%  MeOH-H2O 
fraction  indicated  an  isotope  distribution  pattern  characteristic 
of brominated compounds. Successive  RP18-HPLC  led  to the  isolation  of  four  new 
rubrolides 2-5 (Figure 2.5) as well as the known rubrolides E (6) and F (7).  
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Figure 2.1 
1H NMR spectra at 300 MHz for extracts SAF04-54, -16, -59 and -57 (left 
from top to bottom), and for SAF04-60, -44, -71 and -65 (right from top to bottom). 
 
SAF04-54  SAF04-60 
SAF04-16  SAF04-44 
SAF04-59  SAF04-71 
SAF04-57  SAF04-65 42 
 
 
 
Figure 2.2 
1H (700 MHz) and 
13C (175 MHz) NMR spectra for homarine (1). 
 
Homarine 43 
 
 
 
Figure 2.3 
1H NMR spectrum at 300 MHz for SAF04-56 (upper) and SAF04-68 
(lower). 
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Figure 2.4 2D DOSY spectra at 300 MHz for SAF04-65 and SAF04-54 (left 
upper and lower, respectively), and SAF04-57 and SAF04-44 (right upper and 
lower, respectively). 
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Rubrolides  comprise  a  central  furanone  ring  substituted  at  C-4  and  C-5  with 
phenolic moieties. The phenolic moieties are differentially halogenated in the known 
rubrolides A-O. However, among them only rubrolide F is selectively methylated at 
C-4  (Miao  &  Andersen,  1991;  Ortega  et  al.,  2000;  A.  N.  Pearce  et  al.,  2006). 
Attempts  to  synthesize  new,  more  potent  antimicrobials  resulted  in  a  suite  of 
analogues  having  one  or  two  phenolic  moieties  with  varying  halogenation  and 
hydroxy group methylation (Bellina et al., 2003; Bellina et al., 2001). The biological 
activities  of  the  known  rubrolide  natural  products  and  their  synthetic  analogues 
include antibacterial activity against Staph. aureus and Bacillus subtilis (rubrolides A, 
B, C) (Miao & Andersen, 1991), selective inhibition of protein phosphatases 1 and 2A 
(Miao & Andersen, 1991), weak to moderate activity against various cancer cell lines 
(rubrolides I, K, L, M) (Ortega, et al., 2000), inhibition of human aldose reductase 
(rubrolide  L)  (Manzanaro et  al.,  2006),  and moderate  anti-inflammatory properties 
(rubrolide  O)  (A.  Norrie  Pearce  et  al.,  2006).  Interestingly,  a  synthetic  series  of 
analogues in which the furanone is substituted with an aryl group comprises potent 
inhibitors  of  bacterial  cell  wall  biosynthesis,  which  have  been  patented  for  their 
potential antimicrobial applications (Caufield et al., 2009).  
Figure 2.5 Chemical structures of new rubrolides 2-5 and known rubrolides E (6) and 
F (7). 
 
2: R1 = H, R2 = Br, R3 = Me 
3: R1 = Br, R2 = H, R3 = H 
4: R1 = Br, R2 = H, R3 = Me 
5: R1 = Br, R2 = Br, R3 = H 
6: R1 = H, R2 = H, R3 = H 
7: R1 = H, R2 = H, R3 = Me 
 46 
 
 
A  molecular  formula  of  C18H14O4Br  for  rubrolide  2  was  deduced  from  the 
HRESIMS 1:1 ion cluster [M+H]
+ at m/z 373.0081/375.0070. Inspection of the 
1H 
NMR spectrum revealed nine olefinic or aromatic signals (H 6.23 – 8.10, Table 2.2, 
Figure 2.6) and a 3H midfield singlet consistent with an aromatic O-methyl (H 3.93) 
group.  Multiplicity-edited  HSQC  and  HMBC  data  indicated  the  presence  of  eight 
quaternary carbons (C 120.5, 126.5, 133.5, 146.7, 156.9, 159.4, 159.9, 169.5), nine 
methine carbons (C 111.1, 111.6, 111.7, 115.6, 115.6, 129.9, 129.9, 131.2, 134.6) and 
one O-methyl carbon (C 55.3, Figures 2.7-2.8). HMBC correlations from a 
1H doublet 
at    6.23  (H-3)  to 
13C  resonances  at    169.5  (C-2),  159.4  (C-4)  and  146.7  (C-5) 
defined the furanone (ring A) of the rubrolide skeleton. A para-substituted phenolic 
moiety was indicated by two mutually coupled 2H doublets (H 7.47 and 6.95), and 
confirmed by apparent HMBC correlations from these doublets to their same HSQC-
correlated 
13C resonances (Figure 2.8). This ring B could be located at C-4 of ring A 
based  on  an  HMBC  correlation  from  the  H-2/6  doublet  (H  7.47)  to  the  C-4 
resonance. The presence of COSY couplings between H-5 and H-6 
1H signals, in 
parallel with a long range coupling (2.1 Hz) between H-2 and H-6 resonances, led to 
assignment of ring C  as  a 1, 3, 4-trisubstitued aromatic moiety.  Inspection of the 
HMBC data for 2 to establish the connectivity between rings A and C identified the 
olefinic linkage H-6 (H 6.28, s). HMBC correlations were observed from the H-6 
singlet to 
13C resonances for C-4 and C-5 of ring A, and to C-2 and C-6 of ring C. 
Deshielded methoxy H3-7 showed an HMBC correlation to C-4, thus locating this 
substituent on ring C. A relatively shielded quaternary carbon resonance at C 126.5, 
assigned  as  C-3  (from  HMBC  correlations)  in  the  1,  3,  4-trisubstituted  ring  C, 
remained as the site of bromine substitution. Therefore, rubrolide 2 was assigned as 5-
(3-bromo-4-methoxybenzylidene)-4-(4-hydroxyphenyl)furan-2(5H)-one,  and  given 
the trivial name 3-bromorubrolide F. 
HRESIMS of rubrolide 3 gave an [M+H]
+ ion cluster at m/z 358.9933/360.9916 
for a molecular formula of C17H12O4Br. Comparison of the 
1H NMR spectra for 2 and 47 
 
 
3  indicated  significant  changes  in  the  shifts  for  all  downfield 
1H  signals  and  the 
absence of the midfield 3H singlet (H 3.93, (Table 2.2, Figure 2.10). Assignment of 
COSY and HMBC correlations showed that in the case of 3, ring B is the 1, 3, 4-
trisubstitued  aromatic  moiety,  and  ring  C  is  the  1,4-disubstitued  aromatic  unit. 
Therefore, it could be concluded that in 3, the bromine is located at C-3 of ring B. The 
lack of an O-methyl singlet indicated a free 4-hydroxy group in 3 compared to 2. 
Thus,  the  structure  of  3  was  defined  as  4-(3-bromo-4-hydroxyphenyl)-5-(4-
hydroxybenzylidene)furan-2(5H)-one, and given the trivial name 3-bromorubrolide E. 
 
Table 2.2. 
1H (700 MHz) and 
13C (175 MHz) NMR Data (CD3OD) for Rubrolides 2 
and 3. 
position 
3-Bromorubrolide F (2)  3-Bromorubrolide E  (3) 
δC, mult.  δH (mult., J in Hz)  δC, mult.  δH (mult., J in Hz) 
2  169.5 (C)    170.4 (C)   
3  111.1 (CH)  6.23 (d, 0.6)  111.9 (CH)  6.20 (d, 0.5) 
4  159.4 (C)    158.3 (C)   
5  146.7 (C)    146.3 (C)   
6  111.6 (CH)  6.28 (s)  114.5 (CH)  6.24 (s) 
1  120.5 (C)    123.2 (C)   
2  129.9 (CH)  7.47 (d, 8.6)  133.6 (CH)  7.72 (d, 2.0) 
3  115.6 (CH)  6.95 (d, 8.7)  110.9 (C)   
4  159.9 (C)    157.4 (C)   
5  115.6 (CH)  6.95 (d, 8.7)  116.8 (CH)  7.03 (d, 8.3) 
6  129.9 (CH)  7.47 (d, 8.6)  129.5 (CH)  7.42 (dd, 8.3, 2.0) 
1  133.5 (C)    125.2 (C)   
2  134.6 (CH)  8.10 (d, 2.1)  133.2 (CH)  7.70 (d, 8.7) 
3  126.5 (C)    116.0 (CH)  6.83 (d, 8.7) 
4  156.9 (C)    159.6 (C)   
5  111.7 (CH)  7.10 (d, 8.6)  116.0 (CH)  6.83 (d, 8.7) 
6  131.2 (CH)  7.78 (dd, 8.6, 2.1)  133.2 (CH)  7.70 (d, 8.7) 
7  55.3 (CH3)  3.93 (s)     
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Figure 2.6 
1H NMR spectrum for 3-bromorubrolide F (2; 700 MHz, CD3OD) 
Figure 2.7 HSQC spectrum for 3-bromorubrolide F (2; 700 MHz, CD3OD) 
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Figure 2.8 HMBC spectrum for 3-bromorubrolide F (2; 700 MHz, CD3OD) 
 
Figure 2.9 NOESY spectrum for 3-bromorubrolide F (2; 700 MHz, CD3OD) 
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Figure 2.10 
1H NMR spectrum for 3-bromorubrolide E  (3; 700 MHz, 
CD3OD) 
 
Figure 2.11 COSY spectrum for 3-bromorubrolide E (3; 700 MHz, CD3OD) 
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Figure 2.12 HMBC spectrum for 3-bromorubrolide E (3; 700 MHz, CD3OD) 52 
 
 
The  HRESIMS  data  for  rubrolide  4  gave  an  [M+H]
+  ion  cluster  at  m/z 
373.0060/375.0048,  for  the  same  molecular  formula  of  C18H14O4Br  as  that  for  2. 
Comparison of the 
1H chemical shifts for 3 and 4 showed a slight upfield shift for ring 
B 
1H  resonances  (H-2,  H-5  and  H-6)  and  a  large  downfield  shift  for  ring  C 
1H 
resonances (H-2, H-5 and H-6, Table 2.3, Figure 2.13). The larger variations in H 
values for ring C could be explained by methylation of OH-4 in 3, as confirmed by an 
HMBC correlation from a 3H singlet at   3.84 (H3-7) to the C-4 resonance (C 
162.1).  Therefore,  the  structure  of  rubrolide  4  was  assigned  as  4-(3-bromo-4-
hydroxyphenyl)-5-(4-methoxybenzylidene)furan-2(5H)-one,  and  given  the  trivial 
name 3-bromorubrolide F. 
Rubrolide 5 has a molecular formula of C17H9O4Br2 as assigned from the [M-H]
- 
1:2:1  ion  cluster  at  m/z  434.8873/436.8929/438.8940.  Examination  of  the 
1H  and 
COSY NMR data indicated that the 
1H shifts for ring B protons (H-2, H-5 and H-6) 
were similar to those for ring B of 3-bromorubrolide E (3, Table 2.3, Figures 2.14, 
2.15). Additionally, COSY-coupled H-2/H-6 and H-5/H-6 established ring C as a 
1, 3, 4-trisubstitued benzene. The assignment of quaternary C-3 (C 113.1) and C-3 
(C 112.7), as deduced from HMBC (Figure 2.16) and COSY (Figure 2.15), localized 
bromine substituents at these positions. Thus, rubrolide 5 was assigned as 5-(3-bromo-
4-hydroxybenzylidene)-4-(3-bromo-4-hydroxyphenyl)furan-2(5H)-one, and given the 
trivial name 3,3-dibromorubrolide E. 
For  new  rubrolides  2-5,  determination  of  the  C-5/C-6  double  bond  geometry 
relied on NOE data. NOEs between H-6 and both H-2/H-6 and H-2/H-6 (where 
one  of  the  pair  was  always  distinguishable)  were  observed,  placing  H-6  in  close 
proximity to both phenyl rings and concluding a Z geometry of the exocyclic double 
bond (Pearce, et al., 2006).  
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Table 2.3. 
1H (700 MHz) and 
13C (175 MHz) NMR Data (CD3OD) for Rubrolides 4 
and 5. 
 
 
 
 
 
 
 
 
 
   
position  3-Bromo-rubrolide F (4)  3, 3-Dibromorubrolide E  (5) 
δC  δH (J in Hz)  δC  δH (J in Hz) 
2  171.5 (C)    171.5 (C)   
3  111.4 (CH)  6.16 (s)  111.7 (CH)  6.16 (s) 
4  159.5 (C)    159.5 (C)   
5  147.8 (C)    147.5 (C)   
6  115.0 (CH)  6.31 (s)  114.7 (CH)  6.22 (s) 
1 121.3 (C)    122.3 (C)   
2  134.1 (CH)  7.70 (d, 2.2)  134.4 (CH)  7.7 (d, 2.2) 
3  113.3 (C)    113.1 (C)   
4  161.6 (C)    161.2 (C)   
5  118.9 (CH)  6.94 (d, 8.3)  118.8 (C)  6.97 (d, 8.4) 
6  130.2 (CH)  7.38 (dd, 8.3, 2.2)  130.5 (CH)  7.39 (d, 8.4, 2.2) 
1  127.4 (C)    126.3 (C)   
2  133.5 (CH)  7.79 (d, 8.6)  136.7 (CH)  8.03 (d, 2.1) 
3  115.2 (CH)  6.98 (d, 8.9)  112.7 (C)   
4  162.1 (C)    159.6 (C)   
5  115.2 (CH)  6.98 (d, 8.9)  118.3 (CH)  6.87 (d, 8.5) 
6  133.5 (CH)  7.79 (d, 8.6)  132.9 (CH)  7.59 (dd, 8.6, 2.2) 
7  55.8 (CH3)  3.84 (s)     54 
 
 
 
Figure 2.13 
1H NMR spectrum for 3-bromo-rubrolide F (4; 700 MHz, CD3OD) 
Figure 2.14 
1H NMR spectrum for 3, 3-dibromorubrolide E  (5; 700 MHz, 
CD3OD) 
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Figure 2.15 COSY spectrum for 3, 3-dibromorubrolide E (5; 700 MHz, CD3OD) 
Figure 2.16 HMBC spectrum for 3, 3-dibromorubrolide E (5; 700 MHz, CD3OD) 
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The  HRESIMS  data  for  compounds  6  and  7  suggested  their  identities  as 
rubrolides E and F, respectively. 1D and 2D NMR data were acquired in methanol-d4 
for compound 6, and readily confirmed its identity as rubrolide E, although previously 
reported data were acquired in CDCl3 and DMSO-d6 (Figures 2.17, 2.18), (Miao & 
Andersen, 1991). Our initially acquired NMR data in methanol-d4 for compound 7 
were consistent with previously published 
1H NMR data for rubrolide F (Figure 2.19), 
(Miao  &  Andersen,  1991).  However,  after  additional  purification  of  compound  7, 
significant changes in 
1H shifts for the A and B rings were observed, while 2D NMR 
data provided the same rubrolide F structure as initially assigned (Figure 2.20). One 
explanation for this observation was the interconversion of 7 between phenoxy and 
phenol forms. The addition of NaOH to the NMR tube containing 7 caused a shift in 
ring A and B 
1H resonances, which was reversed after the addition of formic acid 
(Figures  2.21,  2.22).  Although  the  addition  of  NaOH  did  not  reproduce  the  exact 
chemical shifts previously reported (Miao & Andersen, 1991), or observed for the 
initially isolated natural product here, it could be concluded that rubrolide F was first 
isolated as a salt (other than Na
+) of the phenoxy (B-ring) anion in both cases. Our 
exhaustive separation performed under neutral conditions resulted in protonation to 
yield the phenol form. 
Finally, we tested in vitro activities of rubrolides 2-5 as well as 6 and 7 against a 
panel  of  pathogenic  bacteria  including  MRSA,  S.  epidermidis,  gentamycin  and 
vancomycin resistant Enterococcus faecalis and Escherichia coli, (Table 2.4, p. 60). 
Overall, 3-bromo-rubrolide F (4) and rubrolide F (7) showed significantly higher IC50 
values  and  a  lower  percentage  of  growth  inhibition  than  their  non-methylated 
analogues. This trend was previously observed for synthetic rubrolide analogues tested 
against  NCI-H460,  MCF-7  and  SF-268  cell  lines  (Bellina,  et  al.,  2003),  and  may 
indicate a differential cell permeability. 
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Figure 2.17 
1H NMR spectrum for rubrolide E (6; 300 MHz, CD3OD) 
Figure 2.18 HMBC NMR spectrum for rubrolide E (6; 300 MHz, CD3OD) 
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Figure 2.19 
1H NMR spectrum for rubrolide F (7; 300 MHz, CD3OD) 
 
 
Figure 2.20 
1H NMR spectrum for rubrolide F (7; 700 MHz, CD3OD) 59 
 
 
 
Figure 2.21 
1H NMR spectrum for rubrolide F + NaOH  (7; 300 MHz, CD3OD) 
Figure 2.22 
1H NMR spectrum for rubrolide F + NaOH  + HCOOH (7; 300 MHz, 
CD3OD) 
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Table 2.4  Antibacterial Properties of Rubrolides 2-5, 6 and 7.  
Chloramphenicol was tested at 30 μg/mL as a positive control, and caused 100 % 
growth inhibition of all analyzed strains. 
   
Compound 
S. aureus 
(MRSA)  S. epidermidis  E. faecalis  E. coli 
IC50 μM  IC50 μM  Percentage of growth 
inhibition at 100 μg/mL 
3-Bromorubrolide F (2)  256  98  43  22 
3-Bromorubrolide E (3)  82  38  16  0 
3-Bromo-rubrolide F (4)  360  42  2  14 
3, 3-Dibromorubrolide E (5)  89  28  2  25 
Rubrolide E (6)  105  21  89  16 
Rubrolide F (7)  1006  79  47  15 61 
 
 
Inspection of the 
1H NMR spectra for extract ARC-11-01 from an unidentified 
Antarctic tunicate suggested the presence of interesting chemical entities. Successive 
fractionation by RP18-SPE followed by RP18-HPLC led to the isolation of a metabolite 
having  the  same  chemical  shifts  as  those  published  for  opuntioside  III  and 
tetillapyrone (Figure 2.23). However, a discrepancy between the HRESIMS data for 
our  isolated  compounds  and  the  molecular  formula  reported  for  the  previously 
published structures prompted us to revise the structures of opuntioside III (Qiu Y.K. 
et al., 2007) and tetillapyrone (Wattanadilok R et al., 2007).  
 
The HRESIMS data for the first of the metabolites we isolated (8) indicated a 
molecular formula of C10H13N2O5 for an [M-H]
- ion at m/z 241.0857, and implied 5 
degrees of unsaturation. Analysis of 
1H and 
13C NMR spectra revealed the presence of 
four deshielded carbons (δC 166.6, 152.5, 138.4, 111.7) and one deshielded proton (δH 
7.83), suggesting a highly substituted aromatic ring. Five midfield 
13C resonances (δC 
tetillapyrone  opuntioside III  8 
9 
10  11 
Figure 2.23 Chemical structures of tetillapurone, opuntioside III, thymidine (8), 
uracil (9), uridine (10), inosine (11). 62 
 
 
89.0, 86.5, 72.4, 63.0, 41.3) and seven protons coupled in one spin system (δH 6.29, 
4.40, 3.91, 3.79, 3.73, 2.23, 2.22) were consistent with a carbohydrate. The COSY 
spectrum showed that the monosaccharide is dehydroxylated at the 2 position, while 
HMBC  correlations  indicated  its  cyclization  between  C-1  and  C-4,  with  C-1 
additionally connected to the aromatic moiety. Comparison of MS and NMR data for 
8  in  CD3OD  and DMSO with  those of known compounds suggested that  isolated 
compound is the primary metabolite thymidine (Figure 2.24). Since the NMR data for 
previously published tetillapurone and opuntioside III were also consistent with the 
structure of thymidine and no low- or high-resolution mass spectrometric data were 
provided  in  these  publications,  we  conclude  that  the  compounds  reported  as 
tetillapurone and opuntioside III (Qiu Y.K., et al., 2007) are identical to thymidine. 
The [M-H]
- ions at m/z 111.0200, 243.0652 and 267.0763 for compounds 9-11, 
respectively,  provided  their  molecular  formulae  of  C4H3N2O2,  C9H11N2O6  and 
C10H11N4O5, respectively. Comparison of 
1H and 
13C NMR chemical shift values with 
those reported for known nucleotides proved that these isolated metabolites are uracil 
(9), uridine (10) and inosine (11), Figure 2.23. 
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Figure 2.24 
1H and 
13C  NMR spectra for thymidine (8; 700 MHz, CD3OD) 64 
 
 
Experimental 
General Experimental Procedures 
UV  spectra  were  measured  on  a  JASCO  J-815  CD  spectrometer.  The  NMR 
spectra were referenced to  internal  residual  protonated solvent  signals  in  ppm  (
1H 
NMR: CH3OD, 3.31; 
13C NMR: CH3OD, 49.15). LRESIMS data were acquired on a 
Thermo Finnigan LCQ Advantage spectrometer, while HRESIMS data were acquired 
on Water’s Micromass LCT Premier and AB SCIEX Triple TOF 5600 spectrometers. 
Tunicate Collection and Taxonomy 
South  African  tunicate  material  was  collected  in  July  2004  by  hand  using 
SCUBA at depths of 15-20 m from White Sands Reef in Algoa Bay, Eastern Cape 
Province, South Africa (33:59.916S, 25:42.573W). Voucher samples are maintained at 
the South African Institute for Aquatic Biodiversity (SAIAB), South Africa. Antarctic 
tunicates were collected in Maxwell Bay of King George Island, at a depth of 20 feet. 
Synoicum globosum Parker-Nance sp. nov taxonomy. A descriptive synopsis 
of  the  new  species  Synoicum  globosum  Parker-Nance  sp.  nov.  (Ascidiacea, 
Aplousobranchia)  relative  to  known  congeners  and  a  detailed  morphological 
description with figures are provided in the Supporting Information of (Sikorska et al., 
2012). In summary, colonies are gelatinous but firm and consist of egg-shaped heads 
on a short cone-shaped stalk with irregular basal mass. Externally, the surface of the 
head is free of sand, although a dense accumulation of fine sand particles is visible in 
the surface layer of the stalk and the wider irregular basal attachment mass is heavily 
encrusted  with  larger  sand  particles  and  epifauna.  Zooids  are  red  and  arranged  in 
circular systems clearly distinguishable against the mustard yellow test material of 
freshly collected material. The internal test is transparent with fine sand, shell pieces, 
as well as other foreign material that decreases in density towards the central part of 
the colony. The slender zooids (8-20 mm) are closely packed together in a distinct 
layer,  and  comprise  a  thorax  (1.0-2.7  mm),  abdomen  (0.9-2.0  mm)  and  posterior 
abdomen (6.0-14.8 mm). The branchial opening has six small lobes and the atrial 65 
 
 
opening is small with a single ribbon-like tongue with small distal teeth. The branchial 
sac has 11-14 rows of stigmata with 10-11 stigmata in each of the rows. One to two 
larvae are present in developmental sequence in the atrial cavity.  Mature larvae (trunk 
0.56-0.66 mm in length and 0.14-0.40 mm in width) have 12 or more lateral ampullae 
arranged in 2-3 rows with epidermal vesicles present dorsally and ventrally and tail 
wound about halfway around the trunk. 
Extraction and Isolation Procedures 
The lyophilized organisms were extracted exhaustively with CH2Cl2-MeOH 2:1 
and SAF04-29, -38, -44, -48, -51, -53, -55, -56, -59, -61 and -71 were subjected to 
Sephadex LH-20 with 75 % MeOH-CH2Cl2 followed by RP18-SPE using a stepped 
gradient of 50-100% MeOH-H2O. In the case of extracts SAF04-31, -45, -54, -65, -68, 
and ARC-11-01, direct RP18-SPE was performed using a stepped gradient of 50-100% 
MeOH-H2O, 100% acetone, 100% ethyl acetate, 100% CH2Cl2. The 50% MeOH-H2O 
fractions of SAF04-59 and SAF04-56 were further purified by RP18-HPLC (column: 
Phenomenex  Synergi  Hydro-RP,  250  mm  x  4.6  mm,  100%  H2O)  resulting  in  the 
isolation of homarine (3.0 mg). The 75% MeOH-H2O and 100% MeOH fractions from 
SAF04-54 were subsequently separated by RP18-HPLC (column: Phenomenex Synergi 
Fusion-RP, 250 mm x 10 mm, 65% MeOH-H2O) to yield rubrolides E (13.5 mg), F 
(4.3 mg), P (3.0 mg), Q (7.4 mg), R (2.8 mg) and S (1.4 mg). The 50% MeOH-H2O 
fraction  from  the  ARC-11-01  extract  was  separated  by  RP-HPLC  first  on  a 
Phenomenex Synergi Fusion-RP column (250 mm x 10 mm, 10 % MeOH-H2O), and 
then on a Phenomenex Luna Hilic column (250 mm x 4.6 mm, 100 % MeCN). This 
resulted  in  the  isolation  of  homarine  (0.8  mg),  uracil  (1.8  mg),  uridine  (0.5  mg), 
inosine (0.9 mg), thymidine (1.3 mg). 
Cell Viability Assays. Cytotoxicity of the organic extract and crude fractions 
was  evaluated  in  mouse  Neuro-2A  neuroblastoma  cancer  cells  (ATCC,  Manassas, 
VA)  using  a  previously  described  protocol  subjected  to  slight  modifications 
(Thornburg et al., 2011). Cells were seeded into 96-well plates (25,000 cells per well) 66 
 
 
in 50 µL of medium twelve hours before treatment. Each test sample was added in a 
25 µL aliquot generated by serial dilution in serum-free medium on the day of the 
experiment, after prior removal of 25 µL of media from the treated well. Aliquots 
were generated from stock solutions of 6 mg/mL compound in 100% DMSO.  The 
cytotoxicity of extracts was evaluated after 24 h treatment. Each extracts was tested at 
final concentrations of 30 μg/mL. In all cases, cell viability was determined using a 
standard 3-(4,5-dimethylthiazol-2-yl)-2,5,diphenyl tetrazolium bromide (MTT) assay 
(Thornburg, et al., 2011). The cytotoxicity of each extract was assessed in at least 
three independent cultures with the viability of vehicle-treated control cells defined as 
100% in all experiments.  
Antibacterial Assay. Antibacterial activity was determined using the microtiter 
dilution method in a 96-well plate format (Smith et al., 2008). Crude extracts were 
tested  at  125,  12.5,  and  1.25  μg/mL  against  a  panel  of  clinically-relevant  human 
pathogens  including  methicillin-resistant  Staphylococcus  aureus  (ATCC
®  BAA-
1720
TM),  Staphylococcus  epidermidis  (ATCC
®  35984
TM),  gentamycin  and 
vancomycin  resistant  Enterococcus  faecalis  (ATCC
®  700802
TM),  Escherichia  coli 
(O157:H7) (Sikora et al., 2009), Vibro cholerae (N16961, wild type El Tor biotype), 
and Pseudomonas aeruginosa (PAO) to determine the appropriate concentration range 
for testing of pure rubrolides.  Bacterial strains were cultured as follows: MRSA and 
S. epidermidis in tryptic soy broth (Becton, Dickinson and Co.), E. faecalis in brain 
heart infusion medium (Becton, Dickinson and Co.), and all Gram-negative bacteria in 
Luria-Bertani liquid medium (Becton, Dickinson and Co). For all experiments, the 
cultures were inoculated with  5 × 10
5 cfu/mL in a final volume of 200 µL in 96-well 
tissue  culture-treated  microtiter  plates  (Greiner  Bio-One)  and  incubated  without 
shaking  at  37  °C  for  16  h,  at  which  point  bacterial  growth  was  determined 
turbidimetrically (OD600) using a BioTek Synergy HT multimode plate reader.  Each 
microtiter plate contained a positive control (chloramphenicol at a final concentration 
of 30 μg/mL), a negative control (bacteria grown in the presence of DMSO), and a 
contamination control (medium only).  IC50 values for rubrolides 2-7 were determined 67 
 
 
against MRSA and S. epidermidis as described above, using a concentration range of 
130 - 0.3 μg/mL.  Additionally, the susceptibility of E. faecalis and E. coli to pure 
compounds  was  tested  at  100  μg/mL.  Test  samples  were  inoculated  in  technical 
duplicate on each plate and assays were performed in biological triplicate. Percentage 
growth inhibition was determined using the plate-based microtiter dilution assay, and 
IC50 values were derived using nonlinear regression analysis. 
Homarine (1) white amorphous solid; 
1H NMR (700 MHz, CD3OD) 8.75 (1H, d, 
J = 6.6 Hz, H-6), 8.52 (1H, t, J = 7.7 Hz, H-4), 8.08 (1H, d, J = 7.7 Hz, H-3), 7.93 
(1H, d, J = 7.1 Hz, H-5), 4.24 (1H, s, H-1); 
13C NMR (175 MHz, CD3OD) 165.6 (C, 
C-1), 155.6 (C, C-2), 147.2 (CH, C-4), 146.6 (CH, C-6), 127.6 (CH, C-3), 127.6 (CH, 
C-5), 47.6 (CH3, C-1); LRMS m/z 296.9 [2M+Na
+].  
3-Bromorubrolide F (2). Yellow amorphous solid; UV (MeOH) λmax (log ε) 
248  (3.8),  356  (4.0)  nm;  HRESIMS  [M+H]
+  (50%)  m/z  373.0081,  (calcd  for 
C18H14O4
79Br,  373.0075),  [M+H]
+  (50%)  m/z  375.0070,  (calcd  for  C18H14O4
81Br, 
375.0055); 
1H and HSQC, HMBC, NOESY (Table 2.2, Figures 2.6-2.9). 
3-Bromorubrolide E  (3). Yellow amorphous solid; UV (MeOH) λmax (log ε) 
250  (4.1),  371  (4.3)  nm;  HRESIMS  [M+H]
+  (50%)  m/z  358.9933,  (calcd  for 
C17H12O4
79Br,  358.9919),  [M+H]
+  (50%)  m/z  360.9916,  (calcd  for  C17H12O4
81Br, 
360.9898; 
1H and 
13C NMR, COSY, HMBC, NOESY (Table 2.2, Figures 2.10-2.12).  
3-Bromo-rubrolide F (4). Yellow amorphous solid; UV (MeOH) λmax (log ε) 
248  (3.8),  365  (3.9)  nm;  HRESIMS  [M+H]
+  (50%)  m/z  373.0060,  (calcd  for 
C18H13O4
79Br,  373.0051),  [M+H]
+  (50%)  m/z  375.0048,  (calcd  for  C18H14O4
81Br, 
375.0055); 
1H and COSY, HMBC, NOESY (Table 2.3, Figure 2.13). 
3, 3-Dibromorubrolide E  (5). Yellow amorphous solid; UV (MeOH) λmax 
(log ε) 254 (4.0), 366 (4.1), 444 (3.6) nm; HRESIMS [M-H]
- (25%) m/z 434.8872, 
(calcd  for  C17H9O4
79Br2,  434.8868),  [M-H]
-  (50%)  m/z  436.8853,  (calcd  for 68 
 
 
C17H9O4
79Br
81Br, 436.8847), [M-H]
- (25%) m/z 438.8835, (calcd for C17H9O4
81Br2, 
438.8827); 
1H and 
13C NMR, COSY, HMBC, NOESY (Table 2.3, Figures 2.14-2.16). 
Rubrolide E (6). Yellow amorphous solid; UV (MeOH) λmax (log ε) 226 (3.9), 
247  (3.9),  368  (4.0)  nm;  HRESIMS  [M+H]
+  m/z  281.0821  (calcd  for  C17H13O4, 
281.0814); 
1H NMR (400 MHz, CD3OD) 7.69 (2H, d, J = 8.8 Hz, H-2, H-6), 7.44 
(2H, d, J = 8.6 Hz, H-2, H-6), 6.91 (2H, d, J = 8.5 Hz, H-3, H-5) 6.81 (2H, d, J = 
8.8  Hz,  H-2,  H-6),  6.30  (1H,  s,  H-5),  6.11  (1H,  s,  H-2); 
13C  NMR  (100  MHz, 
CD3OD) 171.5 (C, C-1), 161.0 (C, C-3), 159.7 (C, C-4, C-4), 145.0 (C, C-4), 133.7 
(CH, C-2, C-6), 131.2 (CH, C-2, C-6), 126.5 (CH, C-3, C-5), 125.0 (C, C-1), 
120.6 (C, C-1), 117.2 (CH, C-3, C-5), 115.9 (CH, C-5), 110.7 (CH, C-2).  
Rubrolide F (7). Yellow amorphous solid; UV (MeOH) λmax (log ε) 248 (3.8), 
356 (4.0) nm; HRESIMS [M+H]
+ m/z 295.0985, (calcd for C18H15O4, 295.0970); 
1H 
NMR (700 MHz, CD3OD) 7.80 (2H, d, J = 9.2 Hz, H-2, H-6), 7.47 (2H, d, J = 8.5 
Hz, H-2, H-6), 6.98 (2H, d, J = 8.9 Hz, H-3, H-5), 6.95 (2H, d, J = 8.5 Hz, H-3, H-
5), 6.31 (1H, s, H-5), 6.19 (1H, d, J = 0.6Hz, H-2), 3.85 (1H, s, H-7), 
13C NMR (175 
MHz, CD3OD) 171.4 (C, C-1) 162.1 (C, C-4), 161.4 (C, C-4), 160.6 (C, C-3), 147.9 
(C, C-4), 133.7 (2C, CH, C-2, C-6), 131.3 (2C, CH, C-2, C-6), 127.2 (C, C-1), 
122.7 (C, C-1), 116.8 (2C, CH, C-3, C-5), 115.1 (2C, CH, C-3, C-5), 114.9 (CH, 
C-2), 112.0 (CH, C-5), 55.5 (CH3, C-7).  
Thymidine (8). white amorphous solid; HRESIMS [M-H]
- m/z 241.0857, (calcd 
for C10H13N2O5, 241.0830); 
1H NMR (700 MHz, CD3OD) 7.83 (1H, d, J = 1.0Hz, H-
6), 6.29 (1H, dd, J = 7.3, 6.4 Hz, H-1), 4.40 (1H, dt, J = 6.3, 3.3 Hz, H-3), 3.91 (1H, 
dt, J = 3.5, 3.5 Hz, H-4), 3.79 (1H, dd, J = 12.2, 3.2 Hz, H-5b), 3.73 (1H, dd, J = 
12.1, 3.6 Hz, H-5a), 2.22 (2H, m, H-2), 1.88 (3H, d, J = 1.1 Hz, H-7); 
13C NMR (175 
MHz, CD3OD) 166.6 (C, C-4), 152.5 (C, C-2), 138.4 (CH, C-6), 111.7 (C, C-5), 89.0 
(CH, C-4), 86.5 (CH, C-1), 72.4 (CH, C-3), 63.0 (CH2, C-5), 41.3 (CH2, 2), 12.7 
(CH3, C-7); 
1H NMR (700 MHz, DMSO) 11.27 (1H, s, NH), 7.71 (1H, d, J = 1.3Hz, 69 
 
 
H-6), 6.17 (1H, dd, J = 7.5, 6.3 Hz, H-1), 5.25 (1H, d, J = 4.1 Hz,  OH-3),  5.04, (1H, 
t, J = 5.2 Hz,  OH-5), 4.24 (1H, dt, J = 6.3, 3.5 Hz, H-3), 3.77 (1H, dt, J = 3.7, 3.7 
Hz, H-4), 3.60 (1H, m, H-5b), 3.55 (1H, m, H-5a), 2.08 (2H, m, H-2), 1.78 (3H, d, J 
= 1.1Hz, H-7).  
Uracil (9). white amorphous solid; HRESIMS [M-H]
- m/z 111.0200, (calcd for 
C4H3N2O2, 111.0200);  
1H NMR (700 MHz, DMSO) 10.99 (1H, br s, NH), 10.85 (1H, 
br s, NH), 7.40 (1H, d, 7.5 Hz, H-6), 5.45 (1H, d, J = 7.7 Hz, H-5); 
13C NMR (175 
MHz, DMSO) 164.8 (C, C-4), 152.0 (C, C-2), 142.7 (CH, C-6), 100.7 (CH, C-5).  
Uridine (10). white amorphous solid; HRESIMS [M-H]
- m/z 243.0652, (calcd for 
C9H11N2O6, 243.0623);  
1H NMR (700 MHz, CD3OD) 8.01 (1H, d, J = 8.2 Hz, H-6), 
5.90 (1H, d, J = 4.9 Hz, H-1), 5.69 (1H, d, J = 8.0 Hz, H-5), 4.18 (1H, t J = 5.0 Hz, H-
2), 4.14 (1H, t J = 4.9 Hz, H-3), 4.00 (1H, dt J = 4.9, 3.0 Hz, H-4), 3.84 (1H, dd, J = 
12.5, 2.7 Hz, H-5), 3.84 (1H, dd, J = 12.3, 3.0 Hz, H-5);  
13C NMR (175 MHz, 
CD3OD) 166.8 (C, C-4), 152.6 (C, C-2), 142.9 (CH, C-6), 102.8 (CH, C-5), 90.8 (CH, 
C-1), 86.5 (CH, C-4), 75.9 (CH, C-2), 71.5 (CH, C-3), 62.4 (CH2, C-5). 
Inosine (11). white amorphous solid; HRESIMS [M-H]
- m/z 267.0763, (calcd for 
C10H11N4O5,  267.0735);   
1H  NMR  (700  MHz,  CD3OD); 
13C  NMR  (175  MHz, 
CD3OD).   
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Abstract 
 
Mandelalides  A-D  are  variously  glycosylated,  unusual  polyketide  macrolides 
isolated  from  a  new  species  of  Lissoclinum  ascidian  collected  from  South  Africa, 
Algoa Bay near Port Elizabeth and the surrounding Nelson Mandela Metropole. Their 
planar  structures  were  elucidated  on  sub-milligram  samples  by  comprehensive 
analysis of 1D and 2D NMR data, supported by mass spectrometry. The assignment of 
relative  configuration  was  accomplished  by  consideration  of  homonuclear  and 
heteronuclear  coupling  constants  in  tandem  with  ROESY  data.  The  absolute 
configuration  was  assigned  for  mandelalide  A  after  chiral  GC-MS  analysis  of  the 
hydrolyzed monosaccharide (2-O-methyl-ʱ-L-rhamnose) and consideration of ROESY 
correlations between the monosaccharide and aglycone in the intact natural product. 
The resultant absolute configuration of the mandelalide A macrolide was extrapolated 
to propose the absolute configurations of mandelalides B-D. Remarkably, mandelalide 
B contained the C-4 epimeric 2-O-methyl-6-dehydro-ʱ-L-talose. Mandelalides A and 
B showed potent cytotoxicity to human NCI-H460 lung cancer cells (IC50, 12 and 44 
nM, respectively) and mouse Neuro-2A neuroblastoma cells (IC50, 29 and 84 nM, 
respectively).   74 
 
 
Introduction 
 
Over the last  50  years, ascidians  have been shown to  be a prolific source of 
natural  products  with  promising  biomedical  potential  (Blunt  et  al.,  2012).  Indeed, 
ascidian-derived natural products have yielded promising drug leads, among which 
ecteinascidin 743 (Yondelis
®) and dehydrodidemnin B (Aplidin
®) are in clinical use 
for the treatment of specific cancers (Fayette et al., 2006; Le Tourneau et al., 2007). 
The diverse chemotypes reported from Lissoclinum species collected globally have 
important biological properties that range from cancer cell toxicity to antifungal and 
antibacterial activities (Blunt, et al., 2012), and include peptides, alkaloids, chlorinated 
diterpenes, polyether amides, lactones, and macrolides such as haterumalide B (Ueda 
& Hu, 1999) and patellazoles B and C (Corley et al., 1988; Zabriskie et al., 1988). It 
has been noted that many secondary metabolites isolated from Lissoclinum, as well as 
other ascidian species, are present in bacteria, sponges and mollusks (Fu et al., 2004; 
Schupp et al., 2002; Tsukimoto et al., 2011). This diversity of ascidian metabolites can 
be  explained  by  the  fact  that  tunicates  are  often  hosts  to  cyanobacterial  and 
heterotrophic bacterial symbionts, as well as being fed upon by predatory mollusks 
(Fu, et al., 2004; Ogi et al., 2009; Schmidt et al., 2004; Tsukimoto, et al., 2011). 
Therefore, identification of the biogenetic origin of ascidian natural products is very 
often challenging (Schmidt et al., 2012). This is highlighted by the recent isolation of 
didemnin  B  (an  analog  of  Aplidin
®)  from  the  ʱ-proteobacterium  Tistrella  mobilis 
(Pearce et al., 2006; Tsukimoto, et al., 2011). Didemnin B was originally identified 
from the ascidian Aplidium albicans, and is biosynthetically similar to peptides from 
the marine cyanobacterium Lyngbya majuscula (now Moorea producta).  
In our search for new potential anticancer compounds, we encountered the highly 
cytotoxic organic extract (IC50 = 0.7 μg/mL against NCI-H460 lung cancer cells) of a 
new Lissoclinum species from Algoa Bay, South Africa. Bioassay-guided fractionation 
of this extract, yielded a series of new macrolides, named mandelalides A-D (1-4), two 
of which were tested and show good cytotoxicity to mouse Neuro-2A neuroblastoma 75 
 
 
and  human  NCI-H460  lung  cancer  cells.    While  the  relative  configuration  of  the 
compounds  could  be  assigned  from  analysis  of  ROESY  data  in  tandem  with 
homonuclear (
3JHH) and heteronuclear (
2,3JCH) coupling constants, the assignment of 
absolute configuration relied on hydrolysis of the glycosylated mandelalide A and 
chiral GC-MS analysis of the released monosaccharide. Remarkably, mandelalide A 
contains 2-O-methyl-ʱ-L-rhamnose, while mandelalide B contains the C-4 epimer 2-
O-methyl-6-dehydro-ʱ-L-talose.    76 
 
 
Results and Discussion 
 
A new Lissoclinum ascidian species was  collected from White Sands Reef in 
Algoa Bay, South Africa, in July 2004. The organic extract (1.45 g) was subjected to 
bioassay-guided fractionation through consecutive Sephadex LH-20 and RP18-HPLC 
chromatography to yield mandelalides A-D (1-4), of which mandelalide D degraded to 
deacylmandelalide D (4b).  
 
The HRESIMS data for mandelalide A (1) gave an [M+Na]
+ ion at m/z 647.3394, 
which is consistent with a molecular formula of C33H52O11, and implies 8 degrees of 
unsaturation. The 
13C and multiplicity-edited HSQC NMR spectra for compound 1 
(Table 3.1, Figures 3.1-3.3 ) indicated the presence of an ester carbonyl (δC 167.4), 
fourteen sp
3 methines (δC 94.2–68.1, 37.3 and 34.2), twelve of which were oxygen-
bearing, six olefinic methines (δC 147.1, 141.5, 131.3, 126.9, 123.9 and 123.1), eight 
methylenes  (δC  66.1, 43.1, 39.7, 38.8, 37.6, 36.8, 34.1 and 31.1) and four methyl 
groups  (δC  59.1,  18.3,  17.7  and  14.5).  Interpretation  of  COSY  and  TOCSY 
correlations delineated two spin systems (Figures 3.5-3.6), one comprising 25 carbons 77 
 
 
from C-2 to C-26 (Figure 3.4, fragment A), and the other of 6 carbons from C-1 to C-
6 (Figure 3.4, fragment B). The acquisition of a semi-phase sensitive HMBC (Cicero 
et  al.,  2001)  optimized  for  a  4  Hz  coupling  constant  (Figure  3.7),  revealed  a 
correlation between δH 5.23 (H-23) and δC 167.4 (C-1) that indicated cyclization of 
fragment A into a 23-carbon macrolactone. The C-1 carbonyl also showed HMBC 
correlations from the olefinic H-2 and H-3 multiplets, for which a 
3JHH of 15.5 Hz 
indicated an E double bond geometry. An HMBC correlation between H-9 (δ 3.32) 
and C-5 (δ 73.9) delineated a tetrahydropyran ring, while a correlation between H-17 
(δ 3.98) and C-20 (δ 83.2) was consistent with a tetrahydrofuran ring, both within 
fragment A (Table 3.1, Figure 3.4). The four contiguous (TOCSY-coupled) olefinic 
methines CH-12 to CH-15 (δH 5.45, 6.28, 6.05 and 5.28 ppm) were consistent with a 
conjugated diene, situated β to the tetrahydrofuran and γ to the tetrahydropyran on the 
basis of HMBC correlations from H-15 to C-17 and H-12 to C-10, respectively. From 
homonuclear coupling constant values (
3JHH = 14.8 and 10.8 Hz, respectively) it was 
evident that the geometry of H-12 and H-13 is trans, while H-14 and H-15 are cis. 
Knowing that 
3JHH values are not sufficiently characteristic to assign the orientation 
between H-13 and H-14, ROESY data were examined (Tanaka & Higa, 1996). ROEs 
between H-12 and H-10a, as well as between H-13 and H-16b, suggested an anti 
orientation for H-13 and H-14 (Figure 3.8).  In the case of fragment B, the downfield 
shift of C-1 (δC 94.2), the presence of four midfield oxymethine 
13C resonances, an 
upfield methyl doublet (CH3-6, δC 17.7, δH 1.27) and an HMBC correlation between 
H-1  (δ  5.02)  and  C-5  (δ  68.1)  suggested  that  fragment  B  is  a  6-dehydro 
monosaccharide. An HMBC correlation between H-2 (δ 3.40) and deshielded methyl 
C-7 (δ 59.1) indicated methylation of the C-2 hydroxyl group. An HMBC correlation 
from H-7 (δ 3.82) to C-1 placed the monosaccharide (fragment B) at C-7 of fragment 
A. 
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Table 3.1 NMR data at 700 MHz for mandelalide A (1) in CDCl3 
No.  δC (mult)  δH (mult, J in Hz)  COSY  HMBC  ROESY 
1  167.4 (C)         
2  123.1(CH)  6.01 (dd, 15.5, 1.2)  3, 4a  1, 4  3
b, 4a, 4b, 5 
3  147.1(CH)  6.97 (ddd, 15.2, 10.4, 
4.6) 
2, 4a, 4b  1, 2, 4, 5  3
b, 4a
b, 4b
b, 5 
4a  38.8(CH2)  2.36 (m)  2, 3  2, 3, 5, 6  2, 3
b, 5
b, 6ax
b, 6eq 
4b    2.39 (ddd, 14.1, 10.6, 
10.6) 
3, 5  2, 3, 5, 6  2, 3
b, 5
b, 6ax
b, 6eq 
5  73.9 (CH)  3.36 (dddd, 11.4, 11.4, 
2.3, 2.3) 
4a, 4b, 6ax, 6eq  3, 4  2, 3, 4a, 4b, 6eq, 7 
6ax  37.6(CH2)   1.20 (m)  5, 6eq, 7  4, 5, 8  4b
b, 7 
6eq    2.02 (dddd, 12.6, 4.4, 
2.3, 1.6)
a 
5, 6ax, 7, 8eq  7, 8  6ax
b, 4a, 4b, 5, 7, 1 
7  73.1(CH)  3.82 (dddd, 11.1, 10.5, 
4.4, 4.4)
a 
6ax, 6eq, 8ax, 
8eq 
8, 9, 1  5, 6ax
b, 6eq, 8ax
b, 8eq, 9, 1 
8ax  39.7(CH2)  1.22 (m)  7, 8eq, 9  6, 7, 9, 10   6eq
b, 7, 8eq
b 
8eq    1.87 (m)  6eq, 7, 8ax, 9  6, 7  7, 8ax
b, 9, 10b, 5 
9  72.5 (CH)  3.32 (dddd, 11.2, 11.2. 
2.2, 2.2)
a 
8ax, 8eq, 10a, 
10b 
5, 7  7, 8eq, 10a, 10b
b, 25 
10a  43.1(CH2)  1.21 (ddd, 15.2, 9.6, 
2.2)
a 
9, 10b, 11  11, 12, 25  8eq, 9, 10b
b, 11
b, 12, 25 
10b    1.51 (ddd, 15.2, 11.2, 
3.7)
a 
9, 10a, 11  8, 9, 11, 12, 25  8eq, 9
b, 10a
b, 11, 25 
11  34.2 (CH)  2.37 (dqd, 9.6, 6.5, 
3.7)
a 
10a, 10b, 12, 
25 
10, 12, 25  10a
b, 10b, 12
b, 13, 25
b 
12  141.5(CH)  5.45 (dd, 14.8, 9.7)  11, 13  10, 11, 14, 25  11
b, 10a, 13
b, 14
b, 25 
13  123.9(CH)  6.28 (dd, 14.8, 11.0)  12, 14  10, 11, 14, 15  11, 12
b, 14
b, 15
b, 16b, 21 
14  131.3(CH)  6.05 (dd,  10.9, 10.9)  13, 15  12, 13,16, 17  12
b, 13
b, 15
b, 16a 
15  126.9(CH)  5.28 (ddd, 10.8, 10.8, 
5.6) 
14, 16a, 16b  13, 16, 17  13
b, 14
b, 16a, 16b
b, 17
b 
16a  31.1(CH2)  1.88 (m)  14, 15, 16b, 17  14, 15, 17  14, 15, 16b, 17
b, 26 
16b    2.28 (ddd, 13.1, 11.4, 
11.4) 
15, 16a, 17  14, 15, 17, 18  13,15
b,16a,17
b,19a,21,26 
17  81.0 (CH)  3.98 (ddd, 11.1, 8.1, 
1.8) 
16a, 16b, 18  15, 19, 20  15, 16a
b, 16b
b,18, 26 
18  37.3 (CH)  2.52 (dddq, 12.0, 7.0, 
7.0, 7.0)
a 
17, 19a, 19b, 
26 
16, 17, 19, 26  17, 19a
b, 19b, 20, 26
b 
19a  36.8(CH2)  1.17 (ddd, 11.9, 11.9, 
10.3) 
18, 19b, 20  18, 20, 21, 26  16b, 18
b, 21, 22b, 26 
19b    2.01 (ddd, 12.2, 7.0, 
5.6)
a 
18, 19a, 20  17, 18  18, 19a, 20, 22a, 22b, 26 
20  83.2 (CH)  3.63 (m)  19a, 19b, 21  21, 22  18, 19b, 21
b, 22a, 22b 
21  73.0 (CH)  3.42 (ddd, 11.1, 8.8, 
1.8) 
20, 22a, 22b  20, 22, 23  13, 16b, 19a, 22a
b, 22b, 23 
22a  34.1(CH2)   1.46 (ddd, 14.1, 11.1, 
1.9) 
21, 22b, 23  20, 21  19b, 21
b, 22b
b, 23, 24a, 24b 
22b    1.76 (ddd, 13.9, 11.7, 
1.8) 
21, 22a, 23  23, 24  19a, 19b, 21, 22a
b,23
b, 24a, 
24b  23  72.3 (CH)  5.23 (dddd, 11.7, 4.9, 
2.9, 1.9) 
22a, 22b, 24a, 
24b 
1  21, 22a, 22b
b, 24a, 24b 
24a  66.1(CH2)  3.61 (m)
  23, 24b  22, 23  22a, 22b, 23, 24b 
24b    3.81 (dd, 12.2, 2.9)
a  23, 24a  22, 23  22a, 22b, 23, 24a  
25  18.3(CH3)  0.85 (d, 6.6)  11  10, 11, 12  9, 10a, 10b, 11
b, 12 
26  14.5(CH3)  1.03 (d, 6.9)  18  17, 18, 19  16a, 16b, 18
b, 19a, 19b 
1  94.2 (CH)  5.02  (d, 1.1)  2  7, 2, 3, 5  6eq, 7, 8eq, 2, 7 
2  80.8 (CH)  3.40 (dd, 3.8, 1.4)  1, 3  3, 4, 7  1 
3  71.7 (CH)  3.68 (m)  2, 4, 8    2, 4
b 
4  74.3 (CH)  3.34 (dd, 9.4, 9.4)  3, 5  3, 5, 6  3
b, 5
b, 6 
5  68.1 (CH)  3.62 (m)  4, 6  3, 4, 6  8eq, 4
b, 6 
6  17.7(CH3)  1.27 (d, 6.3)    4, 5  4, 5
b 
7  59.1(CH3)  3.45 (s)    2  1 
  OH-3  2.24 (s)  2, 4a, 4b     
  OH-4  1.54 (s)  2, 3     
HMBC correlations are presented from proton to indicated carbon; 
a 
3JHH values obtained from 
DQFCOSY and/or NMRSim; 
bCOSY artifacts observed in ROESY spectrum. 
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Figure 3.1 
1H NMR spectrum for mandelalide A (1; 700 MHz, CDCl3) 
 
Figure 3.2 
13C NMR spectrum for mandelalide A (1; 175 MHz, CDCl3) 80 
 
 
 
Figure 3.3 HSQC spectrum for mandelalide A (1; 700 MHz, CDCl3)    
  
 
Figure 3.4.  Planar structure of 1 showing TOCSY correlations from H-2, H-6, 
H-8, H-10b, H-13, H-17, H-21, H-1, H-2 (black circles) indicated as bolded 
lines and key HMBC correlations represented by single-headed arrows.   
Fragment A 
Fragment B 81 
 
 
 
Figure 3.5 COSY spectrum for mandelalide A (1; 700 MHz, CDCl3) 
  Figure 3.6 TOCSY spectrum for mandelalide A (1), TOCSY mixing time = 100 
ms (700 MHz, CDCl3) 82 
 
 
   
 Figure  3.8  ROESY  spectrum  for  mandelalide  A  (1;  700  MHz,  CDCl3).  The 
assignment  of  geometry  around  the  C -13/C-14  bond  in  1  using  key  ROESY 
correlations indicated by double-headed arrows on partial structure localized in right 
corner.  
 
 
C-1 
H-23 
 Figure 3.7 HMBC spectrum for mandelalide A (1; 700 MHz, CDCl3) 83 
 
 
The  second  compound  characterized,  mandelalide  B  (2),  was  assigned  a 
molecular formula of C37H58O13 based on HRESIMS data for [M+Na]
+
 m/z 733.3773, 
which is consistent with 9 degrees of unsaturation. Inspection of the 
1H and 
13C NMR 
spectra  for  mandelalide  B  (2,  Figures  3.9,  3.10)  suggested  that  it  was  structurally 
related  to  mandelalide  A  (1).  However,  the 
1H  NMR  spectrum  for  2  lacked  the 
coupled olefinic signals at δ 6.01 (H-2) and 6.97 (H-3) and the relatively deshielded 
diastereotopic  H2-24  signals  at  δ  3.81  and  3.61.  Instead  an  additional  oxymethine 
double doublet at δ 5.48 was evident, as well as a methyl triplet (δH 0.95) indicative of 
an aliphatic chain.  Correspondingly, comparison of the 
13C NMR spectra for 1 and 2 
revealed the absence of olefinic 
13C resonances at δ 123.1 (C-2) and 147.1 (C-3) from 
the spectrum for 2, and the presence of two additional midfield 
13C resonances (δ 79.3 
and 69.5), as well as a second carbonyl resonance (δC 173.6). These data accounted for 
8 of the 9 degrees of unsaturation, implying the presence of an additional cycle in 2.  
The  analysis  of  HSQC  and  HMBC  data  (Figures  3.11,  3.12)  for  2  permitted 
assignment of an oxygenated quaternary C-2 (δ 79.3) and an oxymethine CH-3 (δ 
69.5, δ 5.48). While the same C-1/C-23 macrolactone linkage was apparent in both 
compounds, two-and three-bond HMBC correlations from H2-24 (δ 1.93, 2.39) to C-2 
and  C-3,  respectively,  indicated  a  C-2/C-24  bond  in  2.  These  data  described  a  -
butyrolactone  ring  around  the  ester  linkage  of  the  mandelalide  B  macrocycle. 
Placement of the second carbonyl carbon (δC 173.6) in a butyrate substituent at C-3 
was facilitated by HMBC correlations to δC 173.6 from δH 5.48 (H-3), as well as 2.35 
(H2-2) and 1.67 (H2-3).  Further analysis of NMR data confirmed the presence of a 
2-O-methyl-6-dehydro sugar in 2. However, differences in both 
1H and 
13C shifts for 
CH-3 to CH-6 compared to compound 1 suggested a different relative configuration 
for the monosaccharide in 2 (Table 3.2). 
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Figure 3.9 
1H NMR spectrum for mandelalide B (2; 700 MHz, CDCl3) 
 
Figure 3.10 
13C NMR spectrum for mandelalide B (2; 175 MHz, CDCl3) 
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Figure 3.11 . HSQC spectrum for mandelalide B, (2; 700 MHz, CDCl3) 
Figure 3.12 HMBC spectrum for mandelalide B, (2; 700 MHz, CDCl3) 
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Table 3.2 
1H and 
13C NMR data for mandelalides B-C (2-3) in CDCl3 
  Mandelalide  B (2)  Mandelalide  C (3) 
No.  δC (mult)  δH (mult, J in Hz)  δC (mult)  δH (mult, J in Hz) 
1  175.6 (C)  -  174.7 (C)  - 
2  79.3 (C)  -  82.0 (C)  - 
3  69.5 (CH)  5.48 (dd, 6.0, 1.7)  68.3 (CH)  5.51 (dd, 6.6, 0.9) 
4a  36.3 (CH2)  1.59 (m)  36.4 (CH2)  1.65 (m) 
4b    2.14 (ddd, 15.0, 11.7, 1.5)    2.14 (ddd, 15.6, 11.7, 1.0) 
5  72.7 (CH)  3.30 (dddd, 11.4, 11.4, 1.5, 1.5)  72.3 (CH)  3.25 (dddd, 11.4, 11.4, 1.8, 1.8) 
6ax  37.4 (CH2)  1.10 (ddd, 11.7, 11.7, 11.7)  41.2 (CH2)  1.11 (ddd, 12.5, 11.4, 11.4) 
6eq    1.89 (m)    1.86 (m) 
7  73.3 (CH)  3.75 (m)  68.3 (CH)  3.76 (dddd, 10.9, 10.9, 4.6, 4.1) 
8ax  39.6 (CH2)  1.23 (m)  41.8 (CH2)  1.13 (ddd, 12.5, 11.2, 11.2) 
8eq    1.81 (dddd, 12.4, 4.8, 1.8, 1.8)    1.83 (m) 
9  72.4 (CH)  3.39 (dddd, 11.0, 11.0, 2.2, 2.2)  72.3 (CH)  3.37 (dddd, 10.9, 10.9, 2.1, 2.1) 
10a  42.2 (CH2)  1.18 (ddd, 14.1, 12.3, 2.8)  42.1 (CH2)  1.19 (ddd, 14.2, 12.1, 2.8) 
10b    1.57 (m)    1.57 (m) 
11  33.9 (CH)  2.50 (m)  34.0 (CH2)  2.49 (m) 
12  142.1 (CH)  5.50 (dd, 15.1, 9.8)  142.2 (CH)  5.50 (dd, 14.6, 9.6) 
13  123.3 (CH)  6.40 (dd, 14.7, 11.3)  123.2 (CH)  6.39 (dd, 14.6, 11.4) 
14  131.0 (CH)  6.10 (dd, 11.1, 11.1)  131.1 (CH)  6.10 (dd, 11.0, 11.0) 
15  127.1 (CH)  5.28 (ddd, 11.1, 11.1, 5.2)  127.1 (CH)  5.28 (ddd, 11.0, 11.0, 5.4) 
16a  30.7 (CH2)  1.90 (m)  30.7 (CH2)  1.90 (ddd, 13.6, 5.2, 1.1) 
16b    2.31 (ddd, 13.6, 11.6, 11.5,)    2.30 (ddd, 13.8, 11.9, 11.9) 
17  81.5 (CH)  3.95 (ddd, 11.6, 7.46, 1.6)  81.6 (CH)  3.95 (ddd, 11.5, 7.5, 1.1) 
18  38.3 (CH)  2.52 (m)  38.3 (CH)  2.53 (m) 
19a  35.6 (CH2)  1.33 (ddd, 12.2, 12.2, 8.2)  35.7 (CH2)  1.33 (ddd, 12.2, 12.2, 9.1) 
19b    2.05 (ddd, 12.8, 6.9, 6.9)    2.10 (ddd, 12.5, 7.0, 6.8) 
20  82.1 (CH2)  3.77 (m)  82.4 (CH)  3.82 (ddd, 9.2, 9.2, 7.0) 
21  74.5 (CH)  3.76 (m)  74.4 (CH)  3.73 (ddd, 10.8, 9.5, 1.2) 
22a  37.9 (CH2)  1.51 (m)  32.1(CH2)  1.59 (m) 
22b    1.64 (m)     1.82 (ddd, 14.4, 11.0, 1.0)  
23  74.9 (CH)  4.84 (dddd, 10.4, 10.4, 4.9, 1.0)  78.9 (CH)  5.01 (ddd, 11.2, 2.0, 2.0) 
24a  39.7 (CH2)  1.93 (dd, 12.7, 10.7)  72.2 (CH)  3.98 (d, 2.8) 
24b    2.39 (dd, 12.8, 4.9)  -  - 
25  18.5 (CH3)  1.07 (d, 6.6)  18.4(CH3)  1.06 (d, 6.2) 
26  14.2 (CH3)  1.03 (d, 6.9)  14.2(CH3)  1.03 (d, 6.9) 
  OH-21  2.70 (br s)  OH  2.80 (br s) 
  OH-2  2.87 (s)  -  - 
1  94.8 (CH)  5.04 (s)  173.4 (C)  - 
2a  80.9 (CH)  3.33 (ddd, 3.0, 1.5. 1.3)  36.3(CH2)  2.34 (td, 7.5, 1.2)  
2b  -  -  -  - 
3  66.6 (CH)  3.74 (m)  18.7(CH2)  1.65 (m) 
4  73.3 (CH)  3.49 (ddt, 11.8, 3.3, 1.2, 1.2)  13.9(CH3)  0.94 (t, 7.5) 
5  67.4 (CH)  3.85(br q, 6.6)  -  - 
6  16.6 (CH3)  1.23 (d, 6.5)  -  - 
7  59.6 (CH3)  3.45 (s)  -  - 
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a  – 
3JHH values obtained from DQFCOSY and/or NMRSim 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.2 (continued) 
1H and 
13C NMR data for mandelalides B-C (2-3) in CDCl3 
  Mandelalide  B (2)  Mandelalide  C (3) 
No.  δC (mult)  δH (mult, J in Hz)  No.  δC (mult) 
8  OH  2.86 (d, 11.6)  -  - 
9  OH  2.74 (d, 11.6)  -  - 
1  173.6 (C)  -  -  - 
2a  36.3 (CH2)  2.35 (t, 7.5)  -  - 
2b  -  -  -  - 
3  18.8 (CH2)  1.67 (tq, 7.4, 7.4)  -  - 
4  14.0 (CH3)  0.95 (t, 7.4)  -  - 88 
 
 
The HRESIMS data ([M+Na]
+
 m/z 589.2970) for mandelalide C (3) supported a 
molecular formula of C30H46O10, for 8 degrees of unsaturation. The 
1H NMR spectrum 
for 3 was reminiscent of that for 2. However, a careful comparison of the two spectra 
revealed the absence of midfield glycosidic signals in the 
1H spectrum for 3. Similarly, 
inspection of the 
13C NMR spectrum for 3 showed a lack of midfield resonances for a 
methoxy methyl (δ 59.6, C-7 in 2), anomeric carbon (δ 94.8, C-1 in 2), and other 
glycosidic carbons. Together, the MS and 1D NMR data for compound 3 indicated 
that the structure of 3 is related to the aglycone of mandelalide B (2, Table 3.2, Figures 
3.13,  3.14).  Indeed,  the  only  difference  between  the 
13C  NMR  signals  for  the 
aglycones of compounds 2 and 3 was a relatively downfield methine resonance at δ 
72.2 in the spectrum for 3, compared to the methylene signal at δ 37.9 (C-24) in the 
spectrum for 2. This methine was HSQC-correlated to a 1H doublet at δH 3.98, and 
could be assigned to an oxymethine CH-24 on the basis of HMBC correlations from 
the latter 
1H doublet to C-1, C-2, C-3 and C-23. Thus, considering its MS and NMR 
data,  mandelalide  C  (3)  could  be  assigned  as  the  C-24  hydroxylated  aglycone  of 
mandelalide B (2). Unfortunately, an attempt to crystallize mandelalide C (0.5 mg) 
was unsuccessful and degradation of the compound over several months prevented the 
acquisition of additional spectroscopic or biological data. 
The  molecular  formula  of  mandelalide  D  (4)  was  assigned  by  HRESIMS 
([M+Na]
+
  m/z  659.3424)  as  C34H52O11,  implying  9  degrees  of  unsaturation. 
Comparison of the similar 
1H NMR spectra (Table 3.3) for mandelalides C (3) and D 
(4) indicated a second aglycone structure (Figure 3.15). A key difference between the 
1H spectra for the two compounds was the further deshielded H-24 doublet (δH 5.17) 
for 4 relative to that for 3 (δH 3.98).  In the HMBC spectrum (Figure 3.16) for 4, the 
H-24 doublet was correlated to a carbonyl 
13C resonance (δC 173.1, C-1"), which also 
showed  correlations  from  H-2a",  H-2b"  and  H-3",  consistent  with  an  additional 
butyrate substituent at C-24. Thus, mandelalide D (4) is 24-butyro mandelalide C (3). 
Over a period of 12 months, we observed changes in the 
1H NMR spectrum for 4 that 89 
 
 
were consistent with the loss of both butyrate moieties, resulting in the new compound 
deacylmandelalide D (4b, m/z 519.3 [M+Na]
+, Table 3.3).  
 
Figure 3.13 
1H NMR spectrum for mandelalide C (3; 700 MHz, CDCl3) 
 
Figure 3.14 
13C NMR spectrum for mandelalide C (3; 175 MHz, CDCl3) 
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Figure 3.15 
1H NMR spectrum for mandelalide D (4; 700 MHz, CDCl3) 
 
Figure 3.16 HMBC spectrum for mandelalide D (4; 700 MHz, CDCl3) 
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Table 3.3. 
1H and 
13C NMR data for mandelalides D (4 in CDCl3 and 4b in CD3OD). 
  Mandelalide  D (4)  Deacylmandelalide D  (4b) 
No.  δC (mult)  δH (mult, J in Hz)  δC (mult)  δH (mult, J in Hz) 
1  172.9 (C)  -  176.3 (C)  - 
2  81.3 (C)  -  82.4 (C)  - 
3  68.6 (CH)  5.56 (dd, 6.6, 0.7)  66.6 (CH)  4.06 (d, 7.5) 
4a  36.2 (CH2)  1.68 (m)  37.4 (CH2)  1.56 (ddd, 15.1, 7.7, 1.6) 
4b    2.18 (ddd, 15.4, 11.5, 0.9)    2.02 (dd, 15.2, 11.1) 
5  72.2 (CH)  3.21 (dddd, 11.2, 11.2, 1.3, 1.3)  72.3(CH)  3.39 (m) 
6ax  41.2 (CH2)  1.12 (ddd, 11.3, 11.3, 11.3)  40.3( CH2)  1.11 (m) 
6eq    1.85 (dddd, 12.2, 4.6, 1.5, 1.5)    1.88 (dddd, 12.1, 4.7, 1.6, 1.6) 
7  68.4 (CH)  3.75 (m)  67.1( CH)  3.76 (m) 
8ax  41.8 (CH2)  1.12 (ddd, 11.3, 11.3, 11.3)  40.7( CH2)   1.08 (m) 
8eq    1.83 (dddd, 12.2, 4.6, 1.5, 1.5)    1.83 (m) 
9  72.2 (CH)  3.36 (dddd, 11.0, 11.0, 2.2, 2.2)  71.1(CH)  3.39 (m) 
10a  42.1 (CH2)  1.19 (ddd, 13.9, 11.5, 2.8)  41.2(CH2)  1.23 (m) 
10b    1.57 (ddd, 14.0, 11.5, 4.0)    1.49 (ddd, 13.8, 11.4, 4.1) 
11  34.2 (CH)  2.48 (m)  33.5 (CH)  2.49 (m) 
12  142.3 (CH)  5.50 (dd, 14.8, 9.7)  140.7 (CH)  5.51 (dd, 14.6, 9.9) 
13  123.1 (CH)  6.38 (dd, 15.0, 11.3)  122.8 (CH)  6.42 (dd, 14.6, 11.2) 
14  131.1 (CH)  6.10 (dd, 11.0, 11.0)  130.0 (CH)  6.10 (dd, 10.9, 10.9) 
15  127.1 (CH)  5.28 (ddd, 11.3, 11.3, 5.4)  126.3 (CH)  5.30 (ddd, 16.0, 10.9, 5.1) 
16a  30.6 (CH2)  1.90 (ddd, 13.6, 5.3, 1.0)  31.2(CH2)  1.94 (ddd, 13.5, 5.2, 1.8) 
16b    2.29 (ddd, 13.1, 11.3, 11.3)    2.38 (ddd, 13.1, 11.4, 11.4) 
17  81.6 (CH)  3.94 (ddd, 12.0, 7.5, 1.1)  81.0 (CH)  3.98 (ddd, 11.6, 7.3, 1.4) 
18  38.3 (CH)  2.54 (dddq, 12.3, 7.5, 7.02, 6.8)
  37.6 (CH)  2.52 (m)
 
19a  35.7 (CH2)  1.34 (ddd, 12.3, 12.3, 9.2)  34.7 (CH2)  1.37 (m) 
19b    2.08 (ddd, 12.2, 7.02, 7.02)    2.14 (m) 
20  82.2 (CJ)  3.79 (ddd, 9.3, 9.3, 7.0)  82.2 (CH)  3.84 (ddd, 9.6, 9.6, 6.8) 
21  74.3 (CH)  3.73 (ddd, 10.0, 10.0, 1.6)  73.9 (CH)  3.75 (dd, 9.1, 9.1) 
22a  32.5 (CH2)  1.47 (ddd, 14.2, 10.5, 1.0)  32.0 (CH2)  1.52 (ddd, 13.7, 9.7, 1.0) 
22b    1.65 (m)    1.81 (m) 
23  76.7 (CH)  5.13 (ddd, 10.8, 3.3, 0.8)  78.3 (CH)  4.81 (dd, 10.8, 2.6) 
24  74.0 (CH)  5.17 (d, 3.3)  71.7 (CH)  4.32 (d, 3.0) 
25  18.3 (CH3)  1.07 (d, 6.6)  17.0 (CH3)  1.01 (d, 6.6) 
26  14.3 (CH3)  1.04 (d, 6.8)  12.3 (CH3)  1.08 (d, 7.0) 
  OH  2.71 (br s)     
  OH  2.78 (br s)     
1  173.6 (C)  -     
2a  36.3 (CH2)  2.40 (dt, 15.5, 7.3)     
2b    2.43 (dt, 15.5, 7.3)     
3  18.6 (CH)  1.70 (m)     
4  13.9 (CH3)  0.96 (t, 7.4)     
1  173.1 (CH)  -     
2a  36.0 (CH2)  2.31 (dt, 12.8, 7.5)     
2b    2.33 (dt, 12.8, 7.5)     
3  18.6 (CH2)  1.63 (m)     
4  13.8 (CH3)  0.93 (t, 7.3)     92 
 
 
Consideration  of  the  differences  in  the  planar  macrocyclic  structures,  and 
available  amounts,  of  mandelalides  A-D  (1-4)  led  to  the  conclusion  that  the 
assignment of relative configuration should be performed on mandelalide A and one 
of mandelalides B-D. Similarities in coupling constant (
3JHH) values for mandelalides 
B-D suggested retention of the relative configuration of the macrocycle between these 
structures (Tables 3.2, 3.3). Therefore besides mandelalide A, mandelalide B (2) was 
selected  for  further  analysis  because  it  also  possesses  a  monosaccharide  moiety, 
although it lacks the C-24 chiral center present in 3 and 4.  For both mandelalides A 
(1) and B (2), the relative configuration of the macrocycle could be assigned fully 
using a combination of ROESY and J-based configuration analysis of data acquired in 
CDCl3 and pyridine-d5, which were consistent between the two solvents.   
Considering the tetrahydropyran ring of 1, ROESY correlations between H-5, H-
7 and H-9 supported their axial orientation, consistent with a chair conformation and 
equatorial  C-7 glycosidic bond (Figures  3.8, 3.17a). The relative configuration for 
fragment C-9 to C-11 (-CHCH2CH-) was assigned on the basis of coupling constants 
obtained from the 
1H spectrum and a DQFCOSY (Figure 3.5). In CDCl3, 
3JHH values 
of  2.2  and  11.2  Hz  for  H-9/H-10a  and  H-9/H-10b,  respectively,  localized  H-10a 
gauche and H-10b anti to H-9 in two possible rotamers (Figure 3.17b), the correct one 
of which should be distinguishable from ROESY data. 
1H signal overlap in the CDCl3 
ROESY spectrum for mandelalide A (1) obscured ROE interactions in the region of 
interest.  However,  acquisition  of  NMR  data  for  1  in  py-d5  provided  sufficient 
resolution  (0.16  ppm,  Figure  3.18)  between  H-8ax  and  H-10a  to  reveal  ROESY 
correlations  between  H-8ax  and  H-10b,  and  H-8eq  and  H-10a.  This  led  to  the 
conclusion that rotamer A is correct, orienting H-10a to the outside of the macrocycle 
(Figure 3.17). The assignment of relative configuration around the C-10/C-11 bond 
required direct measurement of 
3JHH values from DQFCOSY, again due to significant 
overlap. In CDCl3, 
3JHH values of 9.6 Hz for H-10a/H-11 and 3.7 Hz for H-10b/H-11 
indicated anti and gauche orientations, respectively (Figure 3.17c). Finally, ROESY 
correlations between H-9 and H3-25, and H-11 and H-13 were consistent with the 93 
 
 
relative  configuration  shown  in  Figure  3.17a.  This  assignment  was  supported  by 
HETLOC data in CDCl3 (Figure 3.19), which provided very weak, but measurable 
3JHC between H-10a and C-25 (0.9 Hz), and between H-10b and C-25 (8.9 Hz).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the tetrahydrofuran ring of 1, H-17 and H-20 could be in a cis or trans 
configuration. There are two close conformational minima (envelope and half-chair) 
for THF rings (Grindley, 2008). However, in the envelope conformation CH3-26, H-
18, H-19a and H-19b in 1 would be eclipsed, while these same moieties would be 
gauche  in  the  half-chair  conformation  and  there  would  be  no  eclipsed  interaction 
along the C-18/19 bond (Grindley, 2008). Therefore we decided to analyze ROESY 
correlations in the context of a half-chair THF ring to assign the relationship of H-17 
and H-20. 
Figure 3.17 a) Key ROESY correlations indicated on the C-5/C-15 fragment of 1; 
b) Two possible rotamers around the C-9/C-10 bond; c) Most feasible rotamers 
around the C-10/C-11 bond of 1, with anticipated large/small heteronuclear 
coupling constant indicated on each.  For b) and c) the JHH and JHC values (CDCl3) 
are listed below the Newman projections and the rotamer of best fit is indicated by a 
dashed outline. 
a)  b) 
c) 94 
 
 
 
Figure 3.18 ROESY NMR spectrum for mandelalide A (1; 700 MHz, py-d5) 
 
Figure 3.19 HETLOC spectrum for mandelalide A (1; 700 MHz, CDCl3) 
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The  relatively  large 
3JHH  couplings  between  vicinal  proton  pairs  H-16b/H-17 
(11.4 Hz) and H-20/H-21 (8.8 Hz) supported their anti orientation in each case (Figure 
3.20a). Moreover, ROESY correlations between H-16b and H-19a, H-16b and H-21, 
and H-19a and H-21 were consistent with a cis localization of H-17 and H-20 (Figure 
3.20b), despite that no direct ROESY correlation was observed between H-17 and H-
20. Instead, the proposed conformation, consistent with ROESY correlations between 
H3-26/H2-16  and  H-16b/H-21,  brings  ROE-correlated  H-18  and  H-20  into  close 
proximity (Figure 3.20b). For the C-21 chiral center, the large values of 
3JHH and 
2JHC 
(8.8 and -4.0 Hz, respectively), in parallel with the lack of NOE contact between H-20 
and H-21 (resolved in py-d5), are consistent with their anti orientation (Figure 3.20a), 
as stated above. Analysis of 
3JHH between H-21/H-22a (11.1 Hz), and H-21/H-22b (1.8 
Hz),  placed  H-22a  anti  and  H-22b  gauche  with  respect  to  H-21  (Figure  3.20c). 
ROESY correlations between H-19a and H-22b, H-19b and H-22a, and H-19b and H-
22b suggested that H2-22 are directed away from the center of macrocycle, with the C-
21 hydroxyl pointing towards the center. Analogous reasoning was used to resolve the 
relative configuration at C-23.  The respective large and small 
3JHH values between H-
22b/H-23 (11.7 Hz) and H-22a/H-23 (1.9 Hz) suggested anti and gauche orientations, 
respectively (Figure 3.20d).  
Configurational assignment of the mandelalide A monosaccharide (C-1' to C-
6') relied on 
3JHH values, obtained from the 
1H NMR and assigned by DQFCOSY, 
given the overlap for H-3' to H-5' signals in both CDCl3 and py-d5 ROESY spectra. 
Although the small value of 
3JH-1'/H-2' = 1.1 Hz was inconclusive, H-2' was assigned as 
equatorial based on 
3JH-2'/H-3' = 3.8 Hz. The H-4' multiplet indicated couplings of 9.4 
Hz with both H-3' and H-5', indicative of axial hydrogens, although the direct analysis 
of H-3' and H-5' multiplets was impeded by their overlap with other 
1H shifts. Overall, 
these data for CH-2' to CH-5' were consistent with the relative configuration of 2-O-
methylrhamnose. To confirm this and to assign the monosaccharide as ʱ- or β-2-O-
methylrhamnose, we decided to analyze the magnetization transfer pattern of TOCSY 
signals originating from the anomeric center (CH-1'), following the method proposed 96 
 
 
by Gheysen et al (2008). This “TOCSY matching” approach takes advantage of the 
fact that the size of the 
3JHH scalar couplings affects the rate of magnetization transfer 
through a 
1H spin system during the TOCSY spin-lock period. The acquisition of a 
TOCSY with a spin-lock of 100 ms (Figure 3.21) affords a differential presence or 
absence  of  the  CH3-6'  signal  in  ʱ-  and  β-rhamnose,  respectively.  In  the  TOCSY 
acquired for mandelalide A (1), the intensity of peaks fit to previously reported data 
for ʱ-rhamnose (Figure 3.21), (Gheysen, et al., 2008). Additional confirmation that the 
monosaccharide  attached  to  1  is  2-O-methyl-ʱ-rhamnose  was  provided  by  the 
measurement of 
1JHC = 167.2 Hz for the anomeric CH-1' from a HETLOC experiment 
(Figure  3.22).  This  value  is  in  agreement  with  that  reported  previously  for  2-O-
methyl-ʱ-rhamnose, although is smaller than in the case of nonmethylated common 
sugars [~170 Hz, (Bock & Pedersen, 1974; Motohashi et al., 2010)]. 
a)  b) 
c)  d) 
Figure 3.20. a) Newman projections along the C-16/C-17 and C-20/C-21 bonds in 
1; b) The most feasible cis orientation of the THF ring with double-headed arrows 
indicating ROESY correlations; c) Newman projection along the C-21/C-22 bond 
with applicable JHH and JHC values (CDCl3) indicated on the right. d) Newman 
projection along the C-22/C-23 bond and relevant coupling constants. 
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ʱ-L-rhamnose 
H-1  H-2  H-3  H-4  H-5  H3-
6 
mandelalide A  
H-
1 
H-
2 
H-
3’ 
H-4  H3-6  H-
5 
β-L-rhamnose 
H-1  H-2  H-3  H-4  H-5  H3-
6 
b)  
a)  
Figure 3.21. a) Partial TOCSY spectrum for mandelalide A (1) showing the ʱ-2-O-
methylrhamnose region, TOCSY mixing time = 100 ms (700 MHz, CDCl3), b) The 
magnetization  transfer  pattern  of  TOCSY  signa ls  for  the  mandelalide  A 
monosaccharide  and  ʱ-  and  β-L-rhamnose.  The  grey  ovals  indicate  intensity  or 
signal greater than 1.5 % of intensity measured for the anomeric 
1H signal, while 
white ovals indicate intensity of at least 0.5 % but no more than 1.5% i ntensity 
measured for the anomeric 
1H signal. 
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As  in  the  case  of  1,  the  coupling  constant  values  and  ROESY  correlations 
measured from both CDCl3 and py-d5 data for mandelalide B (2) were comparable, 
indicating similar conformations in both solvents. The chair conformation of the THP 
ring in 2 (C-5 to C-9) was confirmed by the presence of diaxial ROESY correlations 
between  H-5,  H-7  and  H-9  (Figure  3.23a).  For  the  C-9/C-11  segment,  coupling 
constants of 2.2 and 11 Hz, between H-9/H-10a, and H-9/H-10b confirmed gauche 
and anti relationships, respectively. Similarly for H-10a/H-11 and H-10b/H-11, large 
(12.3 Hz) and small (4.1 Hz in CDCl3, 3.8 Hz in py-d5) coupling constants assigned 
from  DQFCOSY  supported  anti  and  gauche  relationships,  respectively,  overall 
leading to the same relative configuration in this region as for 1. For the C-3/C-5 
fragment  of  2, 
3JHH  values  of  1.5  and  11.7  Hz  between  H-4a/H-5  and  H-4b/H-5 
supported  gauche  and  anti  orientations,  respectively.  A  small  coupling  of  1.6  Hz 
between H-3 and H-4b indicated their gauche relationship (Figure 3.23b), and was in 
Figure 3.22. F2 slice of HETLOC spectrum for mandelalide A (1) anomeric C-1 
(700 MHz, CDCl3)  
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agreement with large H-4a/C-3 (-5.6 Hz) and small H-4b/C-3 (0 Hz) heteronuclear 
couplings. However, medium couplings for H-3/H-4a (6.0 Hz) and H-5/C-3 (4.3 Hz) 
suggested that the staggered orientation along C-3/4 may be distorted or that more 
than one conformation is present along this bond. Clear ROESY correlations between 
H-3 and each of H-4b,  H-5, H-9, H-11, H-23 and H-24b, but  not  H-4a (apparent 
COSY artifact only), support a distorted rotamer in which 138° and -102° angles are 
present between H-3/H-4a and H-3/H-4b, as calculated using MestReJ for 
3JHH 6.0 and 
1.6 Hz, respectively (Figure 3.23b).  
 
Confirmation  of the  relative configuration around the C-3 stereogenic center 
using  residual  dipolar  couplings  (RDC)  was  attempted.  In  order  to  assign  relative 
configuration of unknown chiral centers in a compound of interest the acquisition of 
data in isotropic and anisotropic solution is necessary, and at least five independent 
experimental values of RDCs should be measured (Gschwind, 2005). These RDCs are 
used  to  obtain  the  alignment  tensor  (measure  of  the  degree  of  alignment  of 
compound),  which  then  is  used  to  back-calculate  the  theoretical  RDCs  for  each 
structural  model  of  the  analyzed  compound.  The  best  fit  of  experimental  and 
theoretical data is assumed to be the correct structure. Given the limited amounts of 
sample in hand, the detection limits of this method on our available instrumentation 
Figure  3.23.  a)  Key  ROESY  correlations  for  the  C-3/C-5  fragment  of  2  are 
indicated by double-headed arrows on the partial structure. b) The most probable 
rotamer along the C-3/C-4 bond highlighted by the dashed outline and alternative 
equilibrium  of  two  rotamers  explaining  medium  size  coupling  constants.  But  = 
butyrate. 
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were examined first. The acquisition of gated decoupled 
13C NMR spectra for 20 mg 
and 2 mg of strychnine in poly-γ-benzyl-L-glutamate (PBLG) and CHCl3 indicated 
insufficient sensitivity for the lower concentration of strychnine, and suggested that 
the measurement of RDCs is not be feasible on submilligram amounts of mandelalide 
B (2, Figure 3.24).  
The presence of a ROESY correlation between H-18 and H-20 on the THF ring 
in  mandelalide  B  (2)  placed  CH3-26  quasi-equatorial,  consistent  with  ROESY 
correlations  from  the  latter  methyl  to  H2-16,  (as  for  1,  Figure  3.20).  ROESY 
correlations and comparative analysis of coupling constant values (Table 3.2) around 
the  C-16/C-21  fragment  confirmed  that  a  cis  conformation  of  the  THF  ring  is 
conserved in mandelalides A (1) and B (2). 
   Given  extensively  overlapped  CDCl3 
1H  chemical  shifts  for  the  C-20/C-23 
fragment in 2, analysis of 
1H NMR and DQFCOSY in py-d5 was used to assign the 
Figure 3.24 Gated decoupled 
13C NMR spectra of 20 and 2.9 mg strychnine in 
PBLG and CHCl3, extended region from 0 - 60 ppm (700 MHz with 
13C cryoprobe) 
20 mg strychnine ∆νQ= 270Hz                                     ns = 2048  
 
 2 mg strychnine ∆νQ= 273Hz                                     ns = 3072 
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relative configuration of this region (Figures 3.25, 3.26).  The 
3JHH values for 2 were 
similar to those for mandelalide A (1), despite the presence of the γ-lactone ring in 2. 
However, in contrast to 1, in which the more shielded H-22a (δ 1.46) is anti to H-21 
and gauche to H-23 (Figure 3.27), for 2 the more shielded H-22a (δ 1.65) is gauche to 
H-21 (
3JHH <1 Hz) and H-22b (δ 1.77) is anti to H-21 (
3JHH = 9.4 Hz), while H-20 and 
H-21 remain antiperiplanar (
3JHH = 9.4 Hz) (Figure 3.27a).  Coupling constant values 
obtained directly from the oxymethine H-23 multiplet, and assigned by DQFCOSY, 
indicate anti relationships with H-22a (JHH = 11.2 Hz), and a gauche relationship with 
H-22b (JHH = 1.0 Hz). The orientation of the ester bond in the butyrolactone ring could 
be assigned knowing the localization of H-23 anti to H-22a. The ester oxygen must 
then be positioned gauche or anti to H-22b. The ROEs observed between H-24a, H-
24b and H-22b in py-d5, in parallel with the absence of ROEs between H2-24 and H-
21 suggested that the ester bond is anti to H-22b (Figure 3.27a). Finally, knowing the 
relative configuration of the C-3/C-11 and C-20/C-23 fragments, the chirality of the 
quaternary  C-2  in  the  butyrolactone  ring  was  considered.  ROESY  correlations 
between H-24b and both H-3 and H-23 were consistent with an ʱ-oriented H-24b, 
while  H-24a,  showing  ROESY  correlations  to  H2-22,  is  oriented  above  the 
butyrolactone ring in a  configuration. Similarly, the C-2 hydroxyl could be oriented 
to the outside of the macrocycle due to the presence of weak ROESY signals between 
this OH-2 and H-4b and H-24a, suggesting a 2R configuration (Figure 3.27b).   102 
 
 
 
Figure 3.25 
1H NMR spectrum for mandelalide B (2; 700 MHz, py-d5) 
 
Figure 3.26 COSY NMR spectrum for mandelalide B (2; 700 MHz, py-d5) 
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The relative configuration of the 2'-O-methyl, 6'-deoxy monosaccharide moiety 
(C1'-C7')  in  2  was  established  analogously  to  that  in  1.  A  very  weak  ROESY 
correlation (py-d5) between H-1' and H-5' together with 
1JHC = 167 Hz for anomeric 
CH-1' suggested the presence of an ʱ-sugar. A ROESY correlation between H-3' and 
H-5' localized these protons axial, while the small 
3JHH between H-2' and H-3' (2.8 
Hz) localized H-2' equatorial (Figure 3.28). The presence of a W coupling (
4JHH = 0.98 
Hz) between H-2' and H-4', as well as 
3JHH = 3.2 Hz between H-3' and H-4' localized 
H-4' equatorial, overall leading to the conclusion that mandelalide B (2) contains 2-O-
methyl-6-dehydro-ʱ-L-talose, the C-4' epimer of the monosaccharide in mandelalide 
A. 
Given  the  assignment  of  relative  configuration  of  the  macrocycle  and 
monosaccharide units of mandelalides A (1) and B (2), it remained to establish the 
absolute configuration of these glycosidic macrolides. Despite our desire to conserve 
the limited sample quantities available for further biological investigations, a chemical 
degradation/derivatization  approach  to  the  absolute  configuration  would  be  most 
rigorous and was facilitated by the contiguous nature of the stereogenic fragments 
throughout the molecular framework. Importantly, inspection of the CDCl3 and py-d5 
ROESY  spectra  for  1  and  2  revealed  clear  correlations  between  protons  of  the 
monosaccharide and THP of the macrocycle (Figure 3.28a, b). Given the well-defined 
solution structures of monosaccharides and glycosidic bond conformations, (Seo et al., 
Figure 3.27 a) Assigned rotamers along the C-21/C-22 and C-22/C-23 bonds in 2. 
b) ROESY correlations around the γ-butyrolactone of 2. But = butyrate. 
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1978) assignment of the rhamnose absolute configuration would permit subsequent 
relay of configurational assignments around the macrocycle, as shown for mandelalide 
B (Figure 3.28b). Therefore, a portion (100 μg) of mandelalide A (1) was sacrificed 
for hydrolysis of the glycosidic bond and chiral GC-MS comparison of the liberated 
derivatized  monosaccharide  with  permethylated  and  silylated  D-  and  L-rhamnose 
standards. During co-injection of each standard with the derivatized natural product 
hydrolysate, the natural product sugar coeluted with the L (97.4 min) and not the D 
(96.4  min)  synthetic  standard,  confirming  that  the  sugar  substituent  of  1  is  2-O-
methyl-ʱ-L-rhamnose (Figure 3.29). The absolute configuration of this sugar could 
then be extrapolated to the aglycone of 1 based on the ROESY correlations between 
H-1' and H-7, H-1' and H-6eq, and H-5' and H-8eq to provide an assignment of the 
mandelalide A (1) aglycone as 2E, 5S, 7S, 9R, 11R, 12E, 14Z, 17R, 18R, 20R, 21R, 
23R.  Given retention of the macrocycle configuration (C-5 to C-21) between 1 and 2, 
the absolute configuration of 2 could be assigned similarly by considering ROESY 
correlations between the monosaccharide and THP moiety, and key correlations across 
this more rigid macrocycle (Figure 3.28b). Thus the aglycone of mandelalide B (2) 
could be assigned as 2R, 3R, 5R, 7S, 9R, 11R, 12E, 14Z, 17R, 18R, 20R, 21R, 23R. 
 
 
  
 
 
 
 
 
 
 
 
Figure 3.28 a) Key ROE correlations (CDCl3) between the monosaccharide and the 
macrolide THP moiety in mandelalide A; b) Key ROE correlations between the 
monosaccharide  and  the  macrolide,  as  well  as  through  ring  correlations  for 
mandelalide B. 
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Figure  3.29  GC-MS  chromatograms  for  a)  1,2-di-O-methyl-3,4-di-O-TMS--L-
rhamnose  (C14H32O5Si2)  co-injected  with  the  permethylated/silylated  hydrolysate  of 
mandelalide  A  (upper),  b)  1,2-di-O-methyl-3,4-di-O-TMS--D-rhamnose  co-injected 
with the permethylated/silylated hydrolysate of mandelalide A (middle chromatogram, 
left and right peaks, respectively), and c) the permethylated and silylated hydrolysate of 
mandelalide A with EI mass spectrum (bottom). 
a) 
b) 
c) 106 
 
 
Computational  modeling  of  mandelalide  B  was  used  to  examine  possible 
mandelalide  B  conformations  (Figure  3.30).  An  attempt  to  investigate  the  fit  of 
calculated conformations to experimental data was based on measurements of ROE 
distances across the macrocycle in py-d5 (Table 3.4), (Zhao et al., 2011). However, as 
could be expected for a flexible macrolide, for the ten lowest energy conformations of 
mandelalide B (2), the differences between the calculated and experimental average 
distances  between  all  analyzed  protons  were  significantly  different  (>  0.2  Å). 
Nevertheless, the lowest energy computational model assists in visualizing the through 
ring ROE contacts that facilitated assignment of the absolute configuration (Figure 
3.30). 
 
Figure 3.30. Computational model of the lowest energy conformer for mandelalide B 
(2).  
 
The 
3JHH values acquired in CDCl3 for mandelalides B-D (2-4) were all similar, 
suggesting  that  the  relative  configuration  of  the  macrocycle  incorporating  a  γ-
butyrolactone is retained. The configuration at the remaining C-24 stereocenter present 
in mandelalides C (3) and D (4) was assigned from ROESY data.  In each case, the H-
24 doublet (δH 3.98 and 5.17 in 3 and 4, respectively) is correlated to the H-3 double 107 
 
 
doublet, localizing the C-24 hydroxyl/butyrate moiety antiperiplanar to H-3 and H-23, 
in an S configuration.  
Table 3.4. The values of interproton distances obtained for mandelalide B (2) from 
ROESY acquired at mixing time = 400ms.   ׀   % error׀ = ׀rclcd - rROE׀ / rclcd, MAE = (% 
error)/n  
H1  H2  Experimental ROE 
distance in Å 
Calculated ROE 
distance in Å 
׀% error׀ 
19a  21  2.54  2.24  13.55 
16b  21  2.79  2.11  32.08 
13  21  2.26  2.81  19.72 
11  21  3.35  4.42  24.18 
11  23  2.99  3.21  6.67 
11  3  3.10  2.59  19.72 
23  3  2.17  2.26  3.96 
23  21  2.46  2.43  1.46 
MAE 
   
  13.92 
 
Cytotoxicity of the organic extract from Lissoclinum sp. was examined against 
mouse  Neuro-2A  neuroblastoma,  and  human  MDA-MB-231  breast  and  NCI-H460 
lung cancer cell lines following 48 h exposure. In all cases low μg/mL IC50 values 
were obtained (Table 3.5). The Neuro-2A cell line was chosen to perform activity-
guided fractionation leading to the purification of mandelalides A–D (1-4). The pure 
compounds mandelalides A and B yielded nanomolar IC50 values against Neuro-2A 
(44.0 and 83.8, respectively) and NCI-H460 (12.0 and 29.4 respectively) cell lines 
(Table 3.5, Figure 3.31). The potent cytotoxicities of these mandelalides are somewhat 
surprising  given  the  reported  minimal  cytotoxicity  of  the  related  glycosylated 
polyketides  madeirolides  A  and  B  (Figure  3.32),  (Winder,  2009).  The  latter 
metabolites caused less than 50% inhibition of AsPC-1 and PANC-1 pancreatic cancer 
cells at 10 μg/mL, but showed potent fungicidal activity against Candida albicans. 
Madeirolides  A  and  B  share  essentially  the  same  western  hemisphere  of  the 
mandelalides (C-5 to C-22), including a THP (alternatively substituted), diene, THF 
and  neighboring  hydroxymethine.  The  two  series  of  compounds  vary  only  in  the 108 
 
 
closure of the macrocycle: the position of the lactone and additional cycle. Given that 
the  madeirolides  were  isolated  from  a  deep-water  lithistid  Leiodermatium  sponge, 
their structural relatedness is consistent with a microbial biogenetic origin. Side-by-
side  evaluation  of  the  biological  properties  of  all  four  mandelalides  and  the  two 
madeirolides would provide insight into the structure-activity relationships that result 
in potent cytotoxicity and fungicidal activity, respectively.  However, the inaccessible 
supply of both source organisms means that further investigation of these metabolites 
will likely await their total syntheses.  
 
Table 3.5 Cytotoxicity of Lissoclinum sp. organic extract and mandelalides A (1) and 
B (2) to mouse Neuro-2A neuroblastoma and human NCI-H460 lung and MDA-MB-
231 breast cancer cells.  
 
 
aIC50 (at 48 h) in Cancer Cell Lines:
 
  NCI-H460  Neuro-2A  MDA-MB-231 
organic extract   0.7 μg/mL  5.6 μg/mL  22.1μg/mL 
mandelalide A (1)  12 nM  44 nM  - 
mandelalide B (2)  29 nM  84 nM  -  
aCell viability was assessed by MTT assay and IC50 values were derived using nonlinear regression 
analysis. 
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Figure 3.31. The dose response curves for mandelalides A (1) and B (2) in mouse 
Neuro2A neuroblastoma and human NCI-H460 cell lines, following 48 h incubation. 
Cell viability was assessed by MTT assay and is expressed relative to the response of 
solvent vehicle-treated cells.   
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Figure 3.32 Chemical structures for madeirolides A and B.   111 
 
 
Experimental 
 
General  Experimental  Methods.  As  described  previously  (Thornburg  et  al., 
2011). In addition, NMR data in CDCl3 were acquired at 700 (
1H) and 175 (
13C) MHz 
on a 5 mm inverse cryogenic probe. The NMR data in py-d5, TOCSY (mixing time 
100 ms), HETLOCs and gated-decoupled 
13C NMR experiments were obtained at 700 
(
1H) and 175 (
13C) MHz on a 5 mm 
13C cryogenic probe. The spectra were referenced 
to  internal  residual  solvent  signals  in  ppm  (
1H  NMR:  CDCl3,  7.24,  py-d5,  8.74, 
CD3OD,  3.31; 
13C  NMR:  CDCl3,  77.23,  py-d5,  150.35,  CD3OD,  49.15).  High-
resolution  MS  data  were  acquired  using  a  Water’s  Micromass  LCT  Premier 
spectrometer. 
Extraction  and  Isolation.  The  ascidian,  Lissoclinum  sp.  (Ascidiacea, 
Aplousobranchia, Didemnidae) was collected by hand using SCUBA at a depth of 18 
m (July 20, 2004) from White Sands Reef in Algoa Bay, Eastern Cape Province, South 
Africa  (33:59.916S,  25:42.573W).  The  type  specimen  (SAF2004-55)  for  this  new 
ascidian  species  is  housed  at  the  South  African  Institute  for  Aquatic  Biodiversity 
(SAIAB), Grahamstown, South Africa. 
The  freeze-dried  organism  (15.1  g)  was  extracted  with  2:1  CH2Cl2-MeOH 
yielding 1.45 g of organic extract. This organic extract was fractionated on Sephadex 
LH-20 (CH2Cl2-MeOH, 1:3) to give eight fractions, of which fractions six and seven 
were subjected to reversed phase C18 solid phase extraction (RP-SPE) using a stepped 
gradient of 50-100% MeOH in H2O. The 75% MeOH-H2O and 100% MeOH fractions 
were further separated by RP-HPLC (C18 column, 250 mm x 10 mm, 7:3 MeOH-0.1% 
FA in H2O) to yield mandelalides A (1, 0.8 mg), B (2, 0.5 mg), C (3, 0.8 mg) and D 
(4, 0.6 mg).  
Mandelalide A (1). Amorphous solid; [ʱ]
23
D –9  (c = 0.25, MeOH); UV (MeOH) 
max (log ε) 279 (2.7), 217 (4.1); LRESIMS [M+Na]
+ m/z 647.4; HRESIMS [M+Na]
+ 112 
 
 
m/z 647.3394, (calcd for C33H52O11Na, 647.3407); 
1H and 
13C NMR, COSY, HMBC, 
ROESY data (Table 3.1). 
Mandelalide B (2). Amorphous solid; [ʱ]
24
D –13 (c = 0.5, MeOH); UV (MeOH) 
max (log ε) 279 (3.0), 229 (4.1); LRESIMS [M+Na]
+ m/z 733.5; HRESIMS [M+Na]
+ 
m/z 733.3773, (calcd for C37H58O13Na, 733.3775); 
1H and 
13C NMR data (Tables 3.2). 
Mandelalide C (3). Amorphous solid; UV (MeOH) max (log ε) 280 (2.7), 229 
(4.0); LRESIMS [M+Na]
+ m/z 589.5; HRESIMS [M+Na]
+m/z 589.2970, (calcd for 
C30H46O10Na, 589.2989); 
1H and 
13C NMR data (Table 3.2). 
Mandelalide D (4). Amorphous solid; [ʱ]
25
D –50 (c = 0.2, MeOH); UV (MeOH) 
max (log ε) 280 (2.7), 229 (4.0); LRESIMS [M+Na]
+m/z 659.5; HRESIMS [M+Na]
+ 
m/z 659.3424, (calcd for C34H52O11Na, 659.3407); 
1H and 
13C NMR data (Table 3.3).  
Deacylmandelalide D (4b). Amorphous solid; [ʱ]
27
D –10 (c = 0.2, MeOH); UV 
(MeOH) max (log ε) 280 (2.8), 227 (3.8); LRESIMS [M+Na]
+ m/z 519.3; HRESIMS 
[M+H]
+ m/z 497.2752, (calcd for C26H41O9, 497.2751); 
1H and 
13C NMR (Table 3.3).  
Measurement  of 
1,2JHC  Coupling  Constants.  The  sensitivity  and  gradient-
enhanced  HETLOC  (ω1-hetero  half-ﬁltered  TOCSY)  experiment  was  employed  to 
measure JHC coupling constants, with DIPSI-2 spin-lock set to 60 ms (Uhrín et al., 
1998). Spectral widths of 6229 Hz and 5597 Hz, with a data matrix of 4K (F2) x 128 
(F1),  and  146  or  96  scans  were  employed  in  py-d5  and  CDCl3,  respectively  for 
mandelalide A. In the case of mandelalide B, a spectral width of 5597 Hz with a data 
matrix of 4K (F2) x 128 (F1) and 136 scans were implemented in CDCl3.  The 1D 
spectra that were obtained after extraction of F2/F1 slices were subjected to inverse 
Fourier transform.  The  resulting  FIDs were multiplied by the exponential  window 
function prior to linear prediction processing (Sugahara et al., 2011). 
TOCSY Data Acquisition. To determine the magnetization transfer pattern in 2-
O-methyl-L-rhamnose a 2D TOCSY was acquired with a DIPSI-2 spin-lock sequence 
in CDCl3. The spectra were recorded with a spin-lock mixing time of 100 ms, 5597 Hz 113 
 
 
spectral width at 2K (F2) x 512 (F1) data matrix for 40 scans. Data were processed 
with a sine-bell squared function with 1.5 Hz (F2) and 0.3 Hz (F1) line broadening 
before measurement of the absolute volumes of peaks. The following designation was 
applied to depict intensity of peaks; grey ovals indicate intensity or signal greater than 
1.5% of intensity measured for the signal of the anomeric proton, white ovals indicate 
intensity of at least 0.5% but no more than 1.5% intensity measured for the anomeric 
1H signal (Gheysen, et al., 2008).  
Sample Preparation and Data Acquisition for RDC Measurement. Poly-γ-
ethyl-L-glutamate (100 mg, PELG, Sigma Aldrich) was placed in a 5 mm NMR tube 
and 20 mg of strychnine dissolved in 1.0 mL CDCl3 was added. The solution was 
vortexed and frozen/thawed 5 times (-70 C for 1-2 h, variable time at rt). The degree 
of alignment was first measured using 
2H NMR and then gated decoupled 
13C NMR 
spectra were acquired (Figure 3.24). 
Calculation of Dihedral Bond Angles in MestReJ (Navarro-Vázquez et al., 
2004).  The  calculation  of  angles  between  H-3/H-4a  and  H-3/H-4b  was  performed 
using the Altona equation with substituents at C-3 defined as CH2OR and OCOR, and 
substituents at C-4 as H and CH2OR. Resulting 
3JHH values for H-3/H-4a (138.7°) and 
H-3/H-4b (-102.2°) were 6.0 and 1.6 Hz, respectively.  
Computational Modeling of Mandelalide B (2). Computational modeling was 
performed using the 2009 version of a contemporary software package. Minimization 
using the Amber* force field with PRCG algorithm, in pyridine (ε = 12.9, 10000 steps, 
maximum derivative less than 0.05 kcal/mol) and constrained torsion angles H-3/H-4a 
(138°), H-3/H-4b (-102.2°), H-4b/H-5, H-9/H-10b, H-20/H-21, H-21/H-22b, H-22a/H-
23 and distance H-4b/H-24b = 5 Å was first performed. All torsions were restrained 
based on the 
3JHH coupling constants values. The minimized structure was subjected to 
conformational searching using the Amber* force field via the low mode sampling 
method, with an energy cut off of 21 kJ/mol and 1000 steps (100 steps per rotatable 
bond, (Foloppe & Chen, 2009; Parish et al., 2002). Torsion restraints H-3/H-4a (138°), 114 
 
 
H-3/H-4b  (-102.2°),  H-4b/H-5,  H-9/H-10b,  H-20/H-21,  H-21/H-22b,  H-22a/H-23 
were applied to obtain ground state conformations. Optimization of the ten lowest 
energy conformations using DFT with the B3LYP functional and 6-31G** basis set in 
the gas phase resulted in the structure presented in Figure 3.30.  
Measurement of Mandelalide B (2) ROE Distances. ROESY experiments were 
acquired at 700 (
1H) and 175 (
13C) MHz on a 5mm 
13C cryogenic probe. The sample 
was dissolved in py-d5 and placed in a 3 mm low pressure/vacuum NMR tube under 
air without degassing (Butts et al., 2011). Ten spectra were acquired with a spin-lock 
that varied from 50 ms to 900 ms, with the ROESY measured at 400 ms being used for 
final calculations. During acquisition, 2K (F2) and 400 (F1) data points were collected 
in  40  scans  using  a  sweep  width  of  6300  Hz.  Data  were  processed  with  Bruker 
TopSpin  3.0  and  during  integration  absolute  values  of  peaks  were  measured.  The 
calculation of ROE inter-proton distances was performed as described by the equation: 
 rij = rref (cref aref / cij aij)
1/6 
where rij is the interproton distance calculated based on ROE peak volume aij; rref is the 
reference distance between two protons with ROE peak volume aref; cij and cref are 
coefficients accounting for the offset of cross peaks relative to the transmitter center 
calculated from the equations:  
cij = 1 / sin
2θi sin
2θj  
tanθʱ = γB1 /(ωʱ - ωθ) 
 where γB1 is the spin lock power (2000 Hz here); ωʱ - ωθ is the difference between the 
chemical shift of the analyzed peak and the center of the spectral window (in Hz,
 
(Caporale et al., 2010; González-Gaitano & González-Benito, 2008).
 
Methanolysis of Mandelalide A (1). Compound 1 (0.1 mg) was treated with 1 N 
methanolic HCl (1.0 mL) and heated for 24 h at 70 °C with stirring. The mixture was 
concentrated in vacuo, redissolved in 0.75 mL of 1-(TMS)-imidazole/py (1:4) and the 
reaction was continued for 40 min at 70 °C with stirring (Lu et al., 2011). The solution 115 
 
 
was concentrated, the final residue partitioned between CH2Cl2 and H2O (1:1), and the 
organic fraction used for GC-MS analysis. 
Preparation of 1,2-di-O-methyl-3,4-di-O-TMS-ʱ-L-Rhamnose and 1,2-di-O-
methyl-3,4-di-O-TMS-ʱ-D-Rhamnose  Standards.  L-rhamnose  (50  mg)  was 
dissolved  in  1N  methanolic  HCl,  heated  for  24  h  at  70  °C  with  stirring,  and 
concentrated in vacuo. The residue was redissolved in dioxane (0.6 mL) and 2 M 
TMS-diazomethane in diethyl ether (1.5 mL) was added, with H3BO3 as catalyst. The 
solution was maintained at room temperature with stirring for 5 h and then evaporated 
to dryness in vacuo (Evtushenko, 1999). Column chromatography on Si gel GF (15 
μm) with 5% MeOH in CH2Cl2 as mobile phase afforded a 1:3 mixture of 1,2-di-O-
methyl-ʱ-L-rhamnose and 1,3-di-O-methyl-ʱ-L-rhamnose in ~65% yield from this rate 
limiting  reaction:  equivalent  to  ~16%  yield  of  the  desired  1,2-di-O-methyl-ʱ-L-
rhamnose  to  be  carried  forward  for  silylation.  This  1:3  mixture  of  methylation 
products  was  treated  with  1-(TMS)-imidazole/py  (1:4)  for  40  min  at  60  °C  and 
concentrated in vacuo (Lu, et al., 2011). Finally, the residue was dissolved in CH2Cl2, 
loaded on a Si gel column, washed with 100% hexanes, and eluted with 3% EtOAc in 
hexanes to obtain pure 1,2-di-O-methyl-3,4-di-O-TMS-ʱ-L-rhamnose in a final yield 
of 5.4%. The same procedure was applied to produce 1,2-di-O-methyl-3,4-di-O-TMS-
ʱ-D-rhamnose in 6.4% yield. 
1H NMR (700 MHz, CDCl3): δ 0.12 (s, 9H), 0.15 (s, 9 
H), 3.31 (s, 3H), 3.32 (dd, J = 1.7, 3.2 Hz, 1H), 3.48 (s, 3H), 3.52 (m, 1H), 3.53 (m, 
1H), 3.78 (dd, J = 3.6, 8.4 Hz, 1H), 4.61 (d, J = 1.3, 1H); 
13C NMR (175 MHz, 
CDCl3): δ 0.7, 1.2, 18.5, 54.8, 60.0, 69.1, 73.1, 74.3, 81.6, 98.8, ppm; CI-LR-MS: m/z 
305 calculated for oxonium ion C13H29O4Si2. 
Absolute Configuration of 2-O-methyl-α-Rhamnose from Mandelalide A (1). 
Analyses of the synthetic standards and permethylated and silylated mandelalide A 
hydrolysate  were  performed  by  GC-MS  using  a  30  m    0.25  mm  i.d.  Cyclosil-B 
column, and electron impact (EI) ionization. The injector and detector were operated 
at 250 °C, while the temperature gradient was set to 75 – 175 °C at 0.5 °/min. The 116 
 
 
retention  times  for  1,2-di-O-methyl-3,4-di-O-TMS-ʱ-D-rhamnose  and  1,2-di-O-
methyl-3,4-di-O-TMS-ʱ-L-rhamnose  injected  separately  were  96.5  and  98.3  min, 
respectively. The retention time for the monosaccharide in the derivatized mandelalide 
A hydrolysate injected separately was 97.5 min. (Figure 3.29). Therefore co-injection 
of the natural product hydrolysate with each standard was performed, yielding two 
peaks with retention times of 96.4 and 97.4 min, which is indicative of the L glycoside 
in mandelalide A (Figure 3.29). 
Cell Viability Assays. Cytotoxicity of the organic extract and crude fractions 
was evaluated in mouse Neuro-2A neuroblastoma, and human MDA-MB-231 breast 
and NCI-H460 lung cancer cells (ATCC, Manassas, VA) using a previously described 
protocol subjected to slight modifications (Thornburg, et al., 2011). Cells were seeded 
into 96-well plates (20,000 cells per well for MDA-MB-231 and NCI-H460; 25,000 
cells per well for Neuro-2A) in 50 µL of medium twelve hours before treatment. Each 
test sample was added in a 25 µL aliquot generated by serial dilution in serum-free 
medium on the day of the experiment, after prior removal of 25 µL of media from the 
treated well. Aliquots were generated from stock solutions of 6 mg/mL compound in 
100% DMSO.  Pure compounds 1 and 2 were evaluated in Neuro-2A and NCI-H460 
cells after 48 h treatment, as described above. Each compound was tested at final 
concentrations ranging from 0.001 μg/mL to 10 μg/mL. In all cases, cell viability was 
determined  after  48  h  treatment  using  a  standard  3-(4,5-dimethylthiazol-2-yl)-
2,5,diphenyl  tetrazolium  bromide  (MTT)  assay  (Thornburg,  et  al.,  2011).  The 
cytotoxicity of each pure compound was assessed in at least three independent cultures 
with the viability of vehicle-treated control cells defined as 100% in all experiments. 
Dose response curves were plotted using contemporary biostatistics and curve fitting 
software.   117 
 
 
Bibliography 
 
Blunt, J. W., Copp, B. R., Keyzers, R. A., Munro, M. H. G., & Prinsep, M. R. (2012). 
Marine natural products. Nat. Prod. Rep., 29(2). 
Bock,  K.,  &  Pedersen,  C.  (1974).  A  study  of  13CH  coupling  constants  in 
hexopyranoses. J. Chem. Soc., Perkin Trans. 2(3), 293-297. 
Butts, C. P., Jones, C. R., Towers, E. C., Flynn, J. L., Appleby, L., & Barron, N. J. 
(2011). Interproton distance determinations by NOE - surprising accuracy and 
precision in a rigid organic molecule. Org. Biomol. Chem., 9(1), 177-184. 
Caporale, A., Sturlese, M., Gesiot, L., Zanta, F., Wittelsberger, A., & Cabrele, C. 
(2010).  Side  Chain  Cyclization  Based  on  Serine  Residues:  Synthesis, 
Structure,  and  Activity  of  a  Novel  Cyclic  Analogue  of  the  Parathyroid 
Hormone Fragment 1−11. J. Med. Chem., 53(22), 8072-8079. 
Cicero, D. O., Barbato, G., & Bazzo, R. (2001). Sensitivity Enhancement of a Two-
Dimensional Experiment for the Measurement of Heteronuclear Long-Range 
Coupling Constants, by a New Scheme of Coherence Selection by Gradients. 
J. Magn. Res., 148(1), 209-213. 
Corley, D. G., Moore, R. E., & Paul, V. J. (1988). Patellazole B: a novel cytotoxic 
thiazole-containing macrolide from the marine tunicate Lissoclinum patella. J. 
Am. Chem. Soc., 110(23), 7920-7922. 
Evtushenko,  E.  V.  (1999).  Regioselective  methylation  of  methyl  glycopyranosides 
with diazomethane in the presence of transition-metal chlorides and of boric 
acid. Carbohydr. Res., 316(1), 187-200. 
Fayette, J., Coquard, I. R., Alberti, L., Boyle, H., Méeus, P., Decouvelaere, A.-V., 
Thiesse, P., Sunyach, M.-P., Ranchère, D., & Blay, J.-Y. (2006). ET-743: a 
novel  agent  with  activity  in  soft-tissue  sarcomas.  Current  Opinion  in 
Oncology, 18(4), 347-353  
Foloppe, N., & Chen, I.-J. (2009). Conformational Sampling and Energetics of Drug-
Like Molecules Curr. Med. Chem., 16, 3381-3413. 
Fu,  X.,  Palomar,  A.  J.,  Hong,  E.  P.,  Schmitz,  F.  J.,  &  Valeriote,  F.  A.  (2004). 
Cytotoxic  Lissoclimide-Type  Diterpenes  from  the  Molluscs  Pleurobranchus 
albiguttatus and Pleurobranchus forskalii. J. Nat. Prod., 67(8), 1415-1418. 
Gheysen, K., Mihai, C., Conrath, K., & Martins, J. C. (2008). Rapid Identification of 
Common Hexapyranose Monosaccharide Units by a Simple TOCSY Matching 
Approach. Chem. Eur. J., 14(29), 8869-8878. 
González-Gaitano,  G.,  &  González-Benito,  J.  (2008).  Pseudorotaxanes  of 
Cyclodextrin  and  Diglycidyl  Ether  of  Bisphenol  A  as  Precursors  of  New 
Intramolecularly  Reinforced  Epoxy-based  Thermosets.  Supramol.  Chem., 
20(3), 335-344. 
Grindley, T. B. (2008). Structure and Conformation of Carbohydrates. In B. O. Fraser-
Reid,  K. Tatsuta, J. Thiem,  G.  L. Coté, S. Flitsch, Y.  Ito,  H. Kondo, S.-I. 
Nishimura & B. Yu (Eds.), Glycoscience: Chemistry and Chemical Biology (2 
ed., pp. 11-13). New York: Springer. 118 
 
 
Gschwind, R. M. (2005). Residual Dipolar Couplings—A Valuable NMR Parameter 
for Small Organic Molecules. Angew. Chem., Int. Ed. Engl. , 44(30), 4666-
4668. 
Le Tourneau, C., Raymond, E., & Faivre, S. (2007). Aplidine: a paradigm of how to 
handle the activity and toxicity of a novel marine anticancer poison. . Curr 
Pharm Des(13), 3427-3439. 
Lu, Z., Van Wagoner, R. M., Harper, M. K., Baker, H. L., Hooper, J. N. A., Bewley, 
C.  A.,  &  Ireland,  C.  M.  (2011).  Mirabamides  E−H,  HIV-Inhibitory 
Depsipeptides from the Sponge Stelletta clavosa. J. Nat. Prod., 74(2), 185-193. 
Motohashi,  K.,  Takagi,  M.,  &  Shin-ya,  K.  (2010).  Tetracenoquinocin  and  5-
Iminoaranciamycin from a Sponge-Derived Streptomyces sp. . J. Nat. Prod., 
73(4), 755-758. 
Navarro-Vázquez, A., Cobas, J. C., Sardina, F. J., Casanueva, J., & Díez, E. (2004). A 
Graphical Tool for the Prediction of Vicinal Proton−Proton 3JHH Coupling 
Constants. J. Chem. Inf. Comput. Sci., 44(5), 1680-1685. 
Ogi,  T.,  Margiastuti,  P.,  Teruya,  T.,  Taira,  J.,  Suenaga,  K.,  &  Ueda,  K.  (2009). 
Isolation of C11 Cyclopentenones from Two Didemnid Species, Lissoclinum 
sp. and Diplosoma sp. Mar. Drugs, 7, 816-832. 
Parish, C., Lombardi, R., Sinclair, K., Smith, E., Goldberg, A., Rappleye, M., & Dure, 
M. (2002). A comparison of the Low Mode and Monte Carlo conformational 
search methods. J. Mol. Graphics  Modell., 21(2), 129-150. 
Pearce, A. N., Chia, E. W., Berridge, M. V., Maas, E. W., Page, M. J., Webb, V. L., 
Harper, J. L., & Copp, B. R. (2006). E/Z-Rubrolide O, an Anti-inflammatory 
Halogenated Furanone from the New Zealand Ascidian Synoicum n. sp. J. Nat. 
Prod., 70(1), 111-113. 
Schmidt, E. W., Donia, M. S., McIntosh, J. A., Fricke, W. F., & Ravel, J. (2012). 
Origin and Variation of Tunicate Secondary Metabolites. J. Nat. Prod., 75(2), 
295-304. 
Schmidt, E. W., Sudek, S., & Haygood, M. G. (2004). Genetic Evidence Supports 
Secondary  Metabolic  Diversity  in  Prochloron  spp.,  the  Cyanobacterial 
Symbiont of a Tropical Ascidian. J. Nat. Prod., 67(8), 1341-1345. 
Schupp, P., Poehner, T., Edrada, R., Ebel, R., Berg, A., Wray, V., & Proksch, P. 
(2002). Eudistomins W and X, Two New β-Carbolines from the Micronesian 
Tunicate Eudistoma sp. J. Nat. Prod., 66(2), 272-275. 
Seo, S., Tomita, Y., Tori, K., & Yoshimura, Y. (1978). Determination of the absolute 
configuration of a secondary hydroxy group in a chiral secondary alcohol using 
glycosidation shifts in carbon-13 nuclear magnetic resonance spectroscopy. J. 
Am. Chem. Soc., 100(11), 3331-3339. 
Sugahara,  K.,  Kitamura,  Y.,  Murata,  M.,  Satake,  M.,  &  Tachibana,  K.  (2011). 
Prorocentrol,  a Polyoxy  Linear Carbon Chain  Compound  Isolated  from  the 
Toxic  Dinoflagellate  Prorocentrum  hoffmannianum.  J.  Org.  Chem.,  76(9), 
3131-3138. 119 
 
 
Tanaka, J.-i., & Higa, T. (1996). Zampanolide, a new cytotoxic marcrolide from a 
marine sponge. Tetrahedron Lett., 37(31), 5535-5538. 
Thornburg, C. C., Thimmaiah, M., Shaala, L. A., Hau, A. M., Malmo, J. M., Ishmael, 
J.  E.,  Youssef,  D.  T.  A.,  &  McPhail,  K.  L.  (2011).  Cyclic  Depsipeptides, 
Grassypeptolides D and E and Ibu-epidemethoxylyngbyastatin 3, from a Red 
Sea Leptolyngbya Cyanobacterium. J. Nat. Prod., 74(8), 1677-1685. 
Tsukimoto, M., Nagaoka, M., Shishido, Y., Fujimoto, J., Nishisaka, F., Matsumoto, 
S., Harunari, E., Imada, C., & Matsuzaki, T. (2011). Bacterial Production of 
the  Tunicate-Derived  Antitumor  Cyclic  Depsipeptide  Didemnin  B.  J.  Nat. 
Prod., 74(11), 2329-2331. 
Ueda, K., & Hu, Y. (1999). Haterumalide B:  A new cytotoxic macrolide from an 
Okinawan ascidian Lissoclinum sp. Tetrahedron Lett., 40(34), 6305-6308. 
Uhrín, D., Batta, G., Hruby, V. J., Barlow, P. N., & Kövér, K. E. (1998). Sensitivity- 
and Gradient-Enhanced Hetero ([omega]1) Half-Filtered TOCSY Experiment 
for Measuring Long-Range Heteronuclear Coupling Constants. J. Magn. Res., 
130(2), 155-161. 
Winder, P. L. (2009).  Therapeutic potential, mechanism of  action, and ecology of 
novel marine natural products. Ph.D., Florida Atlantic University, Boca Raton.    
Zabriskie,  T.  M.,  Mayne,  C.  L.,  &  Ireland,  C.  M.  (1988).  Patellazole  C:  a  novel 
cytotoxic macrolide from  Lissoclinum  patella.  J. Am. Chem. Soc., 110(23), 
7919-7920. 
Zhao, H., Zong, G., Zhang, J., Wang, D., & Liang, X. (2011). Synthesis and Anti-
Fungal Activity of Seven Oleanolic Acid Glycosides. Molecules, 16(2), 1113-
1128. 
 
  
 
 
AMINO ALCOHOLS FROM SOUTH AFRICAN SPECIES OF PSEUDODISTOMA 
TUNICATES. 
 
CHAPTER FOUR 
 
 
Justyna Sikorska, Shirley Parker-Nance, 
Michael T. Davies-Coleman, Jane E. Ishmael, and Kerry L. McPhail 
 
 
 
 
 
 
 
 
 
   121 
 
 
Abstract 
 
New cyclized pseudodistaminols A and B (1 and 2) and linear pseudodistaminol 
C (3), as well as three known linear amino alcohols (4-6), were isolated from South 
African tunicates Pseudodistoma sp. nov. A and Pseudodistoma digitum. After initial 
degradation of these unstable metabolites during purification, their re-isolation as N-
Boc (1-3) or N-Boc-phenylglycine  (4-6) derivatives of the natural products permitted 
the assignment of planar structure through application of 1D and 2D NMR techniques. 
J  coupling  analysis  in  tandem  with  interpretation  of  NOE  data  led  to  partial 
assignment of relative configuration for 1-3. Unfortunately, further determination of 
relative and absolute configuration was impeded by compound degradation and final 
conclusion of stereochemistry must await synthesis or re-isolation of the compounds 
from substantial field recollections. Determination of the relative configuration for 4-6 
was  accomplished  similarly  to  1-3.  The  assignment  of  absolute  configuration  was 
possible after comparison of 
1H NMR chemical shifts for respective N-Boc-R- and N-
Boc-S-phenylglycine derivatives of 4-6 and led to assignment of these known natural 
products  as  2(S)-amino-3(S)-hydroxy-5(E)-tetradecene,  2(S)-amino-3(S)-hydroxy-
5(E),13-tetradecadiene and (R)-(E)-1-aminotridec-5-en-2-ol, respectively. 
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Introduction 
 
Widely  distributed  tunicates  of  the  genus  Pseudodistoma  have  been  reported 
from most oceans and seas, and screening for biologically active components present 
in their extracts has led to the discovery of new purine derivatives (Appleton et al., 
2004), β-carbolines [e.g. opacalines A-C, (Chan et al., 2011), and eudistomin V (Davis 
et  al.,  1998)],  indole  alkaloids  [e.g.  aborescidines  A-D,  (Chbani  et  al.,  1993)],  6-
hydroxyquinoline alkaloids [e.g. distomadines A-B, (Pearce et al., 2003)], and many 
linear or cyclized amino alcohols [e.g. obscuraminol A, (Garrido et al., 2001), and 
pseudodistomin  D,  (Freyer  et  al.,  1997)].    Among  these  nitrogen-containing 
compounds, amino alcohols constitute a large group of primarily antibacterial (Clark 
et al., 2001), but also antifungal (Searle & Molinski, 1993) and moderately cytotoxic 
natural products (Garrido, et al., 2001). To date the characterized amino alcohols vary 
in number, localization and stereochemistry of double bonds as well as in the presence 
or absence of a cyclized (piperidine) terminal moiety. Nevertheless, all compounds 
have a characteristic amino alcohol fragment and a long aliphatic chain that make 
them structurally related to spisulosine, a natural product (isolated from a bivalve) that 
is currently in phase  clinical trials against solid tumors (Vilar et al., 2012). 
In the course of our search for bioactive compounds from a collection of South 
African tunicates, two distinct Pseudodistoma extracts were analyzed: SAF04-53 from 
Pseudodistoma  sp.  and  SAF04-48  from  P.  digitum.  Organic  extracts  from  both 
tunicates showed strong cytotoxicity in the brine shrimp assay. However, nitrogenous 
constituents  identified  in  the  active  fractions  were  inseparable  under  the  available 
chromatographic conditions. Derivatization of the Pseudodistoma sp. extract (SAF04-
53)  with  di-tert-butyl  dicarbonate  enabled  separation  of  the  cyclized 
pseudodistaminols A (1) and B (2) and linear pseudodistaminol C (3) as their tert-
butyloxycarbonyl (Boc) derivatives. To our knowledge this is the first description of 
amino  alcohols  that  possess  a  terminal  tetrahydropyran  moiety.  Unfortunately, 
degradation of these metabolites prevented any assignment of absolute configuration 123 
 
 
or biological testing of the pure compounds. In the case of the extract from P. digitum 
(SAF04-48), direct derivatization of each of two extract portions with either N-Boc-R- 
or  N-Boc-S-phenylglycine  resulted  in  the  purification  and  assignment  of  absolute 
configuration of C13 and C14 amines previously reported by Hooper et al. from an 
unidentified species of South African Pseudodistoma (Hooper et al., 1995).   124 
 
 
Results and Discussion 
 
During  biological  screening  of  South  African  tunicate  extracts  for  cytotoxic 
compounds using brine shrimp assays, two extracts of Pseudodistoma species were 
identified as active, from the new species Pseudodistoma sp., nov. A, Parker-Nance 
2008,  and  from  the  known  P.  digitum  (Parker-Nance,  2003).  Cytotoxicity-guided 
fractionation of the  Pseudodistoma sp.  nov. A extract  led to  identification of new 
cyclized pseudodistaminols A and B (1 and 2) and linear pseudodistaminol C (3), 
which were separable only after conversion to their N-Boc derivatives. Fractionation 
of the P. digitum extract on Sephadex LH-20, and subsequent derivatization of two 
separate portions of the active fraction with N-Boc-R- and N-Boc-S-phenylglycine, 
enabled isolation of the previously reported linear amino alcohols (2S)-amino-(3S)-
hydroxy-(5E)-tetradecene  (4),  (2S)-amino-(3S)-hydroxy-(5E),13-tetradecadiene  (5) 
and  (1R)  -aminotridec-(4E)-en-2-ol  (6)  (Hooper,  et  al.,  1995;  Searle  &  Molinski, 
1993). 
 
 
 
 
 
 
 
 
 
 
 
1   R = H 
1a R = Boc 
2   R = H 
2a R = Boc 
3   R = H 
3a R = Boc 
 
 
4   R = H 
4a R = N-Boc-S-phenylglycine 
4b R = N-Boc-R-phenylglycine 
 
5   R = H 
5a R = N-Boc-S-phenylglycine 
5b R = N-Boc-R-phenylglycine 
 
6   R = H 
6a R = N-Boc-S-phenylglycine 
6b R = N-Boc-R-phenylglycine 
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The HRESIMS of Boc-derivatized pseudodistaminol A (1a) gave an [M+Na]
+ ion 
at m/z 402.2972, indicating a molecular formula of C23H41NO3 and four degrees of 
unsaturation.  The 
1H  NMR  spectrum  for  1a  showed  four  deshielded  olefinic 
resonances (δH 5.54–6.19), and three midfield resonances (δH 3.25, 3.52 and 3.84) 
indicative of heteroatom bearing groups (Figure 4.1, Table 4.1). The 
13C, HSQC and 
HMBC  NMR  spectra  confirmed  the  presence  of  an  N-Boc  group  (δC  28.7,  80.1, 
158.4),  four  olefinic  methine  carbons  (δC  131.5,  131.6,  133.2,  135.9),  three 
heteroatom-bearing methine carbons (δC 51.5, 79.6, 82.1), nine aliphatic methylene 
carbons (δC 23.9–33.8) and two methyl groups (δC 14.6 and 16.8; Figures 4.2–4.4). 
COSY correlations readily delineated a diene moiety (H-8 to H-11), of which H-11 
(H 5.67) was contiguous with a terminal 7-carbon aliphatic chain (H2-12 to H3-18), 
while H-8 (H 5.54) coupled to midfield multiplet H-7 (δH 3.82, Figure 4.5). H-7 was 
in turn COSY-correlated to diastereotopic H2-6 and the spin system could be extended 
through  two  additional  alicyclic  methylenes  to  deshielded  methines  H-3,  H-2  and 
finally H3-1 (H 1.10, d). This continuous spin system spanning H3-1 to H3-18 was 
also supported by HMBC data. A ROESY correlation between H-3 (δH 3.25) and H-7 
(δH 3.84) suggested cyclization of the linear spin system into a tetrahydropyran motif 
ʱ to the diene, despite the absence of any HMBC correlations. Finally, an HMBC 
correlation from H-2 to carboxyl C-1 localized the N-Boc moiety at the C-2 position. 
The trans stereochemistry of olefins H-8/H-9 and H-10/H-11 were established from 
the large size of the 
3JHH coupling constants, 15.3 Hz and 14.1 Hz, respectively. The 
ROESY (noted above) and 1D NOE correlation between H-3 and H-7 was indicative 
of a cis oriented tetrahydropyran ring (Figures 4.6, 4.7). Assignment of the relative 
configuration  between  H-2  and  H-3  was  not  possible  based  on  the  available 
spectroscopic information, which included a medium size 
3JHH value (5.7 Hz) and an 
absence of any ROE correlation between the two protons. Unfortunately, degradation 
of compound 1a made further assignment of the relative and absolute configuration at 
C-2 impossible. 126 
 
 
The molecular formula of Boc-derivatized pseudodistaminol B (2a) is proposed 
as C23H39NO3 based on LRESIMS [M+Na]
+ at m/z 400.2. Five degrees of unsaturation 
suggested the presence of an additional double bond in 2a relative to 1a, which was 
confirmed by six downfield 
1H and 
13C NMR chemical shifts at δH 4.94, 5.55, 5.67, 
5.80, 6.01 and 6.19, and δC 114.9, 131.5, 131.6, 133.2, 135.6 and 140.2 (Figures 4.8 
and 4.9, Table 4.1). A deshielded methylene 
1H resonance at δH 4.94 was COSY-
coupled to the olefinic methine multiplet at δH 5.80, which was in turn coupled to an 
aliphatic  methylene  resonance  at  δH  2.04,  indicating  that  the  third  unsaturation  is 
localized at the terminus of the aliphatic chain (Figures 4.10, 4.11). Comparison of the 
upfield  regions  of  the 
1H  and 
13C  NMR  spectra  for  1a  and  2a  revealed  strong 
similarities, confirming the structure of 2a as the same as that of 1a, but with an 
additional (terminal) double bond. 
3JHH coupling constants for the conjugated diene 
and  a  ROESY  correlation  between  H-3  and  H-7  supported  retention  of  relative 
configuration in the C-3/C11 fragment between 1a and 2a (Figure 4.12). 
The  molecular  formula  of  Boc-derivatized  pseudodistaminol  C  (3a)  was 
calculated as C22H43NO3, based on LRESIMS data for [M+Na]
+ at m/z 392.2. Two 
degrees of unsaturation, in parallel with a downfield 
13C resonance (δC 131.0) that was 
HSQC-correlated to a 2H triplet δH 5.34, indicated the presence of only one double 
bond  and  the  N-Boc  carbonyl  group  (Figures  4.13  –  4.15).  A  pair  of  mid-field 
diastereotopic  methylene  protons  (δH  2.96,  3.11)  were  COSY-correlated  to  an 
oxymethine  (δH  3.56)  and  HMBC-correlated  to  the  amide  carbonyl  at  δC  159.2 
(Figures 4.16, 4.17). These data, together with  the absence of a correlated methyl 
doublet,  suggested  that  the  C-1  terminal  methyl  in  1a  and  2a  is  absent  in  3a. 
Placement  of  the  double  bond  proved  intractable  based  on  COSY  and  HMBC 
interpretation due to strong overlap of the 
1H signals in the aliphatic methylene region 
(δH  1.28–1.38).  Unfortunately,  degradation  of  compound  3a  prevented  further 
structure assignment, for example by GC-MS. 
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Table 4.1. 
1H and 
13C NMR data for Boc-derivatized pseudodistaminols A and B (1a 
and 2a) in CD3OD. 
 
  Pseudodistaminol A  (1a)  Pseudodistaminol B (2a) 
No.  δC (mult)  δH (mult, J in Hz)  δC (mult)  δH (mult, J in Hz) 
1  16.8 (CH3)  1.1 (d, 6.8)  17.8 (CH3)  1.12 (d, 6.7) 
2  51.5 (CH)  3.52 (m)  51.3 (CH)  3.59 (m) 
3  82.1 (CH)  3.25 (ddd, 11.6, 5.7, 1.4)  81.4 (CH)  3.30 (m) 
4ax  29.0 (CH2)  1.22 (m)  33.1 (CH2)  1.26 (m) 
4eq    1.61 (m)    1.52 (m) 
5ax  24.6 (CH2)  1.54 (m)  24.5 (CH2)  1.62 (m) 
5eq    1.89 (m)    1.88 (m) 
6ax  33.2 (CH2)  1.27 (m)  28.9 (CH2)  1.26 (m) 
6eq    1.61 (m)    1.62 (m) 
7  79.6 (CH)  3.84 (dd, 11.0, 5.5)  79.5 (CH)  3.85 (dd, 11.0, 5.8) 
8  133.2 (CH)  5.54 (dd, 15.3, 5.9)  133.2 (CH)  5.55 (dd, 15.0, 5.8) 
9  131.6 (CH)  6.19 (dd, 15.3, 10.0)  131.6 (CH)  6.19 (dd, 15.6, 
11.0) 
10  131.5 (CH)  6.01 (dd, 14.7, 11.2)  131.5 (CH)  6.01 (dd, 15.0, 
11.0) 
11  135.9 (CH)  5.67 (ddd, 14.1, 6.5, 6.5)   135.8 (CH)  5.67 (dt, 14.5 6.7) 
12  33.8 (CH2)  2.08 (dt, 6.9, 6.9)  33.7 (CH2)  2.08 (m) 
13  30.6 (CH2)  1.40 (m)  28.9-30.4 (CH2)  1.39 (m) 
14  30.4 (CH2)  1.30 (m)  28.9-30.4 (CH2)  1.39 (m) 
15  30.4 (CH2)  1.30 (m)  28.9-30.4 (CH2)  1.39 (m) 
16  33.2 (CH2)  1.27 (m)  35.0 (CH2)  2.04 (m) 
17  23.9 (CH2)  1.32 (m)  140.2 (CH2)  5.80 (m) 
18  14.6 (CH2)  0.90 (t, 6.7)  114.9 (CH2)  4.94 (m) 
1  158.4 (C)    158.3 (C)   
2  80.1 (C)    80.1 (C)   
3  28.7 (CH3)  1.44 (s)  28.9 (CH3)  1.44 (s) 
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Figure 4.1 
1H NMR spectrum for Boc-pseudodistaminol A (1a; 400 MHz, 
CD3OD) 
 
Figure  4.2 
13C  NMR  spectrum  for  Boc-pseudodistaminol  A  (1a;  100  MHz, 
CD3OD) 
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Figure 4.3 HSQC spectrum for Boc-pseudodistaminol A  (1a; 400 MHz, CD3OD) 
 
Figure 4.4 HMBC spectrum for Boc-pseudodistaminol A (1a; 400 MHz, CD3OD) 
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Figure 4.5 COSY spectrum for Boc-pseudodistaminol A  (1a; 400 MHz, CD3OD) 
 
Figure 4.6 ROESY spectrum for Boc-pseudodistaminol A (1a; 400 MHz, CD3OD) 
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Figure 4.8 
1H NMR spectrum for Boc-pseudodistaminol B  (2a; 400 MHz, 
CD3OD) 
 
Figure 4.7 1D NOESY spectrum for Boc-pseudodistaminol A confirming a cis 
THP ring, as indicated on partial structure  (1; 400 MHz, CD3OD) 
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Figure 4.9 
13C NMR spectrum for Boc-pseudodistaminol B (2a; 100 MHz, 
CD3OD) 
 
Figure 4.10 HSQC spectrum for Boc-pseudodistaminol B (2a; 400 MHz, 
CD3OD) 
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Figure 4.11 COSY spectrum for Boc-pseudodistaminol B (2a; 400 MHz, 
CD3OD) 
 
Figure 4.12 ROESY spectrum for Boc-pseudodistaminol B (2a; 400 MHz, 
CD3OD) 
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Figure 4.13 
1H NMR spectrum for Boc-pseudodistaminol C (3a; 400 MHz, 
CD3OD) 
 
Figure 4.14 
13C NMR spectrum for Boc-pseudodistaminol C (3a; 100 MHz, 
CD3OD 135 
 
 
 
Figure 4.15 HSQC spectrum for Boc-pseudodistaminol C (3a; 400 MHz, 
CD3OD) 
 
Figure 4.16 COSY spectrum for Boc-pseudodistaminol C (3a; 400 MHz, 
CD3OD) 136 
 
 
 
   
Figure 4.17 HMBC spectrum for Boc-pseudodistaminol C (3a; 400 MHz, 
CD3OD) 
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Compound  4a,  the  N-Boc-S-phenylglycine  derivative  of  compound  4,  has  a 
molecular formula of C27H45N2O4, as calculated for the HRESIMS  [M+H]
+ ion at m/z 
461.3398, which indicates seven degrees of unsaturation. Analysis of 
1H and 
13C NMR 
spectra confirmed the presence of Boc-phenylglycine (δH 1.39, 5.93, 7.28, 7.33, 7.24 
and δC 28.5, 127.3, 128.5, 129.2, 155.3, 169.8), one double bond (δC 124.9, 136.0) and 
two carbons (δC 48.5 and 73.1) attached to nitrogen and oxygen, respectively (Table 
4.2, Figures 4.18 and 4.19). Inspection of the COSY spectrum revealed correlations 
between the olefinic 
1H signals at δH 5.17 and 5.19 (H-5 and H-6) and diastereotopic 
multiplets at δH 1.57 and 1.90 (H-4a,b), with the latter being correlated further to the 
midfield H-3 signal (δH 3.39, Figure 4.20). Thus the double bond was localized β to 
the hydroxylated C-3 and the planar structure of 4 delineated. The measurement of 
coupling constants between H-2 and H-3 localized them in a gauche orientation, while 
the presence of NOE correlations (Figure 4.21, 4.23) confirmed that H-2 is localized 
anti to OH-3 and H-3 is localized anti to NHR-2. The close 
1H overlap between H-5 
and H-6 in the N-Boc-S-phenylglycine derivative required measurement of the H-5/H-
6 coupling constant in the N-Boc-R-phenylglycine amide 4b (
3JHH = 14.3 Hz) and 
indicated a trans double bond geometry (Figure 4.22). Comparison of 
1H NMR shifts 
between N-Boc-R- and N-Boc-S-phenylglycine amides of 4 (Figure 4.23) allowed the 
conclusion that the amino alcohol 4 was previously isolated as a diacetate derivative 
by the Michael T. Davies-Coleman (Hooper, et al., 1995), and M. L. Ciavatta groups 
(Ciavatta et al., 2010). 
The  molecular  formula  of  C27H42N2O4,  calculated  for  compound  5a  from  the 
HRESIMS [M+Na]
+ ion at m/z 481.3040, indicated that 5a lacked two hydrogen atoms 
as compared to 4a. A high degree of similarity was observed when 
1H and 
13C NMR 
spectra for 4a and 5a (Figures 4.24, 4.25) were compared. The main difference was 
the presence of three additional downfield 
1H signals (δH 5.79, 4.98 and 4.92) that 
were HSQC-correlated (Figure 4.26) to downfield methylene (C-13) and methine (C-
14) carbons (δC 114.4 and 139.3, respectively), which supported the presence of a 
terminal double bond in 5a. Analysis of homonuclear coupling constants for the C-2 138 
 
 
and C-3 chiral centers, as well as the 
5 olefin (in the N-Boc-R-phenylglycine amide, 
5b) confirmed retention of relative configuration between 4a, 4b and 5a, 5b (Table 
4.3, Figure 4.27).  Comparison of the chemical structure of 5a with previously isolated 
natural  products  showed  that  similar  to  4a,  the  amino  alcohol  5  was  previously 
isolated as an acetate derivative (Hooper, et al., 1995). 
The  HRESIMS  [M+Na]
+  ion  at  m/z  469.3036  for  6a  suggested  a  molecular 
formula of C26H42N2O4. The 
1H NMR and HSQC spectra showed three midfield 
1H 
signals (δH 3.66, 3.46 and 3.10), the more upfield two of which were correlated to a 
methylene carbon at δC 45.0, suggesting that the terminal methyl group CH3-1 in 4a is 
missing in 6a (Figures 4.28-4.30). In the COSY spectrum for 6a, geminally-coupled 
midfield 
1H resonances at δH 3.44 and 3.10 (H2-1) correlated to the multiplet at δH 3.61 
(H-2), which was further coupled to upfield 
1H resonances at δH 1.95 and 1.20 (H-3a 
and H-3b) and downfield 
1H resonances at δH 5.29 and 5.42 (H-4 and H-5) (Figure 
4.31). The large coupling constant between H-4 and H-5 (
3JHH = 14.5 Hz) in 6a and 6b 
supported a trans double bond geometry (Figure 4.32). Further literature searching 
identified  the  amino  alcohol  of  6a  and  6b  as  (R)-(E)-1-aminotridec-5-en-2-ol 
previously isolated from Didemnum sp. as an N-Boc derivative (Searle & Molinski, 
1993).   
The cytotoxicity of R- and S-BPG derivatives of compounds 4-6 was examined 
against mouse Neuro-2A neuroblastoma, and human NCI-H460 lung cancer cell lines 
following 48 h exposure. The IC50 values against Neuro-2A and NCI-H460 cell lines 
for the pure compounds are reported in Table 4.4. The fractions from organic extracts 
of both Pseudodistoma samples caused 100 % death of Neuro-2A cells at 30 μg/mL 
after 24 h treatment; however compounds 5b, 6a and 6b, after derivatization with 
BPG,  showed  only  mild  activity  against  both  cell  lines  after  48  h  treatment. 
Interestingly,  the  R-BPG  derivative  of  5  showed  stronger  activity  than  its  S-BPG 
analogue, suggesting that the presence of an aromatic group shielding the aliphatic 
chain is detrimental to the activity. A literature report comparing the clavaminols, 139 
 
 
isolated  from  Clavelina  phlegraea,  to  spisulosine  suggested  that  a  2S,  3R 
configuration  of  the  amino  alcohol  leads  to  more  potent  activity  than  a  2R,  3S 
configuration  (Menna,  2009).  However,  no  compound  containing  the  2S,  3S 
stereochemistry, as assigned for compounds 4 – 5 here, was isolated for comparison in 
that report. The presence of an additional cis double bond was detrimental for activity 
of the clavaminols, while in the case of 4b and 5b here, an increase in activity is 
observed  and  presumed  due  to  the  second  unsaturation.  Finally,  for  both  the 
clavaminols and amino alcohols 4 – 6, a marked decrease in activity was observed 
after derivatization, indicating the necessity of the free amine for cytotoxic effect.  
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Table 4.2. 
1H and 
13C NMR data for derivatized amino alcohols 4a and 4b in CDCl3 
 
 
 
 
 
   
  S-BPG derivatized amino alcohol 4a  R-BPG derivatized amino 
alcohol 4b 
No.  δC (mult)  δH (mult, J in Hz)  δH (mult, J in Hz) 
1  18.8 (CH3)  1.18 (d, 6.9)  1.05 (d, 6.9) 
2  48.5 (CH)  3.92 (m)  3.94 (m) 
3  73.2 (CH)  3.39 (ddd, 8.9, 4.1, 2.2)  3.48 (m) 
4a  37.9 (CH2)  1.57 (m)  2.06 (m) 
4b    1.90 (m)  2.17 (m) 
5  124.9 (CH)  5.17 (br s)  5.34 (dt, 15.0, 7.5) 
6  136.0 (CH)  5.19 (br s)  5.50 (dt, 14.4, 6.2) 
7  32.7 (CH2)  1.90 (m)  1.98 (m) 
8  29-30 (CH2)  1.23-1.27 (m)  1.23-1.32 (m) 
9  29-30 (CH2)  1.23-1.27 (m)  1.23-1.32 (m) 
10  29-30 (CH2)  1.23-1.27 (m)  1.23-1.32 (m) 
11  29-30 (CH2)  1.23-1.27 (m)  1.23-1.32 (m) 
12  29-30 (CH2)  1.23-1.27 (m)  1.23-1.32 (m) 
13  29-30 (CH2)  1.23-1.27 (m)  1.23-1.32 (m) 
14  14.3 (CH3)  0.86 (t, 7.1)  0.85 (t, 6.9) 
1  169.8 (C)     
2  59.1 (CH)  5.05 (s)  5.07 (s) 
3  139.2 (C)     
4- 8  127-130 (CH)  7.20-7.40 (m)  7.20-7.40 (m) 
9  155.3 (C)     
10  80.2 (C)     
11-13  28.5 (CH3)  1.39 (s)  1.39 (s) 141 
 
 
Table 4.3. 
1H and 
13C NMR data for derivatized amino alcohols 5a and 5b in CDCl3 
 
 
 
 
   
  S-BPG derivatized amino alcohol 5a  R-BPG derivatized amino 
alcohol 5b 
No.  δC (mult)  δH (mult, J in Hz)  δH (mult, J in Hz) 
1  18.8 (CH3)  1.19 (d, 7.0)  1.05 (d, 6.9) 
2  48.5 (CH)  3.93 (m)  3.95 (m) 
3  73.2 (CH)  3.40 (br d, 8.2)  3.48 (ddd, 8.5, 4.2, 3.0) 
4a  37.9 (CH2)  1.55 (m)  2.08 (m) 
4b    1.89 (m)  2.18 (m) 
5  125.0 (CH)  5.20 (br s)  5.34 (dt, 14.5, 7.0) 
6  135.9 (CH)  5.20 (br s)  5.50 (dt, 14.3, 6.9) 
7  32.7 (CH2)  1.92 (m)  1.98 (m) 
8  29-30 (CH2)  1.27 (m)  1.26 (m) 
9  29-30 (CH2)  1.27 (m)  1.26 (m) 
10  29-30 (CH2)  1.27 (m)  1.26 (m) 
11  29.3 (CH2)  1.36 (m)  1.35 (m) 
12  34.0 (CH2)  2.02 (m)  2.02 (m) 
13  139.3 (CH)  5.79 (ddt, 17.3,10.4, 6.9 )  5.79 (m) 
14a  114.4 (CH2)  4.92  (br d, 10.4)  4.91 (ddd, 10.2, 2.3, 1.2) 
14b    4.98  (br d, 17.3)  4.97 (ddd, 17.2, 3.2, 1.5) 
1  169.9 (C)     
2  59.0 (CH)  5.06 (s)  5.09 (s) 
3  139.3 (C)     
4- 8  127-130 (CH)  7.20-7.40 (m)  7.20-7.40 (m) 
9  155.3 (C)     
10  80.0 (C)     
11-13  28.5 (CH3)  1.40 (s)  1.39 (s) 142 
 
 
Table 4.4 Cytotoxicity of derivatized amino alcohols 4-6 to mouse Neuro-2A 
neuroblastoma and human NCI-H460 lung cancer cell lines. 
 
 
aIC50 (at 48 h) in Cancer Cell Lines:
 
  NCI-H460  Neuro-2A 
(4a)   >50 μM  >50 μM 
(4b)  >50 μM  >50 μM 
(5a)  >50 μM  >50 μM 
(5b)  33 μM  34 μM 
(6a)   27 μM  38 μM 
(6b)  25 μM  19 μM 
aCell viability was assessed by MTT assay and IC50 values were derived using nonlinear regression 
analysis. 
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Figure 4.19 
13C NMR spectrum for S-BPG amide of 4 (4a; 175 MHz, CDCl3) 
 
Figure 4.18 
1H NMR spectrum for S-BPG amide of 4 (4a; 700 MHz, CDCl3) 
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Figure 4.20 COSY spectrum for S-BPG amide of 4 (4a; 700 MHz, CDCl3) 
 
Figure 4.21 NOESY spectrum for S-BPG amide of 4  (4a; 700 MHz, CDCl3) 
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Figure 4.22 
1H NMR spectrum for R-BPG amide of 4 (4b; 700 MHz, CDCl3) 
 
Figure 4.23 The absolute configuration of 4 (2S, 3S) with Δδ = δR – δS values 
indicated on the structure. 
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Figure 4.24 
1H NMR spectrum for S-BPG amide of 5 (5a; 700 MHz, CDCl3) 
 
Figure 4.25 
13C NMR spectrum for S-BPG amide of 5 (5a; 700 MHz, CDCl3) 
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Figure 4.26 HSQC spectrum for S-BPG amide of 5 (5a; 700 MHz, CDCl3) 
 
Figure 4.27 
1H NMR spectrum for R-BPG amide of 5  (5b; 700 MHz, CDCl3) 
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Figure 4.28 
1H NMR spectrum for S-BPG amide of 6  (6a; 700 MHz, CDCl3) 
 
Figure 4.29 
13C NMR spectrum for S-BPG amide of 6  (6a; 175 MHz, CDCl3) 
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Figure 4.30 HSQC spectrum for S-BPG amide of 6  (6a; 700 MHz, CDCl3) 
 
Figure 4.31 COSY spectrum for S-BPG amide of 6  (6a; 700 MHz, CDCl3) 
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Figure 4.32 
1H NMR spectrum for R-BPG amide of 6 (6b; 700 MHz, CDCl3) 
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Experimental 
 
General  Experimental  Methods.  As  described  previously  (Sikorska  et  al., 
2012). In addition, NMR data for 1a-3a were acquired at 400 (
1H) and 100 (
13C) MHz 
on a 5 mm inverse probe. The spectra were referenced to internal residual solvent 
signals  in  ppm  (
1H  NMR:  CDCl3,  7.24,  CD3OD,  3.31; 
13C  NMR:  CDCl3,  77.23, 
CD3OD, 49.15). High-resolution MS data were acquired on a Waters Micromass LCT 
Premier spectrometer. 
Tunicate Collection, Extraction and Isolation. The ascidians Pseudodistoma 
sp. nov. A and P. digitum (Ascidiacea, Aplousobranchia, Didemnidae) were collected 
as described in Chapter 3. Both specimens (SAF2004-53 and SAF2004-48) are housed 
at the South African Institute for Aquatic Biodiversity (SAIAB), Grahamstown, South 
Africa. 
The freeze-dried organisms were extracted with CH2Cl2-MeOH 2:1 to yield 3.87 
g (Pseudodistoma sp.) and 2.71 g (Pseudodistoma digitum) of organic extract. The 
Pseudodistoma  sp.  organic  extract  was  fractionated  on  Sephadex  LH-20  (CH2Cl2-
MeOH, 1:3) to give eight fractions, of which fractions four to six were subjected to 
reversed phase C18 solid phase extraction (RP-SPE) using a stepped gradient of 50-
100% MeOH in H2O. All 75% MeOH-H2O  fractions were dissolved in THF-H2O 
(3:2), and K2CO3 was added followed by di-tert-butyl dicarbonate in a ratio of 1: 1: 1 
before  the  reaction  was  stirred  for  24  h  at  room  temperature  (Searle  &  Molinski, 
1993). The N-Boc derivatized amino alcohols were further separated by RP18-HPLC 
(column:  Phenomenex  Synergi  Hydro,  250  mm  x  10  mm,  85%  MeOH  in  0.1% 
FA/H2O) to yield pseudodistaminol A (1a, 1.0 mg), pseudodistaminol B (2a, 2.5 mg) 
and  pseudodistaminol  C  (3a,  1.0  mg).  Despite  storage  of  these  compounds  under 
argon at -20 C, they degraded over a period of two months. The P. digitum organic 
extract  was  also  subjected  to  consecutive  LH-20  and  RP-SPE  fractionations  as 
described above, but instead of MeOH, EtOH was used at each step. The 50% EtOH-152 
 
 
H2O fraction was divided into two portions and further derivatized with N-Boc-R- or 
N-Boc-S-phenylglycine (R/S-BPG). In each case, the fraction was dissolved in dry 
CH2Cl2  and  1-ethyl-3-(3-dimethylaminopropyl)carbodiimide,  1-hydroxy-7-
azabenzotriazole and R-BPG or S-BPG were added in ratio (1: 1.2: 1: 1.2) at 0 C. The 
reaction mixture was allowed to warm up to room temperature and left for 24 h (Ito et 
al., 2004). The isolation of compounds 4-6 was performed by RP18-HPLC (column: 
Phenomenex Synergy Fusion, 250 mm x 10.0 mm, 65% MeCN) resulting in 4a (1.4 
mg), 4b (1.8 mg), 5a (0.6 mg), 5b (2.5 mg), 6a (1.5 mg) and 6b (3.0 mg). 
Cell viability assays were performed as described previously in chapter 3. 
Boc-pseudodistaminol A (1a). Amorphous solid; [ʱ]
27
D –82  (c = 0.25, MeOH); 
HRESIMS [M+Na]
+ m/z  402.2972; (calcd for C23H41NO3Na, 402.2984); 
1H and 
13C 
NMR, COSY, HSQC, HMBC, ROESY, 1D NOESY data (Figures 4.1-4.7, Table 4.1). 
Boc-pseudodistaminol B (2a). Amorphous solid; LRESIMS [M+Na]
+ m/z 400.2; 
1H and 
13C NMR, COSY, HSQC, HMBC, ROESY data (Figures 4.8-4.12, Table 4.1). 
Boc-pseudodistaminol  C  (3a).  Amorphous  solid;  LRESIMS  [M+Na]
+  m/z 
392.2; 
1H NMR (400 MHz, CD3OD) 5.34 (2H, t, J = 4.6 Hz, H-5, H-6), 3.56 (1H, d, 
m, H-2), 3.11 (1H, dd, J = 13.9, 4.6 Hz, H-1), 2.96 (1H, dd, J = 13.7, 6.7 Hz, H-1), 
2.03 (4H, m, H-5, H-8), 1.43 (9H, s, H-3, H-4, H-5), 1.31-1.35 (14H, m, H-3, H-4, 
H-9/H-13), 1.31 (4H, m, H-15, H-16), 1.29 (2H, m, H-14), 0.90 (3H, t, J = 7.0 Hz, H-
17); 
13C NMR (100 MHz, CD3OD) 159.2 (C, C-1, from HMBC), 130.9 (2C, CH, C-6, 
C-7), 80.4 (C, C-2, from HMBC), 71.9 (CH, C-2), 47.6 (CH, C-1), 33.1 (CH2, C-15), 
30.0-31.0 (8C, CH, C-3/C-4, C-9/C-15), 28.9 (3C, CH3, C-3/ C-5), 28.3 (2C, CH2, C-
5, C-8), 23.9 (CH2, C-16), 14.6 (CH3, C-17). 
S-BPG-(2S)-amino-(3S)-hydroxy-(5E)-tetradecene (4a). Amorphous solid; [ʱ]
 
26
D +48.8 (c = 0.33, MeOH); UV (MeOH) max (log ε) 259 (6.2), 211 (8.0); HRESIMS 
[M+H]
+ m/z 461.3398; (calcd for C27H45N2O4, 461.3379); 
1H and 
13C NMR, COSY, 
NOESY data (Figures 4.18-4.21, Table 4.2). 153 
 
 
R-BPG-(2S)-amino-(3S)-hydroxy-(5E)-tetradecene  (4b).  Amorphous  solid; 
[ʱ]
30
D  -13.3  (c  =  0.33,  MeOH);  UV  (MeOH)  max  (log  ε)  258  (6.3),  211  (8.0); 
HRESIMS [M+Na]
+ m/z 483.3206; (calcd for C27H44N2O4Na, 483.3199);
  1H NMR 
(Figure 4.22, Table 4.2).
 
S-BPG-(2S)-amino-(3S)-hydroxy-(5E),13-tetradecadiene  (5a).  Amorphous 
solid; [ʱ]
25
D +38.6  (c = 0.22, MeOH); UV (MeOH) max (log ε) 259 (6.2), 211 (7.9);  
HRESIMS [M+Na]
+ m/z 481.3040; (calcd for C27H42N2O4Na, 481.3042); 
1H and 
13C 
NMR, HSQC data (Figures 4.24-4.26, Table 4.3). 
R-BPG-(2S)-amino-(3S)-hydroxy-(5E),13-tetradecadiene  (5b).  Amorphous 
solid; [ʱ]
31
D –19.4  (c = 0.33, MeOH); UV (MeOH) max (log ε) 258 (6.4), 214 (8.0); 
HRESIMS [M+Na]
+ m/z 481.3047; (calcd for C27H42N2O4Na, 481.3042); 
1H NMR 
data (Figure 4.27, Table 4.3). 
S-BPG-(1R)-aminotridec-(4E)-en-2-ol (6a). Amorphous solid; [ʱ]
26
D +50.6 (c = 
0.33, MeOH); UV (MeOH) max (log ε) 259 (6.3), 212 (8.0); 
1H and 
13C NMR, COSY, 
HSQC data (Figures 4.28-4.31); 
1H NMR (700 MHz, CDCl3) 7.10-7.35 (5H, m, H-4/ 
H-8), 6.06 (1H, s, NH), 5.42 (1H, dt, J = 15.0, 7.2 Hz, H-5), 5.29 (1H, dt, J = 14.6, 
6.7Hz, H-4),  5.09 (1H, s, H-2), 3.66 (1H, m, H-2), 3.46 (1H, dt, J = 14.0, 6.1, 3.1 Hz, 
H-1b), 3.10 (1H, dt, J = 13.3, 6.0 Hz, H-1a), 2.10 (1H, dt, J = 12.7, 6.0 Hz, H-3b), 
1.96 (2H, m, H-6), 1.95 (1H, m, H-3a), 1.41 (9H, s, H-11/H-13), 1.24-1.30 (8H, m, 
H-7/H-10), 1.29 (2H, m, H-11), 1.24 (2H, m, H-12), 0.86 (3H, t, J = 7.1,  H-13); 
13C 
NMR (175 MHz, CDCl3) 170.8 (C, C-1), 155.6 (C, C-9), 135.8 (CH, C-5), 127.0-
130.0 (5C, CH, C-4/C-8), 124.6 (CH, C-4), 70.1 (CH, C-2), 59.0 (C, C-1), 45.0 
(CH2, C-1), 38.3 (CH2, C-3), 32.1 (CH2, C-12), 29.0-30.0 (4C, CH2, C-7/C-10), 28.5 
(9C, CH3, C-11/C-13), 22.9 (CH2, C-11), 14.3 (CH3, C-13); HRESIMS [M+Na]
+ m/z 
469.3036; (calcd for C26H42N2O4Na, 469.3042). 
R-BPG-(1R)-aminotridec-(4E)-en-2-ol  (6b).  Amorphous  solid;  [ʱ]
30
D  -35.5  (c  = 
0.33, MeOH); UV (MeOH) max (log ε) 258 (6.4), 215 (8.0); 
1H NMR (700 MHz, 154 
 
 
CDCl3) 7.20-7.35 (5H, m, H-4/ H-8), 6.19 (1H, s, NH), 5.45 (1H, dt, J = 14.3, 6.1 
Hz, H-5), 5.30 (1H, dt, J = 14.6, 7.0 Hz, H-4), 5.09 (1H, s, H-2),  3.61 (1H, m, H-2), 
3.44 (1H, m, H-1b), 3.10 (1H, ddd, J = 14.0, 7.6, 5.3 Hz, H-1a), 2.10 (1H, m, H-3b), 
2.05 (1H, m, H-3a), 1.96 (2H, m, H-3a), 1.39 (9H, s, H-11/H-13), 1.23-1.28 (12H, m, 
H-7/H-12), 0.86 (3H, t, 6.7 Hz, H-13); HRESIMS [M+Na]
+ m/z 469.3022; (calcd for 
C26H42N2O4Na, 469.3042). 
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The investigation of marine natural products chemistry has a rich history and has 
resulted  in  the  discovery  of  many  promising  natural  products  for  research  and 
treatment  of  human  diseases,  as  well  as  agriculture.  The  structural  assignment  of 
“inspirational  molecular  structures”  on  a  nanomolar  scale  became  possible  only 
recently, due to spectacular advances in NMR techniques. The focus of this research 
was to identify biologically active natural products through the application of modern 
NMR spectroscopy.  To perform this task effectively and avoid re-isolation of known 
compounds,  biological  and  chemical  screening  was  combined  with  a  dereplication 
approach and led to the isolation of new biologically active compounds.  
The application of biological screening in parallel with 
1H and diffusion-ordered 
(DOSY) NMR analysis of tunicate extracts led to the identification of differentially 
brominated rubrolides, of which four are new and two are known. The analysis of 1D 
and 2D NMR and HRESIMS data permitted determination of the bromination pattern, 
while biological evaluation established their moderate activity against MRSA, as well 
as Staphylococcus epidermidis. 
Structural assignment of mandelalides A-D, isolated in sub-milligram quantities 
from a new Lissoclinum species of tunicate, was accomplished only after acquisition 
of NMR  data on a 700 MHz spectrometer  equipped with  a 5 mm cryogenic 
13C-
observe probe. While a suite of standard modern NMR experiments was implemented 
to assign the planar structure of mandelalides, DQFCOSY, TOCSY, HETLOC and 
gated  decoupled 
13C  NMR  experiments  were  performed  to  establish  the  relative 
configuration of the mandelalides. Moreover, the applicability of quantitative ROESY 
and RDC (residual dipolar coupling) techniques were also explored for the assignment 
of relative configuration. Determination of absolute configuration was accomplished 
on mandelalide A, after degradative methanolysis of the natural product and chiral 
GC-MS  analysis.  Biological  investigation  of  mandelalides  A-D  indicated  potent 
cytotoxicity  against  mouse  Neuro-2A  neuroblastoma  and  human  NCI-H460  lung 
cancer cell lines, once again confirming that tunicates are a prolific source of new, 
chemically  interesting  and  biologically  relevant  natural  products.  Nanomolar 159 
 
 
cytotoxicity in parallel with the unusual skeleton of the mandelalides motivates for 
further investigation of their biological activity and biogenetic origin. This will be 
facilitated in the short term by re-collection of the Lissoclinum tunicate species to 
obtain additional quantities of the mandelalides, and enable the identification (through 
metagenomic  sequencing)  and  possible  cultivation  of  their  microbial  producer. 
Concurrently, these metabolites have been identified as targets for total syntheses that 
are already in progress.     
The extraction and fractionation of two South African Pseudodistoma species led 
to  identification  of  linear  and  cyclized  amino  alcohols,  analogs  of  the  Phase  I 
anticancer compound spisulosine. Due to their polarity and close structural similarity, 
parent fractions containing these metabolites were derivatized to produce N-Boc and 
or  N-Boc phenylglycine analogs  and thus  enable efficient separation and potential 
assignment  of  configuration.  The  N-Boc-phenylglycine  derivatized  amino  alcohols 
appeared to be known compounds isolated previously from tunicates. However, the N-
Boc analogues established an unprecedented group of natural products, presumably 
with  the  hydroxyl  group  of  precursor  linear  amino  alcohols  being  the  point  of 
cyclization to form a tetrahydropyran moiety. Knowing that Pseudodistoma species 
are abundant on White Sands Reef in Algoa Bay, South Africa, we will attempt to 
recollect  the  organism  and  re-isolate  these  natural  products  for  configurational 
assignment and further biological evaluation. In parallel, a synthetic approach may be 
developed to obtain individual compounds and potentially circumvent the problem of 
challenging chromatographic separations of multiple close analogs. 
This  research  has  confirmed  that  the  application  of  parallel  chemical  and 
biological  screening  can  lead  to  the  identification  of  new,  biologically-relevant 
chemical entities that would not otherwise be identified.  Isolation of these cytotoxic 
and antibacterial metabolites contributes to recognition of the importance of marine 
sources  in  the  drug  discovery  process,  and  increases  the  pool  of  ascidian-derived 
natural  product  drug  leads.  Application  of  very  recent  developments  in  NMR 
techniques using a 700  MHz spectrometer equipped with  a 
13C-observe cryoprobe 160 
 
 
contributes  to  the  frontier  of  natural  product  structural  assignment,  which  has 
expanded  to  permit  structure  elucidation  on  sub-milligram  sample  quantities. 
 
 
 